Table of Contents

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

(Mark One)

x                              QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended March 31, 2013

 

OR

 

o                                 TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ____________ to ____________

 

Commission file number 1-12993

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

(Exact name of registrant as specified in its charter)

 

Maryland

 

95-4502084

(State or other jurisdiction of
incorporation or organization)

 

(I.R.S. Employer Identification Number)

 

385 East Colorado Boulevard, Suite 299, Pasadena, California 91101

(Address of principal executive offices) (Zip code)

 

(626) 578-0777

(Registrant’s telephone number, including area code)

 

N/A
(Former name, former address and former fiscal year, if changed since last report)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days.  Yes x     No o

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes x   No  o

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.  See the definitions of “large accelerated filer,” “accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer x

Accelerated filer o

Non-accelerated filer o   (Do not check if a smaller reporting company)

Smaller reporting company o

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o     No x

 

As of May 2, 2013, 63,837,404 shares of common stock, par value $.01 per share, were outstanding.

 



Table of Contents

 

TABLE OF CONTENTS

 

 

 

Page

PART I – FINANCIAL INFORMATION

 

 

 

 

Item 1.

FINANCIAL STATEMENTS (UNAUDITED)

 

 

 

 

 

Condensed Consolidated Balance Sheets as of March 31, 2013, and December 31, 2012

3

 

 

 

 

Condensed Consolidated Statements of Income for the Three Months Ended March 31, 2013 and 2012

4

 

 

 

 

Condensed Consolidated Statements of Comprehensive Income for the Three Months Ended March 31, 2013 and 2012

5

 

 

 

 

Condensed Consolidated Statement of Changes in Stockholders’ Equity and Noncontrolling Interests for the Three Months Ended March 31, 2013

6

 

 

 

 

Condensed Consolidated Statements of Cash Flows for the Three Months Ended March 31, 2013 and 2012

7

 

 

 

 

Notes to Condensed Consolidated Financial Statements

9

 

 

 

Item 2.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

35

 

 

 

Item 3.

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

79

 

 

 

Item 4.

CONTROLS AND PROCEDURES

80

 

 

 

PART II – OTHER INFORMATION

 

 

 

 

Item 1A.

RISK FACTORS

80

 

 

 

Item 6.

EXHIBITS

81

 

 

 

SIGNATURES

82

 



Table of Contents

 

PART I FINANCIAL INFORMATION

 

Item 1.                           FINANCIAL STATEMENTS (UNAUDITED)

 

Alexandria Real Estate Equities, Inc.
Condensed Consolidated Balance Sheets
(In thousands)
(Unaudited)

 

 

 

March 31,

 

December 31,

 

 

 

2013

 

2012

 

Assets

 

 

 

 

 

Investments in real estate, net

 

$

6,375,182

 

$

6,424,578

 

Cash and cash equivalents

 

87,001

 

140,971

 

Restricted cash

 

30,008

 

39,947

 

Tenant receivables

 

9,261

 

8,449

 

Deferred rent

 

170,100

 

170,396

 

Deferred leasing and financing costs, net

 

159,872

 

160,048

 

Investments

 

123,543

 

115,048

 

Other assets

 

135,952

 

90,679

 

Total assets

 

$

7,090,919

 

$

7,150,116

 

 

 

 

 

 

 

Liabilities, Noncontrolling Interests, and Equity

 

 

 

 

 

Secured notes payable

 

$

730,714

 

$

716,144

 

Unsecured senior notes payable

 

549,816

 

549,805

 

Unsecured senior line of credit

 

554,000

 

566,000

 

Unsecured senior bank term loans

 

1,350,000

 

1,350,000

 

Accounts payable, accrued expenses, and tenant security deposits

 

367,153

 

423,708

 

Dividends payable

 

43,955

 

41,401

 

Total liabilities

 

3,595,638

 

3,647,058

 

 

 

 

 

 

 

Commitments and contingencies

 

 

 

 

 

 

 

 

 

 

 

Redeemable noncontrolling interests

 

14,534

 

14,564

 

 

 

 

 

 

 

Alexandria Real Estate Equities, Inc.’s stockholders’ equity:

 

 

 

 

 

Series D Convertible Preferred Stock

 

250,000

 

250,000

 

Series E Preferred Stock

 

130,000

 

130,000

 

Common stock

 

633

 

632

 

Additional paid-in capital

 

3,075,860

 

3,086,052

 

Accumulated other comprehensive loss

 

(22,890

)

(24,833

)

Alexandria Real Estate Equities, Inc.’s stockholders’ equity

 

3,433,603

 

3,441,851

 

Noncontrolling interests

 

47,144

 

46,643

 

Total equity

 

3,480,747

 

3,488,494

 

Total liabilities, noncontrolling interests, and equity

 

$

7,090,919

 

$

7,150,116

 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

3



Table of Contents

 

Alexandria Real Estate Equities, Inc.
Condensed Consolidated Statements of Income
(In thousands, except per share amounts)
(Unaudited)

 

 

 

Three Months Ended
March 31,

 

 

 

2013

 

2012

 

Revenues:

 

 

 

 

 

Rental

 

$

111,776

 

$

101,201

 

Tenant recoveries

 

35,611

 

31,882

 

Other income

 

2,993

 

2,628

 

Total revenues

 

150,380

 

135,711

 

 

 

 

 

 

 

Expenses:

 

 

 

 

 

Rental operations

 

45,224

 

40,453

 

General and administrative

 

11,648

 

10,357

 

Interest

 

18,020

 

16,226

 

Depreciation and amortization

 

46,065

 

41,786

 

Loss on early extinguishment of debt

 

 

623

 

Total expenses

 

120,957

 

109,445

 

 

 

 

 

 

 

Income from continuing operations

 

29,423

 

26,266

 

 

 

 

 

 

 

Income from discontinued operations, net

 

814

 

4,645

 

 

 

 

 

 

 

Gain on sale of land parcel

 

 

1,864

 

Net income

 

30,237

 

32,775

 

 

 

 

 

 

 

Net income attributable to noncontrolling interests

 

982

 

711

 

Dividends on preferred stock

 

6,471

 

7,483

 

Preferred stock redemption charge

 

 

5,978

 

Net income attributable to unvested restricted stock awards

 

342

 

235

 

Net income attributable to Alexandria Real Estate Equities, Inc.’s common stockholders

 

$

22,442

 

$

18,368

 

 

 

 

 

 

 

Earnings per share attributable to Alexandria Real Estate Equities, Inc.’s common stockholders – basic and diluted:

 

 

 

 

 

Continuing operations

 

$

0.35

 

$

0.22

 

Discontinued operations, net

 

0.01

 

0.08

 

Earnings per share – basic and diluted

 

$

0.36

 

$

0.30

 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

4



Table of Contents

 

Alexandria Real Estate Equities, Inc.

Condensed Consolidated Statements of Comprehensive Income

(In thousands)

(Unaudited)

 

 

 

Three Months Ended
March 31,

 

 

 

2013

 

2012

 

Net income

 

$

30,237

 

$

32,775

 

Other comprehensive income:

 

 

 

 

 

Unrealized gains (losses) on marketable securities:

 

 

 

 

 

Unrealized holding gains arising during the period

 

316

 

674

 

Reclassification adjustment for gains included in net income

 

(272

)

(924

)

Unrealized gains (losses) on marketable securities, net

 

44

 

(250

)

Unrealized gains on interest rate swaps:

 

 

 

 

 

Unrealized interest rate swap losses arising during the period

 

(133

)

(4,073

)

Reclassification adjustment for amortization of interest expense included in net income

 

4,308

 

5,775

 

Unrealized gains on interest rate swap agreements, net

 

4,175

 

1,702

 

Foreign currency translation (losses) gains

 

(2,360

)

9,959

 

Total other comprehensive income

 

1,859

 

11,411

 

Comprehensive income

 

32,096

 

44,186

 

Less: comprehensive income attributable to noncontrolling interests

 

(898

)

(699

)

Comprehensive income attributable to Alexandria Real Estate Equities, Inc.’s common stockholders

 

$

31,198

 

$

43,487

 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

5



Table of Contents

 

Alexandria Real Estate Equities, Inc.

Condensed Consolidated Statement of Changes in Stockholders’ Equity and Noncontrolling Interests

(Dollars in thousands)

(Unaudited)

 

 

 

Alexandria Real Estate Equities, Inc.’s Stockholders’ Equity

 

 

 

 

 

 

 

 

 

Series D
Convertible
Preferred
Stock

 

Series E
Preferred
Stock

 

Number of
Common
Shares

 

Common
Stock

 

Additional
Paid-In Capital

 

Retained
Earnings

 

Accumulated
Other
Comprehensive
Loss

 

Noncontrolling
Interests

 

Total
Equity

 

Redeemable
Noncontrolling
Interests

 

Balance as of December 31, 2012

 

$

250,000

 

$

130,000

 

63,244,645

 

$

632

 

$

3,086,052

 

$

 

$

(24,833

)

$

46,643

 

$

3,488,494

 

$

14,564

 

Net income

 

 

 

 

 

 

29,255

 

 

714

 

29,969

 

268

 

Unrealized loss on marketable securities

 

 

 

 

 

 

 

44

 

 

44

 

 

Unrealized gain on interest rate swap agreements

 

 

 

 

 

 

 

4,175

 

 

4,175

 

 

Foreign currency translation loss

 

 

 

 

 

 

 

(2,276

)

(84

)

(2,360

)

 

Contributions by noncontrolling interests

 

 

 

 

 

 

 

 

 

 

 

Distributions to noncontrolling interests

 

 

 

 

 

 

 

 

(129

)

(129

)

(298

)

Issuances pursuant to stock plan

 

 

 

72,651

 

1

 

5,269

 

 

 

 

5,270

 

 

Dividends declared on common stock

 

 

 

 

 

 

(38,245

)

 

 

(38,245

)

 

Dividends declared on preferred stock

 

 

 

 

 

 

(6,471

)

 

 

(6,471

)

 

Distributions in excess of earnings

 

 

 

 

 

(15,461

)

15,461

 

 

 

 

 

Balance as of March 31, 2013

 

$

250,000

 

$

130,000

 

63,317,296

 

$

633

 

$

3,075,860

 

$

 

$

(22,890

)

$

47,144

 

$

3,480,747

 

$

14,534

 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

6



Table of Contents

 

Alexandria Real Estate Equities, Inc.
Condensed Consolidated Statements of Cash Flows
(In thousands)
(Unaudited)

 

 

 

Three Months Ended

 

 

 

March 31,

 

 

 

2013

 

2012

 

Operating Activities

 

 

 

 

 

Net income

 

$

30,237

 

$

32,775

 

Adjustments to reconcile net income to net cash provided by operating activities:

 

 

 

 

 

Depreciation and amortization

 

46,995

 

43,405

 

Loss on early extinguishment of debt

 

 

623

 

Gain on sale of land parcel

 

 

(1,864

)

Loss on sale of real estate

 

340

 

 

Amortization of loan fees and costs

 

2,386

 

2,643

 

Amortization of debt premiums/discounts

 

115

 

179

 

Amortization of acquired above and below market leases

 

(830

)

(800

)

Deferred rent

 

(6,198

)

(8,796

)

Stock compensation expense

 

3,349

 

3,293

 

Equity in loss related to investments

 

 

26

 

Gain on sales of investments

 

(446

)

(1,999

)

Loss on sales of investments

 

386

 

1

 

Changes in operating assets and liabilities:

 

 

 

 

 

Restricted cash

 

1,506

 

862

 

Tenant receivables

 

(818

)

(1,237

)

Deferred leasing costs

 

(11,757

)

(7,011

)

Other assets

 

(7,302

)

(2,411

)

Accounts payable, accrued expenses, and tenant security deposits

 

(10,722

)

(10,004

)

Net cash provided by operating activities

 

47,241

 

49,685

 

 

 

 

 

 

 

Investing Activities

 

 

 

 

 

Proceeds from sale of properties

 

80,203

 

 

Additions to properties

 

(139,245

)

(120,585

)

Purchase of properties

 

 

(19,946

)

Change in restricted cash related to construction projects

 

(17

)

(1,400

)

Distribution from unconsolidated real estate entity

 

 

22,250

 

Contributions to unconsolidated real estate entity

 

(2,074

)

(3,914

)

Additions to investments

 

(10,363

)

(5,438

)

Proceeds from investments

 

1,972

 

4,785

 

Net cash used in investing activities

 

 

(69,524

)

 

(124,248

)

 

7



Table of Contents

 

Alexandria Real Estate Equities, Inc.
Condensed Consolidated Statements of Cash Flows (continued)
(In thousands)
(Unaudited)

 

 

 

Three Months Ended

 

 

 

March 31,

 

 

 

2013

 

2012

 

Financing Activities

 

 

 

 

 

Borrowings from secured notes payable

 

$

17,215

 

$

 

Repayments of borrowings from secured notes payable

 

(2,749

)

(2,688

)

Proceeds from issuance of unsecured senior notes payable

 

 

544,649

 

Principal borrowings from unsecured senior line of credit

 

179,000

 

248,000

 

Repayments of borrowings from unsecured senior line of credit

 

(191,000

)

(451,000

)

Repayment of unsecured senior bank term loan

 

 

(250,000

)

Repurchase of unsecured senior convertible notes

 

 

(83,801

)

Proceeds from issuance of Series E Preferred Stock

 

 

124,868

 

Change in restricted cash related to financings

 

8,656

 

(15,955

)

Deferred financing costs paid

 

(46

)

(5,300

)

Proceeds from exercise of stock options

 

 

112

 

Dividends paid on common stock

 

(35,687

)

(30,386

)

Dividends paid on preferred stock

 

(6,471

)

(7,089

)

Distributions to redeemable noncontrolling interests

 

 

(315

)

Contributions by noncontrolling interests

 

 

625

 

Distributions to noncontrolling interests

 

(427

)

(369

)

Net cash (used in) provided by financing activities

 

(31,509

)

71,351

 

 

 

 

 

 

 

Effect of foreign exchange rate changes on cash and cash equivalents

 

(178

)

2,034

 

 

 

 

 

 

 

Net decrease in cash and cash equivalents

 

(53,970

)

(1,178

)

Cash and cash equivalents at beginning of period

 

140,971

 

78,539

 

Cash and cash equivalents at end of period

 

$

87,001

 

$

77,361

 

 

 

 

 

 

 

Supplemental Disclosure of Cash Flow Information

 

 

 

 

 

Cash paid during the period for interest, net of interest capitalized

 

$

9,964

 

$

11,976

 

 

 

 

 

 

 

Non-Cash Investing Activities

 

 

 

 

 

Note receivable from sale of real estate

 

$

38,820

 

$

 

Change in accrued capital expenditures

 

$

(37,045

)

$

9,396

 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

8



Table of Contents

 

Alexandria Real Estate Equities, Inc.
Notes to Condensed Consolidated Financial Statements
(Unaudited)

 

1.                 Background

 

As used in this quarterly report on Form 10-Q, references to the “Company,” “Alexandria,” “we,” “our,” and “us” refer to Alexandria Real Estate Equities, Inc. and its subsidiaries.

 

Alexandria Real Estate Equities, Inc. (NYSE: ARE), a self-administered and self-managed investment-grade real estate investment trust (“REIT”), is the largest and leading REIT focused principally on owning, operating, developing, redeveloping, and acquiring high-quality, sustainable real estate for the broad and diverse life science industry.  Alexandria’s client tenants span the life science industry, including renowned academic and medical institutions, multinational pharmaceutical companies, public and private biotechnology entities, United States (“U.S.”) government research agencies, medical device companies, industrial biotech companies, venture capital firms, and life science product and service companies.  For additional information on Alexandria Real Estate Equities, Inc., please visit www.are.com.

 

2.                 Basis of presentation

 

We have prepared the accompanying interim condensed consolidated financial statements in accordance with U.S. generally accepted accounting principles (“GAAP”) and in conformity with the rules and regulations of the Securities and Exchange Commission (“SEC”).  In our opinion, the interim condensed consolidated financial statements presented herein reflect all adjustments that are necessary to fairly present the interim condensed consolidated financial statements.  The results of operations for the interim period are not necessarily indicative of the results that may be expected for the year ending December 31, 2013.  These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and the notes thereto included in our annual report on Form 10-K for the year ended December 31, 2012.

 

The accompanying condensed consolidated financial statements include the accounts of Alexandria Real Estate Equities, Inc. and its subsidiaries.  All significant intercompany balances and transactions have been eliminated.

 

We hold interests, together with certain third parties, in companies that we consolidate in our financial statements.  We consolidate the companies because we exercise significant control over major decisions by these entities, such as investment activity and changes in financing.

 

Use of estimates

 

The preparation of condensed consolidated financial statements in conformity with GAAP requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, and equity; the disclosure of contingent assets and liabilities as of the date of the condensed consolidated financial statements; and the amounts of revenues and expenses during the reporting period.  Actual results could materially differ from those estimates.

 

Reclassifications

 

Certain prior period amounts have been reclassified to conform to the current period presentation.

 

9



Table of Contents

 

2.                 Basis of presentation (continued)

 

Investments in real estate, net, and discontinued operations

 

We recognize assets acquired (including the intangible value of above or below market leases, acquired in-place leases, client tenant relationships, and other intangible assets or liabilities), liabilities assumed, and any noncontrolling interest in an acquired entity at their fair value as of the acquisition date.  If there is a bargain fixed rate renewal option for the period beyond the non-cancelable lease term, we evaluate factors such as the business conditions in the industry in which the lessee operates, the economic conditions in the area in which the property is located, and the ability of the lessee to sublease the property during the renewal term, in order to determine the likelihood that the lessee will renew.  When we determine there is reasonable assurance that such bargain purchase option will be exercised, we consider its impact in determining the intangible value of such lease and its related amortization period.  The value of tangible assets acquired is based upon our estimation of value on an “as if vacant” basis.  The value of acquired in-place leases includes the estimated carrying costs during the hypothetical lease-up period and other costs that would have been incurred to execute similar leases, considering market conditions at the acquisition date of the acquired in-place lease.  We assess the fair value of tangible and intangible assets based on numerous factors, including estimated cash flow projections that utilize appropriate discount and capitalization rates and available market information.  Estimates of future cash flows are based on a number of factors, including the historical operating results, known trends, and market/economic conditions that may affect the property.  We also recognize the fair values of assets acquired, the liabilities assumed, and any noncontrolling interest in acquisitions of less than a 100% interest when the acquisition constitutes a change in control of the acquired entity.  Acquisition-related costs and restructuring costs are expensed as incurred.

 

The values allocated to land improvements, tenant improvements, equipment, buildings, and building improvements are depreciated on a straight-line basis using an estimated life of 20 years for land improvements, the respective lease term for tenant improvements, the estimated useful life for equipment, and the shorter of the term of the respective ground lease and up to 40 years for buildings and building improvements.  The values of acquired above and below market leases are amortized over the lives of the related leases and recognized as either an increase (for below market leases) or a decrease (for above market leases) to rental income.  The values of acquired in-place leases are classified in other assets in the accompanying condensed consolidated balance sheets, and amortized over the remaining terms of the related leases.

 

We are required to capitalize project costs, including predevelopment costs, interest, property taxes, insurance, and other costs directly related and essential to the acquisition, development, redevelopment, or construction of a project.  Capitalization of development, redevelopment, and construction costs is required while activities are ongoing to prepare an asset for its intended use.  Fluctuations in our development, redevelopment, and construction activities could result in significant changes to total expenses and net income.  Costs incurred after a project is substantially complete and ready for its intended use are expensed as incurred.  Should development, redevelopment, or construction activity cease, interest, property taxes, insurance, and certain other costs would no longer be eligible for capitalization and would be expensed as incurred.  Expenditures for repairs and maintenance are expensed as incurred.

 

A property is classified as “held for sale” when all of the following criteria for a plan of sale have been met: (1) management, having the authority to approve the action, commits to a plan to sell the property; (2) the property is available for immediate sale in its present condition, subject only to terms that are usual and customary; (3) an active program to locate a buyer and other actions required to complete the plan to sell have been initiated; (4) the sale of the property is probable and is expected to be completed within one year; (5) the property is being actively marketed for sale at a price that is reasonable in relation to its current fair value; and (6) actions necessary to complete the plan of sale indicate that it is unlikely that significant changes to the plan will be made or that the plan will be withdrawn.  When all of these criteria have been met, the property is classified as “held for sale”; if (1) the operations and cash flows of the property have been or will be eliminated from the ongoing operations, and (2) we will not have any significant continuing involvement in the operations of the property after the sale, then its operations, including any interest expense directly attributable to it, are classified as discontinued operations in our condensed consolidated statements of income, and amounts for all prior periods presented are reclassified from continuing operations to discontinued operations.  Depreciation of assets ceases upon designation of a property as “held for sale.”

 

10



Table of Contents

 

2.                 Basis of presentation (continued)

 

Impairment of long-lived assets

 

Long-lived assets to be held and used, including our rental properties, land held for future development, construction in progress, and intangibles, are individually evaluated for impairment when conditions exist that may indicate that the carrying amount of a long-lived asset may not be recoverable.  The carrying amount of a long-lived asset to be held and used is not recoverable if it exceeds the sum of the undiscounted cash flows expected to result from the use and eventual disposition of the asset.  Impairment indicators or triggering events for long-lived assets to be held and used, including our rental properties, land held for future development, and construction in progress, are assessed by project and include significant fluctuations in estimated net operating income, occupancy changes, significant near-term lease expirations, current and historical operating and/or cash flow losses, construction costs, estimated completion dates, rental rates, and other market factors.  We assess the expected undiscounted cash flows based upon numerous factors, including, but not limited to, construction costs, available market information, current and historical operating results, known trends, current market/economic conditions that may affect the property, and our assumptions about the use of the asset, including, if necessary, a probability-weighted approach if multiple outcomes are under consideration.  Upon determination that an impairment has occurred, a write-down is recognized to reduce the carrying amount to its estimated fair value.  If an impairment loss is not required to be recognized, the recognition of depreciation is adjusted prospectively, as necessary, to reduce the carrying amount of the real estate to its estimated disposition value over the remaining period that the real estate is expected to be held and used.  We may adjust depreciation of properties that are expected to be disposed of or redeveloped prior to the end of their useful lives.

 

We use a “held for sale” impairment model for our properties classified as “held for sale.”  The “held for sale” impairment model is different from the held and used impairment model.  Under the “held for sale” impairment model, an impairment loss is recognized if the carrying amount of the long-lived asset classified as “held for sale” exceeds its fair value less cost to sell.  Because of these two different models, it is possible for a long-lived asset previously classified as held and used to require the recognition of an impairment charge upon classification as “held for sale.”

 

Investments

 

We hold equity investments in certain publicly traded companies and privately held entities primarily involved in the life science industry.  All of our investments in actively traded public companies are considered “available for sale” and are reflected in the accompanying condensed consolidated balance sheets at fair value.  Fair value has been determined based upon the closing price as of each balance sheet date, with unrealized gains and losses shown as a separate component of comprehensive income.  The classification of each investment is determined at the time each investment is made, and such determination is reevaluated at each balance sheet date.  The cost of each investment sold is determined by the specific identification method, with net realized gains or losses classified in other income in the accompanying condensed consolidated statements of income.  Investments in privately held entities are generally accounted for under the cost method when our interest in the entity is so minor that we have virtually no influence over the entity’s operating and financial policies.  Certain investments in privately held entities are accounted for under the equity method when our interest in the entity is not deemed so minor that we have virtually no influence over the entity’s operating and financial policies.  Under the equity method of accounting, we recognize our investment initially at cost and adjust the carrying amount of the investment to recognize our share of the earnings or losses of the investee subsequent to the date of our investment.  Additionally, we limit our ownership percentage in the voting stock of each individual entity to less than 10%.  As of March 31, 2013, and December 31, 2012, our ownership percentage in the voting stock of each individual entity was less than 10%.

 

Individual investments are evaluated for impairment when changes in conditions may indicate an impairment exists.  The factors that we consider in making these assessments include market prices, market conditions, available financing, prospects for favorable or unfavorable clinical trial results, new product initiatives, and new collaborative agreements.  If there are no identified events or changes in circumstances that would have an adverse effect on our cost method investments, we do not estimate the investment’s fair value.  For all of our investments, if a decline in the fair value of an investment below the carrying value is determined to be other than temporary, such investment is written down to its estimated fair value with a non-cash charge to current earnings.

 

11



Table of Contents

 

2.      Basis of presentation (continued)

 

Income taxes

 

We are organized and qualify as a REIT pursuant to the Internal Revenue Code of 1986, as amended (the “Code”).  Under the Code, a REIT that distributes 100% of its REIT taxable income as a dividend to its shareholders each year and that meets certain other conditions is not subject to federal income taxes, but could be subject to certain state and local taxes.  We have distributed 100% or more of our taxable income.  Therefore, no provision for federal income taxes is required.  We file tax returns, including returns for our subsidiaries, with federal, state, and local jurisdictions, including jurisdictions located in the U.S., Canada, India, China, and other international locations.  Our tax returns are subject to examination in various jurisdictions for the calendar years 2008 through 2012.

 

We recognize tax benefits of uncertain tax positions only if it is more likely than not that the tax position will be sustained, based solely on its technical merits, with the taxing authority having full knowledge of all relevant information.  The measurement of a tax benefit for an uncertain tax position that meets the “more likely than not” threshold is based on a cumulative probability model under which the largest amount of tax benefit recognized is the amount with a greater than 50% likelihood of being realized upon ultimate settlement with the taxing authority having full knowledge of all the relevant information.  As of March 31, 2013, there were no unrecognized tax benefits.  We do not anticipate a significant change to the total amount of unrecognized tax benefits within the next 12 months.

 

Interest expense and penalties, if any, would be recognized in the first period during which the interest or penalty would begin accruing, according to the provisions of the relevant tax law at the applicable statutory rate of interest.  We did not incur any material tax-related interest expense or penalties for the three months ended March 31, 2013 and 2012.

 

Interest income

 

Interest income was approximately $1.3 million and $0.6 million during the three months ended March 31, 2013 and 2012, respectively.  Interest income is classified in other income in the accompanying condensed consolidated statements of income.

 

Recognition of rental income and tenant recoveries

 

Rental income from leases is recognized on a straight-line basis over the respective lease terms.  We classify amounts currently recognized as income, and expected to be received in later years, as an asset in deferred rent in the accompanying condensed consolidated balance sheets.  Amounts received currently, but recognized as income in future years, are classified in accounts payable, accrued expenses, and tenant security deposits in the accompanying condensed consolidated balance sheets.  We commence recognition of rental income at the date the property is ready for its intended use and the client tenant takes possession of or controls the physical use of the property.

 

Tenant recoveries related to reimbursement of real estate taxes, insurance, utilities, repairs and maintenance, and other operating expenses are recognized as revenue in the period during which the applicable expenses are incurred.

 

Tenant receivables consist primarily of amounts due for contractual lease payments, reimbursements of common area maintenance expenses, property taxes, and other expenses recoverable from client tenants.  Tenant receivables are expected to be collected within one year.  We maintain an allowance for estimated losses that may result from the inability of our client tenants to make payments required under the terms of the lease and for tenant recoveries due.  If a client tenant fails to make contractual payments beyond any allowance, we may recognize additional bad debt expense in future periods equal to the amount of uncollectible rent and deferred rent receivables arising from the straight-lining of rent.  As of March 31, 2013, and December 31, 2012, we had no allowance for estimated losses.

 

As of March 31, 2013, approximately 94% of our leases (on a rentable square footage basis) were triple net leases, requiring client tenants to pay substantially all real estate taxes, insurance, utilities, common area expenses, and other operating expenses (including increases thereto) in addition to base rent.  Approximately 96% of our leases (on a rentable square footage basis) contained effective annual rent escalations that were either fixed or based on a consumer price index or another index.  Additionally, approximately 92% of our leases (on a rentable square footage basis) provided for the recapture of certain capital expenditures.

 

12



Table of Contents

 

3.      Investments in real estate

 

Our investments in real estate, net, consisted of the following as of March 31, 2013, and December 31, 2012 (in thousands):

 

 

 

March 31, 2013

 

December 31, 2012

 

Land (related to rental properties)

 

$

516,957

 

$

522,664

 

Buildings and building improvements

 

4,955,207

 

4,933,314

 

Other improvements

 

163,864

 

189,793

 

Rental properties

 

5,636,028

 

5,645,771

 

Less: accumulated depreciation

 

(849,891

)

(875,035

)

Rental properties, net

 

4,786,137

 

4,770,736

 

 

 

 

 

 

 

Construction in progress (“CIP”)/current value-added projects:

 

 

 

 

 

Active development in North America

 

579,273

 

431,578

 

Investment in unconsolidated real estate entity

 

30,730

 

28,656

 

Active redevelopment in North America

 

141,470

 

199,744

 

Generic infrastructure/building improvement projects in North America

 

62,869

 

80,599

 

Active development and redevelopment in Asia

 

101,357

 

101,602

 

 

 

915,699

 

842,179

 

 

 

 

 

 

 

Subtotal

 

5,701,836

 

5,612,915

 

 

 

 

 

 

 

Land/future value-added projects:

 

 

 

 

 

Land subject to sale negotiations

 

45,378

 

 

Land undergoing preconstruction activities (additional CIP) in North America

 

305,300

 

433,310

 

Land held for future development in North America

 

231,130

 

296,039

 

Land held for future development/land undergoing preconstruction activities (additional CIP) in Asia

 

83,735

 

82,314

 

 

 

673,346

 

811,663

 

 

 

 

 

 

 

Investments in real estate, net

 

$

6,375,182

 

$

6,424,578

 

 

Land held for future development represents real estate we plan to develop in the future but on which, as of each period presented, no construction or preconstruction activities were ongoing.  As a result, interest, property taxes, insurance, and other costs are expensed as incurred.  As of March 31, 2013, and December 31, 2012, we held land in North America supporting an aggregate of 3.8 million and 4.7 million rentable square feet of future ground-up development, respectively.  Additionally, as of March 31, 2013, and December 31, 2012, we held land undergoing preconstruction activities in North America totaling 1.9 million and 2.9 million rentable square feet, respectively.  Land undergoing preconstruction activities (consisting of Building Information Modeling [BIM or 3-D virtual modeling], design development and construction drawings, sustainability and energy optimization review, budgeting, planning for future site and infrastructure work, and other activities prior to commencement of vertical construction of aboveground shell and core improvements) is also classified as construction in progress.  Our objective with preconstruction is to reduce the time it takes to deliver projects to prospective client tenants.  Project costs are capitalized as a cost of the project during periods when activities necessary to prepare an asset for its intended use are in progress.  We generally will not commence ground-up development of any parcels undergoing preconstruction activities without first securing pre-leasing for such space.  If vertical aboveground construction is not initiated at completion of preconstruction activities, the land parcel will be classified as land held for future development.  The largest project primarily included in land undergoing preconstruction consists of our 1.2 million developable square feet at Alexandria Center™ at Kendall Square in East Cambridge, Massachusetts.

 

Real estate asset sales

 

During the three months ended March 31, 2013, we sold six properties in three separate transactions for aggregate consideration of approximately $124.3 million, at a net loss of approximately $0.3 million, which included an aggregate gain of approximately $0.1 million on the sale of two properties in the Suburban Washington, D.C. market, an aggregate loss of approximately $0.4 million on sale of three properties in the Greater Boston market, and no gain or loss on the sale of a property in the Seattle market.

 

13



Table of Contents

 

4.     Investments

 

We hold equity investments in certain publicly traded companies and privately held entities primarily involved in the life science industry.  Investments in “available for sale” securities with gross unrealized losses as of March 31, 2013, had been in a continuous unrealized loss position for less than 12 months.  We have the ability and intent to hold these investments for a reasonable period of time sufficient for the recovery of our investment.  We believe that these unrealized losses are temporary, and accordingly we have not recognized other-than-temporary impairment related to “available for sale” securities as of March 31, 2013.  As of March 31, 2013, and December 31, 2012, there were no unrealized losses in our investments in privately held entities.

 

The following table summarizes our investments as of March 31, 2013, and December 31, 2012 (in thousands):

 

 

 

March 31,

 

December 31,

 

 

 

2013

 

2012

 

“Available-for-sale” securities, cost basis

 

$

1,607

 

$

1,236

 

Gross unrealized gains

 

1,547

 

1,561

 

Gross unrealized losses

 

(29

)

(88

)

“Available-for-sale” securities, at fair value

 

3,125

 

2,709

 

Investments accounted for under cost method

 

120,412

 

112,333

 

Investments accounted for under equity method

 

6

 

6

 

Total investments

 

$

123,543

 

$

115,048

 

 

The following table outlines our net investment income, which is classified in other income in the accompanying condensed consolidated statements of income for the three months ended March 31, 2013 and 2012 (in thousands):

 

 

 

Three Months Ended March 31,

 

 

 

2013

 

2012

 

Equity in loss related to equity method investments

 

$

 

$

(26

)

Gross realized gains

 

446

 

1,999

 

Gross realized losses

 

(386

)

(1

)

Net investment income

 

$

60

 

$

1,972

 

 

 

 

 

 

 

Amount reclassified from accumulated other comprehensive income to realized gains, net

 

$

272

 

$

924

 

 

5.      Secured and unsecured senior debt

 

The following table summarizes our secured and unsecured senior debt and their respective principal maturities, as of March 31, 2013 (in thousands):

 

 

 

Fixed Rate/Hedged
Variable Rate

 

Unhedged
Variable Rate

 

Total
Consolidated

 

Percentage of
Total

 

Weighted Average
Interest Rate at
End of Period (1)

 

Weighted Average
Remaining Term
(Years)

 

Secured notes payable (2)

 

$

620,076

 

$

110,638

 

$

730,714

 

22.9

%

 

5.56

%

 

2.8

 

Unsecured senior notes payable (2)

 

549,816

 

 

549,816

 

17.3

 

 

4.61

 

 

9.0

 

Unsecured senior line of credit (3)

 

 

554,000

 

554,000

 

17.4

 

 

1.40

 

 

4.1

 

2016 Unsecured Senior Bank Term Loan (4)

 

750,000

 

 

750,000

 

23.6

 

 

2.39

 

 

3.3

 

2017 Unsecured Senior Bank Term Loan (5)

 

250,000

 

350,000

 

600,000

 

18.8

 

 

3.68

 

 

3.8

 

Total debt

 

$

2,169,892

 

$

1,014,638

 

$

3,184,530

 

100.0

%

 

3.57

%

 

4.4

 

Percentage of total debt

 

68%

 

32%

 

100%

 

 

 

 

 

 

 

 

 

 

(1)

Represents the contractual interest rate as of the end of the period plus the impact of debt premiums/discounts and our interest rate swap agreements. The weighted average interest rate excludes bank fees and amortization of loan fees.

(2)

Represents amounts net of unamortized premiums/discounts.

(3)

Total commitments available for borrowing aggregate $1.5 billion under our unsecured senior line of credit. As of March 31, 2013, we had approximately $0.9 billion available for borrowing under our unsecured senior line of credit. Weighted average remaining term assumes we exercise our sole option to extend the stated maturity date of April 30, 2016, by six months, twice, to April 30, 2017.

(4)

Assumes we exercise our sole option to extend the stated maturity date of June 30, 2015, by one year, to June 30, 2016.

(5)

Assumes we exercise our sole option to extend the stated maturity date of January 31, 2016, by one year, to January 31, 2017.

 

14



Table of Contents

 

5.      Secured and unsecured senior debt (continued)

 

The following table summarizes fixed rate/hedged variable and unhedged variable rate debt and their respective principal maturities, as of March 31, 2013 (dollars in thousands):

 

Debt

 

Stated Rate

 

Effective
Interest
Rate (1)

 

Maturity
Date

 

2013

 

2014

 

2015

 

2016

 

2017

 

Thereafter

 

Total

 

Secured notes payable

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Suburban Washington, D.C.

 

6.36

%

 

6.36

%

 

9/1/13

 

$

25,946

 

$

 

$

 

$

 

$

 

$

 

$

25,946

 

Greater Boston

 

5.26

 

 

5.59

 

 

4/1/14

 

2,898

 

208,683

 

 

 

 

 

211,581

 

Suburban Washington, D.C.

 

2.19

 

 

2.19

 

 

4/20/14

 

 

76,000

 

 

 

 

 

76,000

 

San Diego

 

6.05

 

 

4.88

 

 

7/1/14

 

95

 

6,458

 

 

 

 

 

6,553

 

San Diego

 

5.39

 

 

4.00

 

 

11/1/14

 

119

 

7,495

 

 

 

 

 

7,614

 

Seattle

 

6.00

 (2)

 

6.00

 

 

11/18/14

 

180

 

240

 

 

 

 

 

420

 

Suburban Washington, D.C.

 

5.64

 

 

4.50

 

 

6/1/15

 

87

 

138

 

5,788

 

 

 

 

6,013

 

San Francisco Bay Area

 

LIBOR+1.50

 

1.74

 

 

7/1/15

(3)

 

 

34,218

 

 

 

 

34,218

 

Greater Boston, San Francisco Bay Area, and San Diego

 

5.73

 

 

5.73

 

 

1/1/16

 

1,205

 

1,713

 

1,816

 

75,501

 

 

 

80,235

 

Greater Boston, San Diego, and Greater NYC

 

5.82

 

 

5.82

 

 

4/1/16

 

657

 

931

 

988

 

29,389

 

 

 

31,965

 

San Francisco Bay Area

 

6.35

 

 

6.35

 

 

8/1/16

 

1,734

 

2,487

 

2,652

 

126,715

 

 

 

133,588

 

San Diego, Suburban Washington, D.C., and Seattle

 

7.75

 

 

7.75

 

 

4/1/20

 

1,018

 

1,453

 

1,570

 

1,696

 

1,832

 

108,469

 

116,038

 

San Francisco Bay Area

 

6.50

 

 

6.50

 

 

6/1/37

 

16

 

17

 

18

 

19

 

20

 

773

 

863

 

Average/Total

 

5.50

%

 

5.56

 

 

 

 

33,955

 

305,615

 

47,050

 

233,320

 

1,852

 

109,242

 

731,034

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$1.5 billion unsecured senior line of credit

 

LIBOR+1.20% (4)

 

1.40

 

 

4/30/17

(5)

 

 

 

 

554,000

 

 

554,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2016 Unsecured Senior Bank Term Loan

 

LIBOR+1.75%

 

2.39

 

 

6/30/16

(6)

 

 

 

750,000

 

 

 

750,000

 

2017 Unsecured Senior Bank Term Loan

 

LIBOR+1.50%

 

3.68

 

 

1/31/17

(7)

 

 

 

 

600,000

 

 

600,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Unsecured senior notes payable (8)

 

4.60

%

 

4.61

 

 

4/1/22

 

 

250

 

 

 

 

550,000

 

550,250

 

Average/Subtotal

 

 

 

 

3.57

 

 

 

 

33,955

 

305,865

 

47,050

 

983,320

 

1,155,852

 

659,242

 

3,185,284

 

Unamortized discounts

 

 

 

 

 

 

 

 

(350

)

(78

)

(12

)

(44

)

(47

)

(223

)

(754

)

Average/Total

 

 

 

 

3.57

%

 

 

 

$

33,605

 

$

305,787

 

$

47,038

 

$

983,276

 

$

1,155,805

 

$

659,019

 

$

3,184,530

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balloon payments

 

 

 

 

 

 

 

 

$

25,757

 

$

297,330

 

$

39,946

 

$

980,029

 

$

1,154,000

 

$

653,791

 

$

3,150,853

 

Principal amortization

 

 

 

 

 

 

 

 

7,848

 

8,457

 

7,092

 

3,247

 

1,805

 

5,228

 

33,677

 

Total consolidated debt

 

 

 

 

 

 

 

 

$

33,605

 

$

305,787

 

$

47,038

 

$

983,276

 

$

1,155,805

 

$

659,019

 

$

3,184,530

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fixed rate/hedged variable rate debt

 

 

 

 

 

 

 

 

$

33,425

 

$

229,547

 

$

12,820

 

$

983,276

 

$

251,805

 

$

659,019

 

$

2,169,892

 

Unhedged variable rate debt

 

 

 

 

 

 

 

 

180

 

76,240

 

34,218

 

 

904,000

 

 

1,014,638

 

Total consolidated debt

 

 

 

 

 

 

 

 

$

33,605

 

$

305,787

 

$

47,038

 

$

983,276

 

$

1,155,805

 

$

659,019

 

$

3,184,530

 

 

(1)

Represents the contractual interest rate as of the end of the period plus the impact of debt premiums/discounts and our interest rate swap agreements. The weighted average interest rate excludes bank fees and amortization of loan fees.

(2)

Represents a loan assumed with the acquisition of a property. The interest rate is based upon 10-year U.S. treasury bills plus 3%, with a floor of 6% and a ceiling of 8.5%.

(3)

We have two, one-year options to extend the stated maturity date of July 1, 2015 to July 1, 2017.

(4)

In addition to the stated rate, we are subject to an annual facility fee of 0.25%.

(5)

Assumes we exercise our sole option to extend the stated maturity date of April 30, 2016, by six months, twice, to April 30, 2017.

(6)

Assumes we exercise our sole option to extend the stated maturity date of June 30, 2015, by one year, to June 30, 2016.

(7)

Assumes we exercise our sole option to extend the stated maturity date of January 31, 2016, by one year, to January 31, 2017.

(8)

Includes $550.0 million of our 4.60% unsecured senior notes payable due in April 2022, and $250,000 of our 8.00% unsecured senior convertible notes payable with a maturity date of April 15, 2014.

 

4.60% Unsecured senior notes payable

 

In February 2012, we completed a $550.0 million public offering of our unsecured senior notes payable at a stated interest rate of 4.60%.  The unsecured senior notes payable were priced at 99.915% of the principal amount with a yield to maturity of 4.61% and are due April 1, 2022.  The unsecured senior notes payable are unsecured obligations of the Company and are fully and unconditionally guaranteed by Alexandria Real Estate Equities, L.P., a 100% owned subsidiary of the Company.  The unsecured senior notes payable rank equally in right of payment with all other senior unsecured indebtedness.  However, the unsecured senior notes payable are effectively subordinated to existing and future mortgages and other secured indebtedness (to the extent of the value of the collateral securing such indebtedness) and to all existing and future preferred equity and liabilities, whether secured or unsecured, of the Company’s subsidiaries, other than Alexandria Real Estate Equities, L.P.  We used the net proceeds of this offering to prepay the outstanding principal balance of $250.0 million on our unsecured senior bank term loan (“2012 Unsecured Senior Bank Term Loan”) and to reduce the outstanding borrowings on our unsecured senior line of credit.

 

15



Table of Contents

 

5.     Secured and unsecured senior debt (continued)

 

The requirements of the key financial covenants under our unsecured senior notes payable as of March 31, 2013, are as follows:

 

Covenant Ratios (1)

 

Requirement

 

Total Debt to Total Assets

 

Less than or equal to 60%

 

Consolidated EBITDA to Interest Expense

 

Greater than or equal to 1.5x

 

Unencumbered Total Asset Value to Unsecured Debt

 

Greater than or equal to 150%

 

Secured Debt to Total Assets

 

Less than or equal to 40%

 

 

(1)

For a definition of the ratios used in the table above, refer to the indenture dated February 29, 2012 (“Indenture”), which governs the unsecured senior notes payable, which was filed as an exhibit to our Current Report on Form 8-K filed with the SEC on February 29, 2012.

 

In addition, the terms of the Indenture, among other things, limit the ability of the Company, Alexandria Real Estate Equities, L.P., and the Company’s other subsidiaries to (1) consummate a merger, or consolidate or sell all or substantially all of the Company’s assets, and (2) incur certain secured or unsecured indebtedness.

 

Unsecured senior line of credit and unsecured senior bank term loans

 

In April 2012, we amended our $1.5 billion unsecured senior line of credit with Merrill Lynch, Pierce, Fenner & Smith Incorporated, J.P. Morgan Securities Inc., and Citigroup Global Markets Inc. as joint lead arrangers, and certain lenders, to extend the maturity date of our unsecured senior line of credit, provide an accordion option for up to an additional $500.0 million, and reduce the interest rate for outstanding borrowings.  The maturity date of the unsecured senior line of credit was extended to April 2017, assuming we exercise our sole right to extend the maturity date twice by an additional six months after each exercise.  Borrowings under the unsecured senior line of credit bear interest at LIBOR or the base rate specified in the amended unsecured senior line of credit and unsecured senior bank term loan agreements, plus in either case a specified margin (the “Applicable Margin”).  The Applicable Margin for LIBOR borrowings under the unsecured senior line of credit was set at 1.20%, down from the 2.40% in effect immediately prior to the modification.  In addition to the Applicable Margin, our unsecured senior line of credit is subject to an annual facility fee of 0.25% based on the aggregate commitments outstanding.  In connection with the modification of our unsecured senior line of credit in April 2012, we recognized a loss on early extinguishment of debt of approximately $1.6 million related to the write-off of a portion of unamortized loan fees.

 

In April 2012, we also amended our 2016 unsecured senior bank term loan (“2016 Unsecured Senior Bank Term Loan”) and 2017 unsecured senior bank term loan (“2017 Unsecured Senior Bank Term Loan”), conforming the financial covenants contained in our unsecured senior bank term loan agreements to those contained in our amended $1.5 billion unsecured senior line of credit.

 

In February 2012, we recognized a loss on early extinguishment of debt of approximately $0.6 million related to the write-off of unamortized loan fees as a result of the early repayment of $250.0 million of our 2012 Unsecured Senior Bank Term Loan.  The requirements of the key financial covenants under our unsecured senior line of credit and unsecured senior bank term loans as of March 31, 2013, are as follows:

 

Covenant Ratios (1)

 

Requirement

 

Leverage Ratio

 

Less than or equal to 60.0%

 

Fixed Charge Coverage Ratio

 

Greater than or equal to 1.50x

 

Secured Debt Ratio

 

Less than or equal to 40.0%

 

Unsecured Leverage Ratio

 

Less than or equal to 60.0%

 

Unsecured Interest Coverage Ratio

 

Greater than or equal to 1.75x

 

 

(1)

For a definition of the ratios used in the table above, refer to the amended unsecured senior line of credit and unsecured senior bank term loan agreements, dated April 30, 2012, which were filed as exhibits to our Quarterly Report on Form 10-Q filed with the SEC on August 8, 2012.

 

16



Table of Contents

 

5.      Secured and unsecured senior debt (continued)

 

In addition, the terms of the unsecured senior line of credit and unsecured senior bank term loan agreements, among other things, limit the ability of the Company, Alexandria Real Estate Equities, L.P., and the Company’s subsidiaries to (1) consummate a merger, or consolidate or sell all or substantially all of the Company’s assets, and (2) incur certain secured or unsecured indebtedness.  Additionally, the terms of the unsecured senior line of credit and unsecured senior bank term loan agreements include a restriction that may limit our ability to pay dividends, including distributions with respect to common stock or other equity interests, during any time a default is continuing, except to enable us to continue to qualify as a REIT for federal income tax purposes.  As of March 31, 2013, we were in compliance with all such covenants.

 

Unsecured senior convertible notes

 

The following tables summarize the balances, significant terms, and components of interest cost recognized (excluding amortization of loan fees and before the impact of capitalized interest) on our unsecured senior convertible notes (dollars in thousands):

 

 

 

8.00% Unsecured Senior
Convertible Notes

 

 

 

March 31,

 

December 31,

 

 

 

2013

 

2012

 

Principal amount

 

$

250

 

$

250

 

Unamortized discount

 

(8

)

(9

)

Net carrying amount of liability component

 

$

242

 

$

241

 

 

 

 

 

 

 

Carrying amount of equity component

 

$

27

 

$

27

 

Number of shares on which the aggregate consideration to be delivered on conversion is determined

 

6,146

 

6,146

 

 

 

 

 

 

 

Issuance date

 

April 2009

 

Stated interest rate

 

8.00%

 

Effective interest rate at March 31, 2013

 

11.00%

 

Conversion rate per $1,000 principal value of unsecured senior convertible notes, as adjusted, as of March 31, 2013

 

24.5836

 

 

 

 

8.00% Unsecured Senior
Convertible Notes

 

 

 

Three Months Ended

 

 

 

March 31,

 

 

 

2013

 

2012

 

Contractual interest

 

$

5

 

$

5

 

Amortization of discount on liability component

 

1

 

1

 

Total interest cost

 

$

6

 

$

6

 

 

17



Table of Contents

 

5.      Secured and unsecured senior debt (continued)

 

The following table outlines our interest expense for the three months ended March 31, 2013 and 2012 (in thousands):

 

 

 

Three Months Ended

 

 

 

March 31,

 

 

 

2013

 

2012

 

Gross interest

 

$

32,041

 

$

31,493

 

Capitalized interest

 

(14,021

)

(15,266

)

Interest expense (1)

 

$

18,020

 

$

16,227

 

 

(1)         Includes interest expense related to and classified in income from discontinued operations in the accompanying condensed consolidated statements of income.

 

6.      Interest rate swap agreements

 

During the three months ended March 31, 2013 and 2012, our interest rate swap agreements were used primarily to hedge the variable cash flows associated with certain of our existing LIBOR-based variable rate debt, including our unsecured senior line of credit and unsecured senior bank term loans.  The ineffective portion of the change in fair value of our interest rate swap agreements is required to be recognized directly in earnings.  During the three months ended March 31, 2013 and 2012, our interest rate swap agreements were 100% effective; because of this, no hedge ineffectiveness was recognized in earnings.  The effective portion of changes in the fair values of our interest rate swap agreements that are designated and that qualify as cash flow hedges is classified in accumulated other comprehensive loss.

 

The following table reflects the effective portion of the unrealized loss recognized in other comprehensive loss for our interest rate swaps related to the change in fair value for the three months ended March 31, 2013 and 2012 (in thousands):

 

 

 

Three Months Ended
March 31,

 

 

 

2013

 

2012

 

Unrealized loss recognized in other comprehensive loss related to the effective portion of changes in the fair values of our interest rate swap agreements

 

$

(133

)

$

(4,073

)

 

Losses are subsequently reclassified into earnings in the period during which the hedged transactions affect earnings.  During the next 12 months, we expect to reclassify approximately $14.0 million accumulated other comprehensive loss to interest expense as an increase to interest expense.  The following table indicates the classification in the condensed consolidated statements of income and the effective portion of the loss reclassified from accumulated other comprehensive income into earnings for our cash flow hedge contracts for the three months ended March 31, 2013 and 2012 (in thousands):

 

 

 

Three Months Ended
March 31,

 

 

 

2013

 

2012

 

Loss reclassified from accumulated other comprehensive income to earnings as an increase to interest expense (effective portion)

 

$

4,308

 

$

5,775

 

 

18



Table of Contents

 

6.      Interest rate swap agreements (continued)

 

As of March 31, 2013, and December 31, 2012, the fair values of our interest rate swap agreements were classified in accounts payable, accrued expenses, and tenant security deposits based upon their respective fair values, aggregating a liability balance of approximately $16.5 million and $20.7 million, respectively, which included accrued interest and adjustments for non-performance risk, with the offsetting adjustment reflected as unrealized loss in accumulated other comprehensive loss in total equity.  Under our interest rate swap agreements, we have no collateral posting requirements.  We had the following outstanding interest rate swap agreements that were designated as cash flow hedges of interest rate risk as of March 31, 2013 (in thousands):

 

 

 

 

 

 

 

Interest Pay

 

Fair Value as of

 

Notional Amount in Effect as of

 

Transaction Date

 

Effective Date

 

Termination Date

 

Rate (1)

 

March 31, 2013 (2)

 

March 31, 2013

 

December 31, 2013

 

December 2006

 

December 29, 2006

 

March 31, 2014

 

4.990

%

 

$

(2,398

)

$

50,000

 

$

50,000

 

October 2007

 

October 31, 2007

 

September 30, 2013

 

4.642

%

 

(1,120

)

50,000

 

 

December 2006

 

November 30, 2009

 

March 31, 2014

 

5.015

%

 

(3,616

)

75,000

 

75,000

 

December 2006

 

November 30, 2009

 

March 31, 2014

 

5.023

%

 

(3,622

)

75,000

 

75,000

 

December 2011

 

December 31, 2012

 

December 31, 2013

 

0.640

%

 

(791

)

250,000

 

 

December 2011

 

December 31, 2012

 

December 31, 2013

 

0.640

%

 

(791

)

250,000

 

 

December 2011

 

December 31, 2012

 

December 31, 2013

 

0.644

%

 

(399

)

125,000

 

 

December 2011

 

December 31, 2012

 

December 31, 2013

 

0.644

%

 

(399

)

125,000

 

 

December 2011

 

December 31, 2013

 

December 31, 2014

 

0.977

%

 

(1,676

)

 

250,000

 

December 2011

 

December 31, 2013

 

December 31, 2014

 

0.976

%

 

(1,674

)

 

250,000

 

Total

 

 

 

 

 

 

 

 

$

(16,486

)

$

1,000,000

 

$

700,000

 

 

(1)

In addition to the interest pay rate, borrowings outstanding under our unsecured senior line of credit and unsecured senior bank term loans include an applicable margin currently ranging from 1.20% to 1.75%.

(2)

Includes accrued interest and credit valuation adjustment.

 

7.      Fair value measurements

 

Recurring fair value measurements

 

We are required to disclose fair value information about all financial instruments, whether or not recognized in the balance sheet, for which it is practicable to estimate fair value.  We measure and disclose the estimated fair value of financial assets and liabilities utilizing a fair value hierarchy that distinguishes between data obtained from sources independent of the reporting entity and the reporting entity’s own assumptions about market participant assumptions.  This hierarchy consists of three broad levels as follows: (1) quoted prices in active markets for identical assets or liabilities, (2) “significant other observable inputs,” and (3) “significant unobservable inputs.”  “Significant other observable inputs” can include quoted prices for similar assets or liabilities in active markets, as well as inputs that are observable for the asset or liability, such as interest rates, foreign exchange rates, and yield curves that are observable at commonly quoted intervals.  “Significant unobservable inputs” are typically based on an entity’s own assumptions, since there is little, if any, related market activity.  In instances in which the determination of the fair value measurement is based on inputs from different levels of the fair value hierarchy, the level in the fair value hierarchy within which the entire fair value measurement falls is based on the lowest level of input that is significant to the fair value measurement in its entirety.  Our assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the asset or liability.  There were no transfers between the levels in the fair value hierarchy during the three months ended March 31, 2013 and 2012.

 

19



Table of Contents

 

7.      Fair value measurements (continued)

 

The following tables set forth the assets and liabilities that we measure at fair value on a recurring basis by level within the fair value hierarchy as of March 31, 2013, and December 31, 2012 (in thousands):

 

 

 

 

 

March 31, 2013

 

Description

 

Total

 

Quoted Prices in
Active Markets
for Identical
Assets

 

“Significant
Other
Observable
Inputs”

 

“Significant
Unobservable
Inputs”

 

Assets:

 

 

 

 

 

 

 

 

 

Marketable securities

 

$

3,125

 

$

3,125

 

$

 

$

 

 

 

 

 

 

 

 

 

 

 

Liabilities:

 

 

 

 

 

 

 

 

 

Interest rate swap agreements

 

$

16,486

 

$

 

$

16,486

 

$

 

 

 

 

 

 

December 31, 2012

 

Description

 

Total

 

Quoted Prices in
Active Markets
for Identical
Assets

 

“Significant
Other
Observable
Inputs”

 

“Significant
Unobservable
Inputs”

 

Assets:

 

 

 

 

 

 

 

 

 

Marketable securities

 

$

2,709

 

$

2,709

 

$

 

$

 

 

 

 

 

 

 

 

 

 

 

Liabilities:

 

 

 

 

 

 

 

 

 

Interest rate swap agreements

 

$

20,661

 

$

 

$

20,661

 

$

 

 

The carrying amounts of cash and cash equivalents, restricted cash, tenant receivables, other assets, accounts payable, accrued expenses, and tenant security deposits approximate fair value.  Our “available-for-sale” securities and our interest rate swap agreements, respectively, have been recognized at fair value.  The fair values of our secured notes payable, unsecured senior notes payable, unsecured senior line of credit, unsecured senior bank term loans, and unsecured senior convertible notes were estimated using widely accepted valuation techniques, including discounted cash flow analyses of “significant other observable inputs” such as available market information on discount and borrowing rates with similar terms, maturities, and credit ratings.  Because the valuations of our financial instruments are based on these types of estimates, the actual fair value of our financial instruments may differ materially if our estimates do not prove to be accurate.  Additionally, the use of different market assumptions or estimation methods may have a material effect on the estimated fair value amounts.

 

As of March 31, 2013, and December 31, 2012, the book and fair values of our marketable securities, interest rate swap agreements, secured notes payable, unsecured senior notes payable, unsecured senior line of credit, and unsecured senior bank term loans were as follows (in thousands):

 

 

 

March 31, 2013

 

December 31, 2012

 

 

 

Book Value

 

Fair Value

 

Book Value

 

Fair Value

 

Marketable securities

 

$

3,125

 

$

3,125

 

$

2,709

 

$

2,709

 

Interest rate swap agreements

 

$

(16,486

)

$

(16,486

)

$

(20,661

)

$

(20,661

)

Secured notes payable

 

$

(730,714

)

$

(799,242

)

$

(716,144

)

$

(788,455

)

Unsecured senior notes payable

 

$

(549,816

)

$

(588,743

)

$

(549,805

)

$

(593,350

)

Unsecured senior line of credit

 

$

(554,000

)

$

(554,000

)

$

(566,000

)

$

(567,196

)

Unsecured senior bank term loans

 

$

(1,350,000

)

$

(1,358,228

)

$

(1,350,000

)

$

(1,405,124

)

 

Fair value measurements for other than on a recurring basis

 

See discussion under Note 3, Investments in Real Estate, Net – Impairment of Real Estate Assets.

 

20



Table of Contents

 

8.                     Earnings per share

 

We use income from continuing operations attributable to Alexandria Real Estate Equities, Inc.’s common stockholders as the “control number” in determining whether potential common shares, including potential common shares issuable upon conversion of our 8.00% unsecured senior convertible notes (“8.00% Unsecured Senior Convertible Notes”), are dilutive or antidilutive to earnings per share.  Pursuant to the presentation and disclosure literature on gains or losses on sales or disposals by REITs and earnings per share required by the SEC and the Financial Accounting Standards Board, gains or losses on sales or disposals by a REIT that do not qualify as discontinued operations are classified below income from discontinued operations in the condensed consolidated statements of income and included in the numerator for the computation of earnings per share for income from continuing operations.

 

The land parcels we sold during the three months ended March 31, 2012 did not meet the criteria for classification as discontinued operations because the land parcels did not have significant operations prior to disposition.  Accordingly, for the three months ended March 31, 2012, we classified approximately $1.9 million as gain on sales of land parcels below income from discontinued operations, net, in the accompanying condensed consolidated statements of income, and included the gain in income from continuing operations attributable to Alexandria Real Estate Equities, Inc.’s common stockholders in the “control number,” or numerator for computation of earnings per share.

 

We account for unvested restricted stock awards that contain nonforfeitable rights to dividends as participating securities and include these securities in the computation of earnings per share using the two-class method.  Our Series D convertible preferred stock (“Series D Convertible Preferred Stock”) and our 8.00% Unsecured Senior Convertible Notes are not participating securities, and are not included in the computation of earnings per share using the two-class method.  Under the two-class method, we allocate net income after preferred stock dividends, preferred stock redemption charge, and amounts attributable to noncontrolling interests to common stockholders and unvested restricted stock awards based on their respective participation rights to dividends declared (or accumulated) and undistributed earnings.  Diluted earnings per share is computed using the weighted average shares of common stock outstanding determined for the basic earnings per share computation plus the effect of any dilutive securities, including the dilutive effect of stock options using the treasury stock method.

 

21



Table of Contents

 

8.                     Earnings per share (continued)

 

The table below is a reconciliation of the numerators and denominators of the basic and diluted earnings per share computations for the three months ended March 31, 2013 and 2012 (dollars in thousands, except per share amounts):

 

 

 

Three Months Ended
March 31,

 

 

 

2013

 

2012

 

Income from continuing operations

 

$

29,423

 

$

26,266

 

Gain on sale of land parcel

 

 

1,864

 

Net income attributable to noncontrolling interests

 

(982

)

(711

)

Dividends on preferred stock

 

(6,471

)

(7,483

)

Preferred stock redemption charge

 

 

(5,978

)

Net income attributable to unvested restricted stock awards

 

(342

)

(235

)

Income from continuing operations attributable to Alexandria Real Estate Equities, Inc.’s common stockholders – basic and diluted

 

21,628

 

13,723

 

 

 

 

 

 

 

Income from discontinued operations, net

 

814

 

4,645

 

Net income attributable to Alexandria Real Estate Equities, Inc.’s common stockholders – basic and diluted

 

$

22,442

 

$

18,368

 

 

 

 

 

 

 

Weighted average shares of common stock outstanding – basic

 

63,161,319

 

61,507,807

 

Dilutive effect of stock options

 

 

1,160

 

Weighted average shares of common stock outstanding – diluted

 

63,161,319

 

61,508,967

 

 

 

 

 

 

 

Earnings per share attributable to Alexandria Real Estate Equities, Inc.’s common stockholders – basic and diluted:

 

 

 

 

 

Continuing operations

 

$

0.35

 

$

0.22

 

Discontinued operations, net

 

0.01

 

0.08

 

Earnings per share – basic and diluted

 

$

0.36

 

$

0.30

 

 

For purposes of calculating diluted earnings per share, we did not assume conversion of our 8.00% Unsecured Senior Convertible Notes for the three months ended March 31, 2013 and 2012, since the impact was antidilutive to earnings per share attributable to Alexandria Real Estate Equities, Inc.’s common stockholders from continuing operations during those periods.

 

For purposes of calculating diluted earnings per share, we did not assume conversion of our Series D Convertible Preferred Stock for the three months ended March 31, 2013 and 2012, since the impact was antidilutive to earnings per share attributable to Alexandria Real Estate Equities, Inc.’s common stockholders from continuing operations during those periods.

 

22



Table of Contents

 

9.                    Net income attributable to Alexandria Real Estate Equities, Inc.

 

The following table shows income from continuing and discontinued operations attributable to Alexandria Real Estate Equities, Inc. for the three months ended March 31, 2013 and 2012 (in thousands):

 

 

 

Three Months Ended
March 31,

 

 

 

2013

 

2012

 

Income from continuing operations

 

$

29,423

 

$

26,266

 

Gain on sale of land parcel

 

 

1,864

 

Less: net income attributable to noncontrolling interests

 

(982

)

(711

)

Income from continuing operations attributable to Alexandria Real Estate Equities, Inc.

 

28,441

 

27,419

 

 

 

 

 

 

 

Income from discontinued operations, net

 

814

 

4,645

 

Less: net income from discontinued operations attributable to noncontrolling interests

 

 

 

Net income attributable to Alexandria Real Estate Equities, Inc.

 

$

29,255

 

$

32,064

 

 

10.             Stockholders’ equity

 

“At the market” common stock offering program

 

In June 2012, we established an “at the market” common stock offering program under which we may sell, from time to time, up to an aggregate of $250.0 million of our common stock through our sales agents, BNY Mellon Capital Markets, LLC and Credit Suisse Securities (USA) LLC, during a three-year period.  Net proceeds from the sales were used to pay down the outstanding balance on our unsecured senior line of credit or other borrowings, and for general corporate purposes.  As of March 31, 2013, approximately $150.0 million of our common stock remained available for issuance under the “at the market” common stock offering program.

 

Dividends

 

In March 2013, we declared cash dividends for the first quarter of 2013 on our common stock aggregating approximately $38.2 million, or $0.60 per share.  In March 2013, we also declared cash dividends for the first quarter of 2013 on our Series D Convertible Preferred Stock aggregating approximately $4.4 million, or $0.4375 per share.  Additionally, we declared cash dividends for the third quarter of 2012 on our Series E Preferred Stock aggregating approximately $2.1 million, or $0.403125 per share.  In April 2013, we paid the cash dividends for the third quarter of 2012 on our common stock, Series D Convertible Preferred Stock, and Series E Preferred Stock.

 

Accumulated other comprehensive loss

 

Accumulated other comprehensive loss attributable to Alexandria Real Estate Equities, Inc. consists of the following (in thousands):

 

 

 

Unrealized gain on
marketable
securities

 

Unrealized gain
on interest rate
swap agreements

 

Unrealized loss
on foreign
currency
translation

 

Total

 

Balance as of December 31, 2012

 

$

1,473

 

$

(20,661

)

$

(5,645

)

$

(24,833

)

 

 

 

 

 

 

 

 

 

 

Other comprehensive income (loss) before reclassifications

 

316

 

(133

)

(2,276

)

(2,093

)

Amounts reclassified from other comprehensive income

 

(272

)

4,308

 

 

4,036

 

Net other comprehensive income (loss)

 

44

 

4,175

 

(2,276

)

1,943

 

 

 

 

 

 

 

 

 

 

 

Balance as of March 31, 2013

 

$

1,517

 

$

(16,486

)

$

(7,921

)

$

(22,890

)

 

23



Table of Contents

 

10.             Stockholders’ equity (continued)

 

The effects on amounts reclassified from accumulated other comprehensive income related to unrealized gain on marketable securities and unrealized gain on interest rate swap agreements are recognized in other income and interest expenses, respectively, in the accompanying condensed consolidated statements of income.

 

Preferred stock and excess stock authorizations

 

Our charter authorizes the issuance of up to 100,000,000 shares of preferred stock, of which 15,200,000 shares were issued and outstanding as of March 31, 2013.  In addition, 200,000,000 shares of “excess stock” (as defined in our charter) are authorized, none of which were issued and outstanding as of March 31, 2013.

 

11.             Noncontrolling interests

 

Noncontrolling interests represent the third-party interests in certain entities in which we have a controlling interest.  These entities owned 10 properties and two development parcels as of March 31, 2013, and are included in our condensed consolidated financial statements.  Noncontrolling interests are adjusted for additional contributions and distributions, the proportionate share of the net earnings or losses, and other comprehensive income or loss.  Distributions, profits, and losses related to these entities are allocated in accordance with the respective operating agreements.

 

Certain of our noncontrolling interests have the right to require us to redeem their ownership interests in the respective entities.  We classify these ownership interests in the entities as redeemable noncontrolling interests outside of total equity in the accompanying condensed consolidated balance sheets.  Redeemable noncontrolling interests are adjusted for additional contributions and distributions, the proportionate share of the net earnings or losses, and other comprehensive income or loss.  Distributions, profits, and losses related to these entities are allocated in accordance with the respective operating agreements.  If the carrying amount of a redeemable noncontrolling interest is less than the maximum redemption value at the balance sheet date, such amount is adjusted to the maximum redemption value.  Subsequent declines in the redemption value are recognized only to the extent that previous increases have been recognized.  As of March 31, 2013, and December 31, 2012, our redeemable noncontrolling interest balances were approximately $14.5 million and $14.6 million, respectively.  Our remaining noncontrolling interests, aggregating approximately $47.1 million and $46.6 million as of March 31, 2013, and December 31, 2012, respectively, do not have rights to require us to purchase their ownership interests and are classified in total equity in the accompanying condensed consolidated balance sheets.

 

12.             Discontinued operations

 

The following is a summary of net assets of discontinued operations and income from discontinued operations, net (in thousands):

 

 

 

March 31,

 

December 31,

 

 

 

2013

 

2012

 

Properties “held for sale,” net

 

$

7,562

 

$

76,440

 

Other assets

 

574

 

4,546

 

Total assets

 

8,136

 

80,986

 

 

 

 

 

 

 

Total liabilities

 

(149

)

(3,233

)

Net assets of discontinued operations

 

$

7,987

 

$

77,753

 

 

 

 

Three Months Ended

 

 

 

March 31,

 

 

 

2013

 

2012

 

Total revenues

 

$

3,496

 

$

9,308

 

Operating expenses

 

1,412

 

3,043

 

Total revenues less operating expenses

 

2,084

 

6,265

 

Interest expense

 

 

1

 

Depreciation expense

 

930

 

1,619

 

Loss on sale of real estate

 

340

 

 

Income from discontinued operations, net

 

$

814

 

$

4,645

 

 

Income from discontinued operations, net, for the three months ended March 31, 2013, includes the results of operations of three operating properties that were classified as “held for sale” as of March 31, 2013, and the results of operations and gain related to the sale of six properties sold during the three months ended March 31, 2013.  Income from discontinued operations, net, for the three months ended March 31, 2012, includes the results of operations of nine operating properties that were classified as “held for sale” as of March 31, 2013.  For additional discussion regarding real estate asset sales, see discussion under Note 3, Investments in Real Estate, Net.

 

24



Table of Contents

 

13.             Condensed consolidating financial information

 

Alexandria Real Estate Equities, Inc. (the “Issuer”) has sold certain debt securities registered under the Securities Act, as amended, that are fully and unconditionally guaranteed by Alexandria Real Estate Equities, L.P. (the “LP”), an indirectly 100% owned subsidiary of the Issuer.  The Company’s other subsidiaries, including, but not limited to, the subsidiaries that own substantially all of its real estate (collectively, the “Combined Non-Guarantor Subsidiaries”) will not provide a guarantee of such securities, including the subsidiaries that are partially or 100% owned by the LP.  The following condensed consolidating financial information presents the condensed consolidating balance sheets as of March 31, 2013, and December 31, 2012, and the condensed consolidating statements of income, comprehensive income, and cash flows for the three months ended March 31, 2013 and 2012, for the Issuer, the guarantor subsidiary (the LP), the Combined Non-Guarantor Subsidiaries, the eliminations necessary to arrive at the information for Alexandria Real Estate Equities, Inc. on a consolidated basis, and consolidated amounts.  In presenting the condensed consolidating financial statements, the equity method of accounting has been applied to (1) the Issuer’s interests in the Guarantor Subsidiary and the Combined Non-Guarantor Subsidiaries, (2) the Guarantor Subsidiary’s interests in the Combined Non-Guarantor Subsidiaries, and (3) the Combined Non-Guarantor Subsidiaries’ interests in the Guarantor Subsidiary, where applicable, even though all such subsidiaries meet the requirements to be consolidated under GAAP.  All intercompany balances and transactions between the Issuer, the Guarantor Subsidiary, and the Combined Non-Guarantor Subsidiaries have been eliminated, as shown in the column “Eliminations.”  All assets and liabilities have been allocated to the Issuer, the Guarantor Subsidiary, and the Combined Non-Guarantor Subsidiaries generally based on legal entity ownership.

 

25


 


Table of Contents

 

13.   Condensed consolidating financial information (continued)

 

Condensed Consolidating Balance Sheet

as of March 31, 2013
(In thousands)

(Unaudited)

 

 

 

Alexandria
Real Estate
Equities, Inc.
(Issuer)

 

Alexandria
Real Estate
Equities, L.P.
(Guarantor
Subsidiary)

 

Combined
Non-
Guarantor
Subsidiaries

 

Eliminations

 

Consolidated

 

Assets

 

 

 

 

 

 

 

 

 

 

 

Investments in real estate, net

 

$

 

$

 

$

6,375,182

 

$

 

$

6,375,182

 

Cash and cash equivalents

 

39,012

 

 

47,989

 

 

87,001

 

Restricted cash

 

45

 

 

29,963

 

 

30,008

 

Tenant receivables

 

52

 

 

9,209

 

 

9,261

 

Deferred rent

 

 

 

170,100

 

 

170,100

 

Deferred leasing and financing costs, net

 

29,093

 

 

130,779

 

 

159,872

 

Investments

 

 

12,306

 

111,237

 

 

123,543

 

Investments in and advances to affiliates

 

5,896,678

 

5,434,845

 

110,924

 

(11,442,447

)

 

Intercompany note receivable

 

3,042

 

 

 

(3,042

)

 

Other assets

 

18,415

 

 

117,698

 

(161

)

135,952

 

Total assets

 

$

5,986,337

 

$

5,447,151

 

$

7,103,081

 

$

(11,445,650

)

$

7,090,919

 

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities, Noncontrolling Interests, and Equity

 

 

 

 

 

 

 

 

 

 

 

Secured notes payable

 

$

 

$

 

$

730,714

 

$

 

$

730,714

 

Unsecured senior notes payable

 

549,816

 

 

 

 

549,816

 

Unsecured senior line of credit

 

554,000

 

 

 

 

554,000

 

Unsecured senior bank term loans

 

1,350,000

 

 

 

 

1,350,000

 

Accounts payable, accrued expenses, and tenant security deposits

 

55,257

 

 

312,057

 

(161

)

367,153

 

Dividends payable

 

43,661

 

 

294

 

 

43,955

 

Intercompany note payable

 

 

 

3,042

 

(3,042

)

 

Total liabilities

 

2,552,734

 

 

1,046,107

 

(3,203

)

3,595,638

 

Redeemable noncontrolling interests

 

 

 

14,534

 

 

14,534

 

Alexandria Real Estate Equities, Inc.’s stockholders’ equity

 

3,433,603

 

5,447,151

 

5,995,296

 

(11,442,447

)

3,433,603

 

Noncontrolling interests

 

 

 

47,144

 

 

47,144

 

Total equity

 

3,433,603

 

5,447,151

 

6,042,440

 

(11,442,447

)

3,480,747

 

Total liabilities, noncontrolling interests, and equity

 

$

5,986,337

 

$

5,447,151

 

$

7,103,081

 

$

(11,445,650

)

$

7,090,919

 

 

26



Table of Contents

 

13.   Condensed consolidating financial information (continued)

 

Condensed Consolidating Balance Sheet

as of December 31, 2012
(In thousands)

(Unaudited)

 

 

 

Alexandria
Real Estate
Equities, Inc.
(Issuer)

 

Alexandria
Real Estate
Equities, L.P.
(Guarantor
Subsidiary)

 

Combined
Non-
Guarantor
Subsidiaries

 

Eliminations

 

Consolidated

 

Assets

 

 

 

 

 

 

 

 

 

 

 

Investments in real estate, net

 

$

38,616

 

$

 

$

6,385,962

 

$

 

$

6,424,578

 

Cash and cash equivalents

 

98,567

 

1,914

 

40,490

 

 

140,971

 

Restricted cash

 

52

 

 

39,895

 

 

39,947

 

Tenant receivables

 

1

 

 

8,448

 

 

8,449

 

Deferred rent

 

1,876

 

 

168,520

 

 

170,396

 

Deferred leasing and financing costs, net

 

31,373

 

 

128,675

 

 

160,048

 

Investments

 

 

12,591

 

102,457

 

 

115,048

 

Investments in and advances to affiliates

 

5,833,368

 

5,358,882

 

110,101

 

(11,302,351

)

 

Intercompany note receivable

 

3,021

 

 

 

(3,021

)

 

Other assets

 

17,613

 

 

73,066

 

 

90,679

 

Total assets

 

$

6,024,487

 

$

5,373,387

 

$

7,057,614

 

$

(11,305,372

)

$

7,150,116

 

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities, Noncontrolling Interests, and Equity

 

 

 

 

 

 

 

 

 

 

 

Secured notes payable

 

$

 

$

 

$

716,144

 

$

 

$

716,144

 

Unsecured senior notes payable

 

549,805

 

 

 

 

549,805

 

Unsecured senior line of credit

 

566,000

 

 

 

 

566,000

 

Unsecured senior bank term loans

 

1,350,000

 

 

 

 

1,350,000

 

Accounts payable, accrued expenses, and tenant security deposits

 

75,728

 

 

347,980

 

 

423,708

 

Dividends payable

 

41,103

 

 

298

 

 

41,401

 

Intercompany notes payable

 

 

 

3,021

 

(3,021

)

 

Total liabilities

 

2,582,636

 

 

1,067,443

 

(3,021

)

3,647,058

 

Redeemable noncontrolling interests

 

 

 

14,564

 

 

14,564

 

Alexandria Real Estate Equities, Inc.’s stockholders’ equity

 

3,441,851

 

5,373,387

 

5,928,964

 

(11,302,351

)

3,441,851

 

Noncontrolling interests

 

 

 

46,643

 

 

46,643

 

Total equity

 

3,441,851

 

5,373,387

 

5,975,607

 

(11,302,351

)

3,488,494

 

Total liabilities, noncontrolling interests, and equity

 

$

6,024,487

 

$

5,373,387

 

$

7,057,614

 

$

(11,305,372

)

$

7,150,116

 

 

27



Table of Contents

 

13.   Condensed consolidating financial information (continued)

 

Condensed Consolidating Statement of Income

for the Three Months Ended March 31, 2013
(In thousands)

(Unaudited)

 

 

 

Alexandria
Real Estate
Equities, Inc.
(Issuer)

 

Alexandria
Real Estate
Equities, L.P.
(Guarantor
Subsidiary)

 

Combined
Non-
Guarantor
Subsidiaries

 

Eliminations

 

Consolidated

 

Revenues:

 

 

 

 

 

 

 

 

 

 

 

Rental

 

$

 

$

 

$

111,776

 

$

 

$

111,776

 

Tenant recoveries

 

 

 

35,611

 

 

35,611

 

Other income (loss)

 

2,567

 

(66

)

3,600

 

(3,108

)

2,993

 

Total revenues

 

2,567

 

(66

)

150,987

 

(3,108

)

150,380

 

 

 

 

 

 

 

 

 

 

 

 

 

Expenses:

 

 

 

 

 

 

 

 

 

 

 

Rental operations

 

33

 

 

45,191

 

 

45,224

 

General and administrative

 

10,247

 

 

4,509

 

(3,108

)

11,648

 

Interest

 

11,720

 

 

6,300

 

 

18,020

 

Depreciation and amortization

 

1,473

 

 

44,592

 

 

46,065

 

Total expenses

 

23,473

 

 

100,592

 

(3,108

)

120,957

 

(Loss) income from continuing operations before equity in earnings of affiliates

 

(20,906

)

(66

)

50,395

 

 

29,423

 

 

 

 

 

 

 

 

 

 

 

 

 

Equity in earnings of affiliates

 

49,807

 

47,239

 

960

 

(98,006

)

 

Income from continuing operations

 

28,901

 

47,173

 

51,355

 

(98,006

)

29,423

 

 

 

 

 

 

 

 

 

 

 

 

 

Income from discontinued operations, net

 

354

 

 

460

 

 

814

 

Net income

 

29,255

 

47,173

 

51,815

 

(98,006

)

30,237

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income attributable to noncontrolling interests

 

 

 

982

 

 

982

 

Dividends on preferred stock

 

6,471

 

 

 

 

6,471

 

Net income attributable to unvested restricted stock awards

 

342

 

 

 

 

342

 

Net income attributable to Alexandria Real Estate Equities, Inc.’s common stockholders

 

$

22,442

 

$

47,173

 

$

50,833

 

$

(98,006

)

$

22,442

 

 

28



Table of Contents

 

13.   Condensed consolidating financial information (continued)

 

Condensed Consolidating Statement of Income

for the Three Months Ended March 31, 2012
(In thousands)

(Unaudited)

 

 

 

Alexandria
Real Estate
Equities, Inc.
(Issuer)

 

Alexandria
Real Estate
Equities, L.P.
(Guarantor
Subsidiary)

 

Combined
Non-
Guarantor
Subsidiaries

 

Eliminations

 

Consolidated

 

Revenues:

 

 

 

 

 

 

 

 

 

 

 

Rental

 

$

 

$

 

$

101,201

 

$

 

$

101,201

 

Tenant recoveries

 

 

 

31,882

 

 

31,882

 

Other income

 

2,536

 

585

 

2,882

 

(3,375

)

2,628

 

Total revenues

 

2,536

 

585

 

135,965

 

(3,375

)

135,711

 

 

 

 

 

 

 

 

 

 

 

 

 

Expenses:

 

 

 

 

 

 

 

 

 

 

 

Rental operations

 

 

 

40,453

 

 

40,453

 

General and administrative

 

9,497

 

 

4,235

 

(3,375

)

10,357

 

Interest

 

10,569

 

 

5,657

 

 

16,226

 

Depreciation and amortization

 

1,018

 

 

40,768

 

 

41,786

 

Loss on early extinguishment of debt

 

623

 

 

 

 

623

 

Total expenses

 

21,707

 

 

91,113

 

(3,375

)

109,445

 

(Loss) income from continuing operations before equity in earnings of affiliates

 

(19,171

)

585

 

44,852

 

 

26,266

 

 

 

 

 

 

 

 

 

 

 

 

 

Equity in earnings of affiliates

 

50,008

 

45,699

 

914

 

(96,621

)

 

Income from continuing operations

 

30,837

 

46,284

 

45,766

 

(96,621

)

26,266

 

 

 

 

 

 

 

 

 

 

 

 

 

Income from discontinued operations, net

 

1,227

 

 

3,418

 

 

4,645

 

Gain on sale of land parcel

 

 

 

 

1,864

 

 

1,864

 

Net income

 

32,064

 

46,284

 

51,048

 

(96,621

)

32,775

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income attributable to noncontrolling interests

 

 

 

711

 

 

711

 

Dividends on preferred stock

 

7,483

 

 

 

 

7,483

 

Preferred stock redemption charge

 

5,978

 

 

 

 

5,978

 

Net income attributable to unvested restricted stock awards

 

235

 

 

 

 

235

 

Net income attributable to Alexandria Real Estate Equities, Inc.’s common stockholders

 

$

18,368

 

$

46,284

 

$

50,337

 

$

(96,621

)

$

18,368

 

 

29



Table of Contents

 

13.   Condensed consolidating financial information (continued)

 

Condensed Consolidating Statement of Comprehensive Income

for the Three Months Ended March 31, 2013
(In thousands)

(Unaudited)

 

 

 

Alexandria
Real Estate
Equities, Inc.
(Issuer)

 

Alexandria
Real Estate
Equities, L.P.
(Guarantor
Subsidiary)

 

Combined
Non-
Guarantor
Subsidiaries

 

Eliminations

 

Consolidated

 

Net income

 

$

29,255

 

$

47,173

 

$

51,815

 

$

(98,006

)

$

30,237

 

Other comprehensive income:

 

 

 

 

 

 

 

 

 

 

 

Unrealized gains on marketable securities:

 

 

 

 

 

 

 

 

 

 

 

Unrealized holding gains arising during the period

 

 

(8

)

324

 

 

316

 

Reclassification adjustment for gains included in net income

 

 

38

 

(310

)

 

(272

)

Unrealized gains on marketable securities, net

 

 

30

 

14

 

 

44

 

Unrealized gains on interest rate swaps:

 

 

 

 

 

 

 

 

 

 

 

Unrealized interest rate swap losses arising during the period

 

(133

)

 

 

 

(133

)

Reclassification adjustment for amortization of interest expense included in net income

 

4,308

 

 

 

 

4,308

 

Unrealized gains on interest rate swaps, net

 

4,175

 

 

 

 

4,175

 

Foreign currency translation losses

 

 

 

(2,360

)

 

(2,360

)

Total other comprehensive income

 

4,175

 

30

 

(2,346

)

 

1,859

 

Comprehensive income

 

33,430

 

47,203

 

49,469

 

(98,006

)

32,096

 

Less: comprehensive income attributable to noncontrolling interests

 

 

 

(898

)

 

(898

)

Comprehensive income attributable to Alexandria Real Estate Equities, Inc.’s common stockholders

 

$

33,430

 

$

47,203

 

$

48,571

 

$

(98,006

)

$

31,198

 

 

30


 


Table of Contents

 

13.   Condensed consolidating financial information (continued)

 

Condensed Consolidating Statement of Comprehensive Income

for the Three Months Ended March 31, 2012
(In thousands)

(Unaudited)

 

 

 

Alexandria
Real Estate
Equities, Inc.
(Issuer)

 

Alexandria
Real Estate
Equities, L.P.
(Guarantor
Subsidiary)

 

Combined
Non-
Guarantor
Subsidiaries

 

Eliminations

 

Consolidated

 

Net income

 

$

32,064

 

$

46,284

 

$

51,048

 

$

(96,621

)

$

32,775

 

Other comprehensive income:

 

 

 

 

 

 

 

 

 

 

 

Unrealized gains (losses) on marketable securities:

 

 

 

 

 

 

 

 

 

 

 

Unrealized holding gains arising during the period

 

 

31

 

643

 

 

674

 

Reclassification adjustment for gains included in net income

 

 

(11

)

(913

)

 

(924

)

Unrealized gains (losses) on marketable securities, net

 

 

20

 

(270

)

 

(250

)

Unrealized gains on interest rate swaps:

 

 

 

 

 

 

 

 

 

 

 

Unrealized interest rate swap losses arising during the period

 

(4,073

)

 

 

 

(4,073

)

Reclassification adjustment for amortization of interest expense included in net income

 

5,775

 

 

 

 

5,775

 

Unrealized gains on interest rate swaps, net

 

1,702

 

 

 

 

1,702

 

Foreign currency translation gain

 

 

 

9,959

 

 

9,959

 

Total other comprehensive income

 

1,702

 

20

 

9,689

 

 

11,411

 

Comprehensive income

 

33,766

 

46,304

 

60,737

 

(96,621

)

44,186

 

Less: comprehensive income attributable to noncontrolling interests

 

 

 

(699

)

 

(699

)

Comprehensive income attributable to Alexandria Real Estate Equities, Inc.’s common stockholders

 

$

33,766

 

$

46,304

 

$

60,038

 

$

(96,621

)

$

43,487

 

 

31



Table of Contents

 

13.   Condensed consolidating financial information (continued)

 

Condensed Consolidating Statement of Cash Flows

for the Three Months Ended March 31, 2013
(In thousands)

(Unaudited)

 

 

 

Alexandria Real
Estate Equities,
Inc. (Issuer)

 

Alexandria Real
Estate Equities,
L.P. (Guarantor
Subsidiary)

 

Combined
Non-Guarantor
Subsidiaries

 

Eliminations

 

Consolidated

 

Operating Activities

 

 

 

 

 

 

 

 

 

 

 

Net income

 

$

29,255

 

$

47,173

 

$

51,815

 

$

(98,006

)

$

30,237

 

Adjustments to reconcile net income to net cash provided by operating activities:

 

 

 

 

 

 

 

 

 

 

 

Depreciation and amortization

 

1,473

 

 

45,522

 

 

46,995

 

Loss on sale of real estate

 

 

 

340

 

 

340

 

Amortization of loan fees and costs

 

1,680

 

 

706

 

 

2,386

 

Amortization of debt premiums/discounts

 

11

 

 

104

 

 

115

 

Amortization of acquired above and below market leases

 

 

 

(830

)

 

(830

)

Deferred rent

 

 

 

(6,198

)

 

(6,198

)

Stock compensation expense

 

3,349

 

 

 

 

3,349

 

Equity in income related to subsidiaries

 

(49,807

)

(47,239

)

(960

)

98,006

 

 

Gain on sales of investments

 

 

(121

)

(325

)

 

(446

)

Loss on sales of investments

 

 

187

 

199

 

 

386

 

Changes in operating assets and liabilities:

 

 

 

 

 

 

 

 

 

 

 

Restricted cash

 

7

 

 

1,499

 

 

1,506

 

Tenant receivables

 

(51

)

 

(767

)

 

(818

)

Deferred leasing costs

 

(350

)

 

(11,407

)

 

(11,757

)

Other assets

 

29,445

 

 

(36,747

)

 

(7,302

)

Intercompany receivables and payables

 

(21

)

 

21

 

 

 

Accounts payable, accrued expenses, and tenant security deposits

 

(16,301

)

 

5,579

 

 

(10,722

)

Net cash (used in) provided by operating activities

 

(1,310

)

 

48,551

 

 

47,241

 

 

 

 

 

 

 

 

 

 

 

 

 

Investing Activities

 

 

 

 

 

 

 

 

 

 

 

Proceeds from sale of properties

 

10,796

 

 

69,407

 

 

80,203

 

Additions to properties

 

 

 

(139,245

)

 

(139,245

)

Change in restricted cash related to construction projects

 

 

 

(17

)

 

(17

)

Contributions to unconsolidated real estate entity

 

 

 

(2,074

)

 

(2,074

)

Investments in subsidiaries

 

(14,842

)

(30,986

)

 

45,828

 

 

Additions to investments

 

 

(3

)

(10,360

)

 

(10,363

)

Proceeds from investments

 

 

252

 

1,720

 

 

1,972

 

Net cash used in investing activities

 

(4,046

)

(30,737

)

(80,569

)

45,828

 

(69,524

)

 

 

 

 

 

 

 

 

 

 

 

 

Financing Activities

 

 

 

 

 

 

 

 

 

 

 

Principal borrowings from secured notes payable

 

 

 

17,215

 

 

17,215

 

Repayments of borrowings from secured notes payable

 

 

 

(2,749

)

 

(2,749

)

Principal borrowings from unsecured senior line of credit

 

179,000

 

 

 

 

179,000

 

Repayments of borrowings from unsecured senior line of credit

 

(191,000

)

 

 

 

(191,000

)

Transfer to/from parent company

 

 

28,823

 

17,005

 

(45,828

)

 

Change in restricted cash related to financings

 

 

 

8,656

 

 

8,656

 

Deferred financing costs paid

 

(41

)

 

(5

)

 

(46

)

Dividends paid on common stock

 

(35,687

)

 

 

 

(35,687

)

Dividends paid on preferred stock

 

(6,471

)

 

 

 

(6,471

)

Distributions to noncontrolling interests

 

 

 

(427

)

 

(427

)

Net cash (used in) provided by financing activities

 

(54,199

)

28,823

 

39,695

 

(45,828

)

(31,509

)

 

 

 

 

 

 

 

 

 

 

 

 

Effect of foreign exchange rate changes on cash and cash equivalents

 

 

 

(178

)

 

(178

)

 

 

 

 

 

 

 

 

 

 

 

 

Net (decrease) increase in cash and cash equivalents

 

(59,555

)

(1,914

)

7,499

 

 

(53,970

)

Cash and cash equivalents at beginning of period

 

98,567

 

1,914

 

40,490

 

 

140,971

 

Cash and cash equivalents at end of period

 

$

39,012

 

$

 

$

47,989

 

$

 

$

87,001

 

 

 

 

 

 

 

 

 

 

 

 

 

Supplemental Disclosure of Cash Flow Information

 

 

 

 

 

 

 

 

 

 

 

Cash paid during the period for interest, net of interest capitalized

 

$

3,735

 

$

 

$

6,229

 

$

 

$

9,964

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-Cash Investing Activities

 

 

 

 

 

 

 

 

 

 

 

Note receivable from sale of real estate

 

$

29,820

 

$

 

$

9,000

 

$

 

$

38,820

 

Changes in accrued capital expenditures

 

$

 

$

 

$

(37,045

)

$

 

$

(37,045

)

 

32



Table of Contents

 

13.   Condensed consolidating financial information (continued)

 

Condensed Consolidating Statement of Cash Flows

for the Three Months Ended March 31, 2012
(In thousands)

(Unaudited)

 

 

 

Alexandria Real
Estate Equities,
Inc. (Issuer)

 

Alexandria Real
Estate Equities,
L.P. (Guarantor
Subsidiary)

 

Combined
Non-Guarantor
Subsidiaries

 

Eliminations

 

Consolidated

 

Operating Activities

 

 

 

 

 

 

 

 

 

 

 

Net income

 

$

32,064

 

$

46,284

 

$

51,048

 

$

(96,621

)

$

32,775

 

Adjustments to reconcile net income to net cash provided by operating activities:

 

 

 

 

 

 

 

 

 

 

 

Depreciation and amortization

 

1,393

 

 

42,012

 

 

43,405

 

Loss on early extinguishment of debt

 

623

 

 

 

 

623

 

Gain on sale of land parcel

 

 

 

(1,864

)

 

(1,864

)

Amortization of loan fees and costs

 

1,792

 

 

851

 

 

2,643

 

Amortization of debt premiums/discounts

 

81

 

 

98

 

 

179

 

Amortization of acquired above and below market leases

 

 

 

(800

)

 

(800

)

Deferred rent

 

17

 

 

(8,813

)

 

(8,796

)

Stock compensation expense

 

3,293

 

 

 

 

3,293

 

Equity in income related to investments

 

 

26

 

 

 

26

 

Equity in income related to subsidiaries

 

(50,008

)

(45,699

)

(914

)

96,621

 

 

Gain on sales of investments

 

 

(611

)

(1,388

)

 

(1,999

)

Loss on sales of investments

 

 

 

1

 

 

1

 

Changes in operating assets and liabilities:

 

 

 

 

 

 

 

 

 

 

 

Restricted cash

 

(3

)

 

865

 

 

862

 

Tenant receivables

 

(9

)

 

(1,228

)

 

(1,237

)

Deferred leasing costs

 

4,266

 

 

(11,277

)

 

(7,011

)

Other assets

 

22

 

 

(2,433

)

 

(2,411

)

Accounts payable, accrued expenses, and tenant security deposits

 

(23,545

)

 

13,541

 

 

(10,004

)

Net cash (used in) provided by operating activities

 

(30,014

)

 

79,699

 

 

49,685

 

 

 

 

 

 

 

 

 

 

 

 

 

Investing Activities

 

 

 

 

 

 

 

 

 

 

 

Additions to properties

 

(304

)

 

(120,281

)

 

(120,585

)

Purchase of properties

 

 

 

(19,946

)

 

(19,946

)

Change in restricted cash related to construction projects

 

 

 

(1,400

)

 

(1,400

)

Distribution from unconsolidated real estate entity

 

 

 

22,250

 

 

22,250

 

Contributions to unconsolidated real estate entity

 

 

 

(3,914

)

 

(3,914

)

Investments in subsidiaries

 

(52,639

)

(43,773

)

(1,216

)

97,628

 

 

Additions to investments

 

 

(119

)

(5,319

)

 

(5,438

)

Proceeds from investments

 

 

1,149

 

3,636

 

 

4,785

 

Net cash used in investing activities

 

$

(52,943

)

$

(42,743

)

$

(126,190

)

$

97,628

 

$

(124,248

)

 

33



Table of Contents

 

13.   Condensed consolidating financial information (continued)

 

Condensed Consolidating Statement of Cash Flows (continued)

for the Three Months Ended March 31, 2012
(In thousands)

(Unaudited)

 

 

 

Alexandria Real
Estate Equities,
Inc. (Issuer)

 

Alexandria Real
Estate Equities,
L.P. (Guarantor
Subsidiary)

 

Combined
Non-Guarantor
Subsidiaries

 

Eliminations

 

Consolidated

 

Financing Activities

 

 

 

 

 

 

 

 

 

 

 

Repayments of borrowings from secured notes payable

 

$

 

$

 

$

(2,688

)

$

 

$

(2,688

)

Proceeds from issuance of unsecured senior notes payable

 

544,649

 

 

 

 

544,649

 

Principal borrowings from unsecured senior line of credit

 

248,000

 

 

 

 

248,000

 

Repayments of borrowings from unsecured senior line of credit

 

(451,000

)

 

 

 

(451,000

)

Repayment of unsecured senior bank term loan

 

(250,000

)

 

 

 

(250,000

)

Repurchase of unsecured senior convertible notes

 

(83,801

)

 

 

 

(83,801

)

Proceeds from issuance of Series E Preferred Stock

 

124,868

 

 

 

 

124,868

 

Change in restricted cash related to financings

 

 

 

(15,955

)

 

(15,955

)

Transfers due to/from parent company

 

 

44,217

 

53,411

 

(97,628

)

 

Deferred financing costs paid

 

(5,184

)

 

(116

)

 

(5,300

)

Proceeds from exercise of stock options

 

112

 

 

 

 

112

 

Dividends paid on common stock

 

(30,386

)

 

 

 

(30,386

)

Dividends paid on preferred stock

 

(7,089

)

 

 

 

(7,089

)

Distributions to redeemable noncontrolling interests

 

 

 

(315

)

 

(315

)

Contributions by noncontrolling interests

 

 

 

625

 

 

625

 

Distributions to noncontrolling interests

 

 

 

(369

)

 

(369

)

Net cash provided by financing activities

 

90,169

 

44,217

 

34,593

 

(97,628

)

71,351

 

 

 

 

 

 

 

 

 

 

 

 

 

Effect of foreign exchange rate changes on cash and cash equivalents

 

 

 

2,034

 

 

2,034

 

 

 

 

 

 

 

 

 

 

 

 

 

Net increase (decrease) in cash and cash equivalents

 

7,212

 

1,474

 

(9,864

)

 

(1,178

)

Cash and cash equivalents at beginning of period

 

10,608

 

 

67,931

 

 

78,539

 

Cash and cash equivalents at end of period

 

$

17,820

 

$

1,474

 

$

58,067

 

$

 

$

77,361

 

 

 

 

 

 

 

 

 

 

 

 

 

Supplemental Disclosure of Cash Flow Information

 

 

 

 

 

 

 

 

 

 

 

Cash paid during the period for interest, net of interest capitalized

 

$

8,855

 

$

 

$

3,121

 

$

 

$

11,976

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-Cash Investing Activities

 

 

 

 

 

 

 

 

 

 

 

Changes in accrued capital expenditures

 

$

(2,000

)

$

 

$

11,396

 

$

 

$

9,396

 

 

34


 


Table of Contents

 

Item 2.  MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

Certain information and statements included in this quarterly report on Form 10-Q, including, without limitation, statements containing the words “believes,” “expects,” “may,” “will,” “should,” “seeks,” “approximately,” “intends,” “plans,” “estimates,” or “anticipates,” or the negative of these words or similar words, constitute “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended.  Forward-looking statements involve inherent risks and uncertainties regarding events, conditions, and financial trends that may affect our future plans of operations, business strategy, results of operations, and financial position.  A number of important factors could cause actual results to differ materially from those included within or contemplated by the forward-looking statements, including, but not limited to, the following:

 

·                  Negative worldwide economic, financial, and banking conditions, and the recent slowdown of the United States (“U.S.”) economy;

·                  Worldwide economic recession, lack of confidence, and/or high structural unemployment;

·                  Potential defaults on national debt by certain countries;

·                  Potential and further downgrade of the U.S. credit rating;

·                  The continuation of the ongoing economic crisis in Europe;

·                  Failure of the U.S. government to agree on a debt ceiling or deficit reduction plan;

·                  Inability of the U.S. government to avoid the fiscal cliff or sequestration;

·                  Potential and further downgrades of the credit ratings of major financial institutions, or their perceived creditworthiness;

·                  Financial, banking, and credit market conditions;

·                  The seizure or illiquidity of credit markets;

·                  Failure to meet market expectations for our financial performance;

·                  Our inability to obtain capital (debt, construction financing, and/or equity) or refinance debt maturities;

·                  Potential negative impact of capital plan objectives to reduce our balance sheet leverage;

·                  Our inability to comply with financial covenants in our debt agreements;

·                  Inflation or deflation;

·                  Prolonged period of stagnant growth;

·                  Increased interest rates and operating costs;

·                  Adverse economic or real estate developments in our markets;

·                  Our failure to successfully complete and lease our existing space held for redevelopment and new properties acquired for that purpose and any properties undergoing development;

·                  Significant decreases in our active development, active redevelopment, or preconstruction activities, resulting in significant increases in our interest, operating, and payroll expenses;

·                  Our failure to successfully operate or lease acquired properties;

·                  The financial condition of our insurance carriers;

·                  General and local economic conditions;

·                  Government changes to the healthcare system and its negative impact on our client tenants;

·                  Adverse developments concerning the life science industry and/or our life science client tenants;

·                  Client tenant base concentration within life science industry;

·                  Potential decreases in U.S. National Institute of Health (“NIH”) funding;

·                  U.S. government client tenants’ not receiving government funding;

·                  Government-driven changes to the healthcare system that may reduce pricing of drugs, negatively impact healthcare coverage, or negatively impact reimbursement of healthcare services and products;

·                  The nature and extent of future competition;

·                  Lower rental rates and/or higher vacancy rates;

·                  Failure to renew or replace expiring leases;

·                  Defaults on or non-renewal of leases by client tenants;

·                  Availability of and our ability to attract and retain qualified personnel;

·                  Our failure to comply with laws or changes in law;

·                  Compliance with environmental laws;

·                  Extreme weather conditions or climate change;

·                  Our failure to maintain our status as a real estate investment trust (“REIT”) for federal tax purposes;

·                  Changes in laws, regulations, and financial accounting standards;

 

35



Table of Contents

 

·                  Certain ownership interests outside the U.S. that may subject us to different or greater risks than those associated with our domestic operations;

·                  Fluctuations in foreign currency exchange rates;

·                  Security breaches through cyber-attacks or cyber-intrusions;

·                  Changes in the method of determining the London Interbank Offered Rate (“LIBOR”); and

·                  Negative impact on economic growth resulting from the combination of federal income tax increases and government spending restrictions.

 

This list of risks and uncertainties is not exhaustive.  Additional information regarding risk factors that may affect us is included under the headings “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our annual report on Form 10-K for the fiscal year ended December 31, 2012.  Readers of this quarterly report on Form 10-Q should also read our Securities and Exchange Commission (“SEC”) and other publicly filed documents for further discussion regarding such factors.

 

As used in this quarterly report on Form 10-Q, references to the “Company,” “we,” “our,” and “us” refer to Alexandria Real Estate Equities, Inc. and its subsidiaries.  The following discussion should be read in conjunction with the condensed consolidated financial statements and the accompanying notes appearing elsewhere in this quarterly report on Form 10-Q.  References to “GAAP” used herein refer to United States generally accepted accounting principles.

 

Overview

 

We are a self-administered and self-managed investment-grade REIT.  We are the largest and leading REIT focused principally on owning, operating, developing, redeveloping, and acquiring high-quality, sustainable real estate for the broad and diverse life science industry.  Founded in 1994, we are the first REIT to identify and pursue the laboratory niche and have since had the first-mover advantage in the core life science cluster locations including Greater Boston, San Francisco Bay Area, San Diego, New York City, Seattle, Suburban Washington, D.C., and Research Triangle Park.  Our high-credit client tenants span the life science industry, including renowned academic and medical institutions, multinational pharmaceutical companies, public and private biotechnology entities, United States government research agencies, medical device companies, industrial biotech companies, venture capital firms, and life science product and service companies.

 

Our primary business objective is to maximize stockholder value by providing our stockholders with the greatest possible total return and long-term asset value based on a multifaceted platform of internal and external growth.  The key elements to our strategy include our consistent focus on high-quality assets and operations in the top life science cluster locations with our properties located in close proximity to life science entities, driving growth and technological advances within each cluster.  These locations are characterized by high barriers to entry for new landlords, high barriers to exit for client tenants and limited supply of available space.  They represent highly desirable locations for tenancy by life science entities because of the close proximity to concentrations of specialized skills, knowledge, institutions, and related businesses.  Our strategy also includes drawing upon our deep and broad life science and real estate relationships in order to attract new and leading life science client tenants and value-added real estate.  We executed our initial public offering in 1997 and received our investment-grade ratings in 2011.

 

As of March 31, 2013, we had 173 properties aggregating approximately 16.7 million rentable square feet, composed of approximately 14.2 million rentable square feet of operating properties, approximately 2.1 million rentable square feet undergoing active development, and approximately 0.4 million rentable square feet undergoing active redevelopment.  Our operating properties were approximately 93.0% leased as of March 31, 2013.   Investment-grade client tenants represented 46% of our total annualized base rent as of March 31, 2013.  The comparability of financial data from period to period is affected by the timing of our property acquisition, development, and redevelopment activities.

 

36



Table of Contents

 

First Quarter Ended March 31, 2013 Highlights

 

·                  FFO per share – diluted of $1.11, up 3%, for the three months ended March 31, 2013, over March 31, 2012

·                  AFFO per share – diluted of $1.08, up 6%, for the three months ended March 31, 2013, over March 31, 2012

·                  EPS - diluted of $0.36, up 20%, for the three months ended March 31, 2013, over March 31, 2012

 

Core operating metrics

 

·                  Total revenues were $150.4 million, up 11%, for the three months ended March 31, 2013, compared to total revenues for the three months ended March 31, 2012, of $135.7 million;

·                  Net operating income (“NOI”) was $105.2 Million, up 10%, for the three months ended March 31, 2013, compared to NOI for the three months ended March 31, 2012, of $95.3 million;

·                  Investment-grade client tenants represented 46% of total annualized base rent (“ABR”);

·                  Investment-grade client tenants represented 78% of top 10 client tenants’ ABR;

·                  Operating margins remained steady at 70% for the three months ended March 31, 2013;

·                  Annual rent escalations in 96% of leases;

·                  Same property net operating income increased by 8.8% and 0.4% on a cash and GAAP basis, respectively, for the three months ended March 31, 2013, compared to same property net operating income for the three months ended March 31, 2012;

·                  Solid leasing activity during the three months ended March 31, 2013;

·                        Executed 44 leases for 703,000 rentable square feet (“RSF”), including 457,000 RSF of development and redevelopment space;

·                        RSF of remaining expiring leases in 2013 are modest at 4.1% of total RSF;

·                        Rental rate increase of 5.9% and 12.7% on a cash and GAAP basis, respectively, on renewed/re-leased space

·                        Key life science space leasing;

·                  ARIAD Pharmaceuticals, Inc. leased 244,000 RSF in the greater Boston market;

·                  Onyx Pharmaceuticals, Inc. leased 107,250 RSF in the San Francisco Bay area market;

·                  Occupancy of 94.2% for North America operating properties as of March 31, 2013, and occupancy of 91.8% for North America operating and redevelopment properties as of March 31, 2013, compared to occupancy of 94.6% for North America operating properties as of December 31, 2012, and occupancy of 91.6% for North America operating and redevelopment properties as of December 31, 2012.

 

Value-added opportunities and external growth

 

During the three months ended March 31, 2013, we executed leases aggregating 355,000 and 102,000 rentable square feet, respectively, related to our development and redevelopment projects.

 

Our initial stabilized yield on a cash basis reflects cash rents at date of stabilization and does not reflect contractual rent escalations beyond the stabilization date.  Our cash rents related to our value-added projects are expected to increase over time and our average stabilized cash yields are expected, in general, to be greater than our initial stabilized yields.  Initial stabilized yield is calculated as the quotient of the estimated amounts of NOI and our investment in the property at stabilization (“Initial Stabilized Yield”).

 

The following table summarizes the commencement of key development projects (dollars in thousands, except per rentable square foot amounts):

 

 

 

 

 

 

 

 

 

Investment

 

 

 

Initial

 

 

 

 

 

Commencement

 

 

 

 

 

at

 

Cost Per

 

Stabilized Yield

 

Key

 

Address/Market

 

Date

 

RSF

 

Pre-Leased %

 

Completion (1)

 

RSF

 

Cash

 

GAAP

 

Client Tenant

 

Development

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

75/125 Binney Street/Greater Boston

 

January 2013

 

386,275

 

63%

 

$

351,439

(1)

$

910

 

8.0%

 

8.2%

 

ARIAD Pharmaceuticals, Inc.

 

269 East Grand Avenue/San Francisco Bay Area

 

March 2013

 

107,250

 

100%

 

$

51,300

 

$

478

 

8.1%

 

9.3%

 

Onyx Pharmaceuticals, Inc.

 

 

(1)             See “Projected Unconsolidated Joint Venture” on page 64 for further details regarding our guidance for funding the costs to complete

 

37



Table of Contents

 

Balance sheet strategy and significant milestones

 

Our balance sheet strategy continues to focus on our leverage of net debt to adjusted EBITDA of approximately 6.5x targeted by December 31, 2013, by funding our significant Class A development and redevelopment projects in top life science cluster locations with leverage-neutral sources of capital and with the continuing execution of our asset recycling program. Our leverage will reflect periodic increases and decreases quarter to quarter as we execute and deliver our construction projects and capital plan, including our asset sales program.  See “Liquidity and Capital Resources – Sources and Uses of Capital” for additional information.  Our strategy to improve leverage includes:

 

·                  We expect growth in annualized EBITDA from the fourth quarter 2012 to the fourth quarter 2013 due primarily to the completion of significant value-added projects; 93% leased;

·                  We continue to execute our asset recycling program to monetize non-strategic income-producing and non-income producing assets to reduce outstanding debt and provide funds for reinvestment into Class A, CBD, and urban locations in close proximity to leading academic medical research centers;

·                        We sold $124.3 million of income-producing asset sales during the three months ended March 31, 2013; assets sold in first quarter of 2013 generated a weighted-average unlevered internal rate of return of 11% during our ownership period);

·                        We are targeting sales of $209 million to $259 million of non-income-producing assets for the remainder of the year ended December 31, 2013;

·                  $45 million of non-income-producing asset sales under negotiation;

·                  $60 million to $70 million projected partial sale of an interest in the ground-up development of 75/125 Binney Street;

·                  $104 million to $144 million to be identified in the near term;

·                  We expect to continue our present strategy of minimizing the issuance of common equity to achieve a net debt to adjusted EBITDA ratio of approximately 6.5x targeted by December 31, 2013;

·                  Our liquidity available under our unsecured senior line of credit and from cash and cash equivalents was approximately $1.0 billion as of March 31, 2013; and

·                  We anticipate reducing our unhedged variable rate debt as a percentage of total debt to less than 18% targeted by December 31, 2013.

 

As of March 31, 2013, we have completed all significant sales of income-producing assets targeted for 2013.  See our real estate sales discussion in our Sources and Uses of Capital section on page 62.  In addition to the asset sales completed in the first quarter of 2013, we have targeted the sale of non-income-producing assets ranging from $209 to $259 million.  See pages 56 and 57 for additional information on our target non-income-producing asset sales for 2013.

 

Results

 

Core operations

 

The key elements to our strategy include our consistent focus on high-quality assets and operations in the top life science cluster locations; our properties are located adjacent to life science entities, driving growth and technological advances within each cluster.  These adjacency locations are characterized by high barriers to entry for new landlords, high barriers to exit for client tenants, and limited supply of available space.  They represent highly desirable locations for tenancy by life science entities because of the close proximity to concentrations of specialized skills, knowledge, institutions, and related businesses.  Our strategy also includes drawing upon our deep and longstanding life science and real estate relationships in order to attract new and leading life science client tenants that provide us with our unique ability to create value through strong tenant retention and strategic development and redevelopment projects.

 

38



Table of Contents

 

The following table presents information regarding our asset base and value-added projects as of March 31, 2013, and December 31, 2012:

 

Rentable square feet

 

March 31, 2013

 

December 31, 2012

 

Operating properties

 

14,168,626

 

14,992,086

 

Development properties

 

2,060,299

 

1,566,774

 

Redevelopment properties

 

430,523

 

547,092

 

Total rentable square feet

 

16,659,448

 

17,105,952

 

 

 

 

 

 

 

Number of properties

 

173

 

178

 

Occupancy of operating properties

 

93.0%

 

93.4%

 

Occupancy of operating and redevelopment properties

 

90.1%

 

89.8%

 

Annualized base rent per leased rentable square foot

 

$

34.92

 

$

34.59

 

 

Leasing

 

For the three months ended March 31, 2013, we executed a total of 44 leases for approximately 703,000 rentable square feet at 29 different properties (excluding month-to-month leases).  Of this total, approximately 156,000 rentable square feet related to new or renewal leases of previously leased space (renewed/re-leased space), and approximately 547,000 rentable square feet related to developed, redeveloped, or previously vacant space.  Of the 547,000 rentable square feet, approximately 457,000 rentable square feet related to our development or redevelopment projects, and the remaining approximately 90,000 rentable square feet related to previously vacant space.  Rental rates for renewed/re-leased spaces were, on average, approximately 5.9% higher on a cash basis and approximately 12.7% higher on a GAAP basis than rental rates for the respective expiring leases.  Additionally, we granted tenant concessions, including free rent averaging approximately 1.2 months, with respect to the 703,000 rentable square feet leased during the three months ended March 31, 2013.  Approximately 65.9% of the number of leases executed during the three months ended March 31, 2013, did not include concessions for free rent.  The weighted average lease term based on leased square feet for the leases executed during the three months ended March 31, 2013, was 8.7 years.

 

As of March 31, 2013, approximately 94% of our leases (on a rentable square footage basis) were triple net leases, requiring client tenants to pay substantially all real estate taxes, insurance, utilities, common area expenses, and other operating expenses (including increases thereto) in addition to base rent.  Additionally, approximately 96% of our leases (on a rentable square footage basis) contained effective annual rent escalations that were either fixed or indexed based on a consumer price index or another index, and approximately 92% of our leases (on a rentable square footage basis) provided for the recapture of certain capital expenditures.

 

39



Table of Contents

 

The following table summarizes our leasing activity at our properties:

 

 

 

Three
Months Ended

 

Twelve
Months Ended

 

Year Ended

 

 

 

March 31, 2013

 

March 31, 2013

 

December 31, 2012

 

December 31, 2011

 

December 31, 2010

 

Leasing activity:

 

Cash

 

GAAP

 

Cash

 

GAAP

 

Cash

 

GAAP

 

Cash

 

GAAP

 

Cash

 

GAAP

 

Lease expirations

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Number of leases

 

49

 

49

 

152

 

152

 

162

 

162

 

158

 

158

 

129

 

129

 

Rentable square footage

 

360,956

 

360,956

 

2,183,948

 

2,183,948

 

2,350,348

 

2,350,348

 

2,689,257

 

2,689,257

 

2,416,291

 

2,416,291

 

Expiring rates

 

$32.83

 

$30.21

 

$30.95

 

$28.15

 

$30.03

 

$27.65

 

$29.98

 

$28.42

 

$27.18

 

$28.54

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Renewed/re-leased space

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Number of leases

 

19

 

19

 

85

 

85

 

102

 

102

 

109

 

109

 

89

 

89

 

Leased rentable square footage

 

155,881

 

155,881

 

1,356,755

 

1,356,755

 

1,475,403

 

1,475,403

 

1,821,866

 

1,821,866

 

1,777,966

 

1,777,966

 

Expiring rates

 

$29.70

 

$28.12

 

$31.78

 

$30.20

 

$30.47

 

$28.87

 

$30.73

 

$28.79

 

$28.84

 

$30.54

 

New rates

 

$31.45

 

$31.70

 

$31.45

 

$32.08

 

$29.86

 

$30.36

 

$30.16

 

$30.00

 

$29.41

 

$32.04

 

Rental rate changes

 

5.9%

 

12.7%

 

(1.0%

)

6.2%

 

(2.0%

) (1)

5.2%

 (1)

(1.9%

)

4.2%

 

2.0%

 

4.9%

 

TI’s/lease commissions per square foot

 

$5.66

 

$5.66

 

$5.93

 

$5.93

 

$6.22

 

$6.22

 

$5.82

 

$5.82

 

$4.40

 

$4.40

 

Average lease terms

 

2.6 years

 

2.6 years

 

4.7 years

 

4.7 years

 

4.7 years

 

4.7 years

 

4.2 years

 

4.2 years

 

8.1 years

 

8.1 years

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Developed/redeveloped/previously vacant space leased

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Number of leases

 

25

 

25

 

83

 

83

 

85

 

85

 

81

 

81

 

53

 

53

 

Rentable square footage

 

547,020

 

547,020

 

1,715,316

 

1,715,316

 

1,805,693

 

1,805,693

 

1,585,610

 

1,585,610

 

966,273

 

966,273

 

New rates

 

$50.89

 

$52.54

 

$35.08

 

$36.30

 

$30.66

 

$32.56

 

$33.45

 

$36.00

 

$36.33

 

$39.89

 

TI’s/lease commissions per square foot

 

$7.52

 

$7.52

 

$9.77

 

$9.77

 

$11.02

 

$11.02

 

$12.78

 

$12.78

 

$8.10

 

$8.10

 

Average lease terms

 

10.4 years

 

10.4 years

 

9.2 years

 

9.2 years

 

9.0 years

 

9.0 years

 

8.9 years

 

8.9 years

 

9.7 years

 

9.7 years

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Leasing activity summary:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Totals (2)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Number of leases

 

44

 

44

 

168

 

168

 

187

 

187

 

190

 

190

 

142

 

142

 

Rentable square footage

 

702,901

 

702,901

 

3,072,071

 

3,072,071

 

3,281,096

 

3,281,096

 

3,407,476

 

3,407,476

 

2,744,239

 

2,744,239

 

New rates

 

$46.58

 

$47.92

 

$33.48

 

$34.44

 

$30.30

 

$31.57

 

$31.69

 

$32.79

 

$31.84

 

$34.80

 

TI’s/lease commissions per square foot

 

$7.11

 

$7.11

 

$8.07

 

$8.07

 

$8.87

 

$8.87

 

$9.06

 

$9.06

 

$5.70

 

$5.70

 

Average lease terms

 

8.7 years

 

8.7 years

 

7.3 years

 

7.3 years

 

7.1 years

 

7.1 years

 

6.4 years

 

6.4 years

 

8.7 years

 

8.7 years

 

 

(1)

Excluding one lease for 48,000 rentable square feet in the Research Triangle Park market, and two leases for 141,000 rentable square feet in the Suburban Washington, D.C., market, rental rates for renewed/re-leased space were, on average, 0.4% higher and 7.1% higher than rental rates for expiring leases on a cash and GAAP basis, respectively.

(2)

Excludes 14 month-to-month leases for approximately 53,946 rentable square feet.

 

During the three months ended March 31, 2013, we granted tenant concessions/free rent averaging approximately 1.2 month with respect to the 702,901 rentable square feet leased.

 

Lease Structure

 

March 31, 2013

 

Percentage of triple net leases

 

94%

 

Percentage of leases containing annual rent escalations

 

96%

 

Percentage of leases providing for the recapture of capital expenditures

 

92%

 

 

The following chart presents development/redevelopment space leased and renewed/re-leased/previously vacant space leased:

 

GRAPHIC

 

40


 


Table of Contents

 

Summary of Lease Expirations

 

The following table summarizes information with respect to the lease expirations at our properties as of March 31, 2013:

 

Year of Lease Expiration

 

Number of Leases Expiring

 

RSF of Expiring Leases

 

Percentage of
Aggregate Total RSF

 

Annualized Base Rent of Expiring Leases (per RSF)

 

2013

 

63

 (1)

 

568,189

 (1)

 

4.1%

 

 

$29.30

 

2014

 

93

 

 

1,175,374

 

 

8.6%

 

 

$29.20

 

2015

 

75

 

 

1,385,596

 

 

10.1%

 

 

$32.75

 

2016

 

57

 

 

1,342,621

 

 

9.8%

 

 

$30.20

 

2017

 

63

 

 

1,573,451

 

 

11.5%

 

 

$30.58

 

2018

 

28

 

 

1,185,758

 

 

8.6%

 

 

$39.80

 

2019

 

22

 

 

680,031

 

 

5.0%

 

 

$32.85

 

2020

 

16

 

 

762,229

 

 

5.6%

 

 

$40.25

 

2021

 

20

 

 

799,802

 

 

5.8%

 

 

$37.12

 

2022

 

15

 

 

551,214

 

 

4.0%

 

 

$29.43

 

Thereafter

 

26

 

 

2,278,602

 

 

16.6%

 

 

$39.96

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Annualized

 

 

 

 

 

2013 RSF of Expiring Leases

 

Base Rent of

 

 

 

 

 

 

 

Negotiating/

 

Targeted for

 

Remaining

 

 

 

Expiring Leases

 

Market Rent

 

Market

 

Leased

 

Anticipating

 

Redevelopment

 

Expiring Leases

 

Total

 

(per RSF)

 

per RSF (2)

 

Greater Boston

 

4,543

 

31,640

 

 

93,642

 

129,825

 

$

38.24

 

$25.00 - $59.00

 

San Francisco Bay Area

 

49,125

 

29,184

 

 

49,915

 

128,224

 

24.76

 

$20.00 - $47.00

 

San Diego

 

 

 

 

61,463

 

61,463

 

23.12

 

$16.00 - $36.00

 

Greater NYC

 

 

 

 

 

 

 

N/A           

 

Suburban Washington, D.C.

 

 

121,068

 (3)

 

54,163

 

175,231

 

33.83

 

$15.00 - $32.00

 

Seattle

 

 

1,350

 

 

5,938

 

7,288

 

17.12

 

$17.00 - $44.00

 

Research Triangle Park

 

1,658

 

10,603

 

 

39,044

 

51,305

 

16.46

 

$10.00 - $32.00

 

Canada

 

 

 

 

 

 

 

N/A           

 

Non-cluster markets

 

 

3,508

 

 

1,000

 

4,508

 

12.35

 

$14.00 - $25.00

 

Asia

 

 

5,587

 

 

4,758

 

10,345

 

13.14

 (4)

$11.00 - $26.00

 

Total

 

55,326

 

202,940

 

 

309,923

 

568,189

 (1)

$

29.30

 

 

 

Percentage of expiring leases

 

10

 %

36

 %

 %

54

 %

100

 %

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Annualized

 

 

 

 

 

2014 RSF of Expiring Leases

 

Base Rent of

 

 

 

 

 

 

 

Negotiating/

 

Targeted for

 

Remaining

 

 

 

Expiring Leases

 

Market Rent

 

Market

 

Leased

 

Anticipating

 

Redevelopment

 

Expiring Leases

 

Total

 

(per RSF)

 

per RSF (2)

 

Greater Boston

 

 

63,360

 

 

258,609

 

321,969

 

$

37.97

 

$25.00 - $59.00

 

San Francisco Bay Area

 

19,177

 

31,760

 

 

292,842

 

343,779

 

27.22

 

$20.00 - $47.00

 

San Diego

 

 

 

 

42,717

 

42,717

 

24.72

 

$16.00 - $36.00

 

Greater NYC

 

 

5,271

 

 

85,497

 

90,768

 

38.65

 

$20.00 - $70.00

 

Suburban Washington, D.C.

 

7,638

 

8,319

 

85,297

 (5)

71,474

 

172,728

 

19.36

 

$15.00 - $32.00

 

Seattle

 

 

13,935

 

 

5,794

 

19,729

 

43.01

 

$17.00 - $44.00

 

Research Triangle Park

 

 

10,527

 

 

38,721

 

49,248

 

21.96

 

$10.00 - $32.00

 

Canada

 

12,649

 

 

 

80,008

 

92,657

 

23.29

 

$20.00 - $30.00

 

Non-cluster markets

 

 

 

 

15,817

 

15,817

 

19.99

 

$14.00 - $25.00

 

Asia

 

 

15,760

 

 

3,862

 

19,622

 

13.43

 (4)

$11.00 - $26.00

 

Total

 

39,464

 

148,932

 

85,297

 

895,341

 

1,169,034

 

$

29.20

 

 

 

Percentage of expiring leases

 

3

 %

13

 %

7

 %

77

 %

100

 %

 

 

 

 

 

(1)

Excludes 14 month-to-month leases for approximately 53,946 rentable square feet.

(2)

Based upon rental rates achieved in recently executed leases over the trailing 12 months and our estimate of market rents.

(3)

Includes 54,906 rentable square feet at 5 Research Court. We expect the tenant to extend their lease beyond their 2013 lease expiration date. This property consists of non-laboratory space and upon rollover will undergo conversion into laboratory space through redevelopment.

(4)

Our current investment in this property is approximately $90 per rentable square foot.

(5)

Represents projects containing 60,000 rentable square feet and 25,000 rentable square feet at 930 Clopper Road and 1500 East Gude Drive, respectively, which we expect to convert from non-laboratory space to laboratory space through redevelopment.

 

41



Table of Contents

 

Location of properties

 

The locations of our properties are diversified among a number of life science cluster markets.  The following table sets forth, as of March 31, 2013, the total rentable square feet and annualized base rent of our properties in each of our existing markets (dollars in thousands):

 

 

 

Rentable Square Feet

 

Number of

 

 

Market

 

Operating

 

Development

 

Redevelopment

 

Total

 

% Total

 

Properties

 

Annualized Base Rent (1)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Greater Boston

 

3,043,048

 

691,487

 

76,241

 

3,810,776

 

23

%

 

36

 

 

$

118,060

 

27

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

San Francisco Bay Area

 

2,486,751

 

330,030

 

53,980

 

2,870,761

 

17

 

 

26

 

 

93,816

 

22

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

San Diego

 

2,575,121

 

 

68,423

 

2,643,544

 

16

 

 

33

 

 

83,636

 

20

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Greater NYC

 

494,656

 

419,806

 

 

914,462

 

5

 

 

6

 

 

31,844

 

7

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Suburban Washington, D.C.

 

2,086,468

 

 

67,055

 

2,153,523

 

13

 

 

29

 

 

43,172

 

10

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Seattle

 

680,835

 

 

65,681

 

746,516

 

4

 

 

10

 

 

28,346

 

7

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Research Triangle Park

 

941,807

 

 

 

941,807

 

6

 

 

14

 

 

18,852

 

4

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Canada

 

1,103,507

 

 

 

1,103,507

 

7

 

 

5

 

 

9,258

 

2

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-cluster markets

 

61,002

 

 

 

61,002

 

 

 

2

 

 

611

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

North America

 

13,473,195

 

1,441,323

 

331,380

 

15,245,898

 

91

 

 

161

 

 

427,595

 

99

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Asia

 

603,987

 

618,976

 

99,143

 

1,322,106

 

8

 

 

9

 

 

4,337

 

1

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Continuing operations

 

14,077,182

 

2,060,299

 

430,523

 

16,568,004

 

99

 

 

170

 

 

431,932

 

100

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Discontinued operations

 

91,444

 

 

 

91,444

 

1

 

 

3

 

 

1,138

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total

 

14,168,626

 

2,060,299

 

430,523

 

16,659,448

 

100

%

 

173

 

 

$

433,070

 

 

 

 

(1)               Annualized base rent means the annualized fixed base rental amount in effect as of March 31, 2013 (using rental revenue computed on a straight-line basis in accordance with GAAP).  Represents annualized base rent related to our operating rentable square feet.

 

The chart below illustrates our annualized base rent as of March 31, 2013, in leading “brain trust” cluster markets:

 

GRAPHIC

 

42



Table of Contents

 

Summary of occupancy percentages

 

The occupancy percentages of our properties are consistent throughout our science cluster markets.  The following table sets forth the occupied percentage for our operating assets and our assets under redevelopment in each of our existing markets as of March 31, 2013:

 

 

 

Operating Properties

 

Operating and Redevelopment Properties

 

Market

 

March 31, 2013

 

December 31, 2012

 

March 31, 2012

 

March 31, 2013

 

December 31, 2012

 

March 31, 2012

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Greater Boston

 

95.8

%

 

94.6

%

 

91.7

%

 

93.5

%

 

91.6

%

 

83.0

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

San Francisco Bay Area

 

95.8

 

 

97.8

 

 

96.2

 

 

93.8

 

 

95.7

 

 

93.9

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

San Diego

 

93.4

 

 

95.1

 

 

96.1

 

 

91.0

 

 

91.9

 

 

81.5

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Greater NYC

 

98.4

 

 

95.7

 

 

93.0

 

 

98.4

 

 

95.7

 

 

93.0

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Suburban Washington, D.C.

 

90.8

 

 

90.9

 

 

94.2

 

 

88.0

 

 

88.1

 

 

90.4

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Seattle

 

96.7

 

 

93.9

 

 

96.7

 

 

88.2

 

 

80.1

 

 

91.4

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Research Triangle Park

 

93.6

 

 

95.5

 

 

95.8

 

 

93.6

 

 

95.5

 

 

95.8

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Canada

 

94.7

 

 

98.1

 

 

91.8

 

 

94.7

 

 

98.1

 

 

91.8

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-cluster markets

 

54.0

 

 

51.4

 

 

51.4

 

 

54.0

 

 

51.4

 

 

51.4

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

North America

 

94.2

 

 

94.6

 

 

94.2

 

 

91.8

 

 

91.6

 

 

87.9

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Asia

 

67.1

 

 

66.2

 

 

N/A

 

 

57.7

 

 

55.3

 

 

N/A

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Continuing operations

 

93.0

%

 

93.4

%

 

94.2

%

 

90.1

%

 

89.8

%

 

87.9

%

 

 

For a detail listing of our complete properties portfolio please see our “Earnings Release and Supplemental Information for First Quarter Ended March 31, 2013”.

 

43



Table of Contents

 

Client tenants

 

Our life science properties are leased to a diverse group of client tenants, with no client tenant accounting for more than 7.1% of our annualized base rent.  The following table sets forth information regarding leases with our 20 largest client tenants based upon annualized base rent as of March 31, 2013 (dollars in thousands):

 

 

 

 

 

 

 

Remaining Lease

 

Approximate
Aggregate

 

Percentage
of
Aggregate

 

 

 

Percentage
of
Aggregate

 

Investment-Grade
Client Tenants (3)

 

 

 

 

 

 

 

Number

 

Term in Years

 

Rentable

 

Total

 

Annualized

 

Annualized

 

Fitch

 

Moody’s

 

S&P

 

Education/

 

 

 

Client Tenant

 

of Leases

 

(1)

 

(2)

 

Square Feet

 

Square Feet

 

Base Rent

 

Base Rent

 

Rating

 

Rating

 

Rating

 

Research

 

1

 

Novartis AG

 

11

 

3.8

 

3.9

 

612,424

 

3.7

%

 

 

$

30,515

 

7.1

%

 

AA

 

Aa2

 

AA-

 

 

2

 

Illumina, Inc.

 

1

 

18.6

 

18.6

 

497,078

 

3.0

 

 

 

19,531

 

4.5

 

 

 

 

 

 

3

 

Bristol-Myers Squibb Company

 

6

 

4.6

 

4.9

 

419,624

 

2.5

 

 

 

15,840

 

3.7

 

 

A

 

A2

 

A+

 

 

4

 

Eli Lilly and Company

 

5

 

8.3

 

9.9

 

262,182

 

1.6

 

 

 

15,068

 

3.5

 

 

A

 

A2

 

AA-

 

 

5

 

FibroGen, Inc.

 

1

 

10.6

 

10.6

 

234,249

 

1.4

 

 

 

14,197

 

3.3

 

 

 

 

 

 

6

 

Roche

 

3

 

5.0

 

5.1

 

348,918

 

2.1

 

 

 

13,867

 

3.2

 

 

AA-

 

A1

 

AA

 

 

7

 

United States Government

 

9

 

4.0

 

5.0

 

332,578

 

2.0

 

 

 

13,103

 

3.0

 

 

AAA

 

Aaa

 

AA+

 

 

8

 

GlaxoSmithKline plc

 

5

 

6.7

 

6.4

 

208,394

 

1.2

 

 

 

10,232

 

2.4

 

 

A+

 

A1

 

A+

 

 

9

 

Celgene Corporation

 

3

 

8.4

 

8.3

 

250,586

 

1.5

 

 

 

9,340

 

2.2

 

 

 

Baa2

 

BBB+

 

 

10

 

Massachusetts Institute of Technology

 

4

 

4.2

 

4.4

 

185,403

 

1.1

 

 

 

8,499

 

2.0

 

 

 

Aaa

 

AAA

 

ü

 

11

 

Onyx Pharmaceuticals, Inc.

 

2

 

10.1

 

10.1

 

228,373

 

1.4

 

 

 

8,498

 

2.0

 

 

 

 

 

 

12

 

NYU-Neuroscience Translational Research Institute

 

2

 

11.9

 

10.8

 

86,756

 

0.5

 

 

 

8,012

 

1.8

 

 

A-

 

A3

 

AA-

 

ü

 

13

 

The Regents of the University of California

 

3

 

8.4

 

8.4

 

188,654

 

1.1

 

 

 

7,787

 

1.8

 

 

AA

 

Aa1

 

AA

 

ü

 

14

 

Alnylam Pharmaceuticals, Inc.

 

1

 

3.5

 

3.5

 

129,424

 

0.8

 

 

 

6,081

 

1.4

 

 

 

 

 

 

15

 

Gilead Sciences, Inc.

 

1

 

7.3

 

7.3

 

109,969

 

0.7

 

 

 

5,824

 

1.3

 

 

 

Baa1

 

A-

 

 

16

 

Pfizer Inc.

 

2

 

6.2

 

5.9

 

116,518

 

0.7

 

 

 

5,502

 

1.3

 

 

A+

 

A1

 

AA

 

 

17

 

The Scripps Research Institute

 

2

 

3.7

 

3.6

 

101,475

 

0.6

 

 

 

5,200

 

1.2

 

 

AA-

 

Aa3

 

 

ü

 

18

 

Theravance, Inc. (4)

 

2

 

7.2

 

7.2

 

130,342

 

0.8

 

 

 

4,895

 

1.1

 

 

 

 

 

 

19

 

Infinity Pharmaceuticals, Inc.

 

2

 

1.8

 

1.8

 

68,020

 

0.4

 

 

 

4,423

 

1.0

 

 

 

 

 

 

20

 

Quest Diagnostics Incorporated

 

1

 

3.8

 

3.8

 

248,186

 

1.5

 

 

 

4,341

 

1.0

 

 

BBB+

 

Baa2

 

BBB+

 

 

 

 

Total/Weighted Average Top 20:

 

66

 

7.3

 

7.5

 

4,759,153

 

28.6

%

 

 

$

210,755

 

48.8

%

 

 

 

 

 

 

 

 

 

 

(1)

Represents remaining lease term in years based on percentage of leased square feet.

(2)

Represents remaining lease term in years based on percentage of annualized base rent in effect as of March 31, 2013.

(3)

Ratings obtained from Fitch Ratings, Moody’s Investors Service, and Standard & Poor’s.

(4)

As of February 14, 2013, GlaxoSmithKline plc owned approximately 27% of the outstanding stock of Theravance, Inc.

 

The chart below shows client tenant business type by annualized base rent as of March 31, 2013:

 

GRAPHIC

 

44



Table of Contents

 

Development, Redevelopment, and Future Value-Added Projects

 

A key component of our business model is our value-added development and redevelopment projects.  These programs are focused on providing high-quality, generic, and reusable life science laboratory space to meet the real estate requirements of a wide range of clients in the life science industry.  Upon completion, each value-added project is expected to generate significant revenues and cash flows.  Our development and redevelopment projects are generally in locations that are highly desirable to life science entities, which we believe results in higher occupancy levels, longer lease terms, and higher rental income and returns.

 

Development projects generally consist of the ground-up development of generic and reusable life science laboratory facilities.  Redevelopment projects generally consist of the permanent change in use of office, warehouse, and shell space into generic life science laboratory space.  We anticipate execution of new active development projects for aboveground vertical construction of new life science laboratory space generally with significant pre-leasing.  Preconstruction activities include entitlements, permitting, design, site work, and other activities prior to commencement of vertical construction of aboveground shell and core improvements.  Our objective also includes the advancement of preconstruction efforts to reduce the time required to deliver projects to prospective client tenants.  These critical activities add significant value for future ground-up development and are required for the vertical construction of buildings.  Ultimately, these projects will provide high-quality facilities for the life science industry and are expected to generate significant revenue and cash flows for the Company.

 

As of March 31, 2013, we had six ground-up development projects in process, including an unconsolidated joint venture development project, aggregating approximately 1,854,859 rentable square feet.  We also had seven projects undergoing conversion into laboratory space through redevelopment, aggregating approximately 331,380 rentable square feet.  These projects, along with recently delivered projects, certain future projects, and contribution from same properties, are expected to contribute significant increases in rental income, NOI, and cash flows.

 

Our investments in real estate, net, consisted of the following as of March 31, 2013 (dollars in thousands):

 

 

 

March 31, 2013

 

 

 

Book Value

 

Square Feet

 

Rental properties:

 

 

 

 

 

Land (related to rental properties)

 

$

516,957

 

 

 

Buildings and building improvements

 

4,955,207

 

 

 

Other improvements

 

163,864

 

 

 

Rental properties

 

5,636,028

 

14,168,626

 

Less: accumulated depreciation

 

(849,891

)

 

 

Rental properties, net

 

4,786,137

 

 

 

 

 

 

 

 

 

Construction in progress (“CIP”)/current value-added projects:

 

 

 

 

 

Active development in North America

 

579,273

 

1,441,323

 

Investment in unconsolidated real estate entity

 

30,730

 

413,536

 

Active redevelopment in North America

 

141,470

 

331,380

 

Generic infrastructure/building improvement projects in North America

 

62,869

 

 

 

Active development and redevelopment in Asia

 

101,357

 

718,119

 

 

 

915,699

 

2,904,358

 

 

 

 

 

 

 

Subtotal

 

5,701,836

 

17,072,984

 

 

 

 

 

 

 

Land/future value-added projects:

 

 

 

 

 

Land subject to sale negotiations (1)

 

45,378

 

399,888

 

Land undergoing preconstruction activities (additional CIP) in North America

 

305,300

 

2,017,667

 

Land held for future development in North America

 

238,933

 

3,692,181

 

Land held for future development/land undergoing preconstruction activities (additional CIP) in Asia

 

83,735

 

6,828,864

 

 

 

673,346

 

12,938,600

 

 

 

 

 

 

 

Investments in real estate, net

 

$

6,375,182

 

30,011,584

 

 

(1)         See pages 56 and 57 for additional information on our target non-income-producing asset sales for 2013.

 

45



Table of Contents

 

As of March 31, 2013, our active development and redevelopment projects represent 13% of gross investments in real estate, a significant amount of which is pre-leased and expected to be primarily delivered over the next one to eight quarters.  Land undergoing preconstruction activities represents 5% of gross investment in real estate.  The largest project primarily included in land undergoing preconstruction consists of our 1.2 million developable square feet at Alexandria Center™ at Kendall Square in East Cambridge, Massachusetts.  Land held for future development represent 4% of our non-income-producing assets.  Over the next few years, we may also identify certain land parcels for potential sale.  Non-income-producing assets as a percentage of our gross investments in real estate is targeted to decrease to a range from 15% to 17% by December 31, 2013, and targeted to be 15% or less for the subsequent periods.

 

The chart below shows the historical trend of non-income-producing assets as a percentage of our gross investments in real estate:

 

GRAPHIC

 

46


 


Table of Contents

 

The following table provides detail on all of our active development projects in North America as of March 31, 2013 (dollars in thousands, except per rentable square foot amounts):

 

 

 

Project RSF (1)

 

Leased Status RSF (1)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

% Leased/

 

 

Property/Market Submarket

 

CIP

 

Total

 

Leased

 

Negotiating

 

Marketing

 

Total

 

Negotiating

 

Client Tenants

All active development projects in North America

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Consolidated development projects in North America

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

225 Binney Street/Greater Boston – Cambridge

 

305,212

 

305,212

 

305,212

 

 

 

305,212

 

100%

 

Biogen Idec Inc.

499 Illinois Street/San Francisco Bay Area – Mission Bay

 

222,780

 

222,780

 

 

162,549

 

60,231

 

222,780

 

  73%

 

TBA

269 East Grand Avenue/San Francisco Bay Area – South San Francisco

 

107,250

 

107,250

 

107,250

 

 

 

107,250

 

100%

 

Onyx Pharmaceuticals, Inc.

430 East 29th Street/Greater NYC – Manhattan

 

419,806

 

419,806

 

60,816

 

152,488

 (2)

206,502

 

419,806

 

  51%

 

Roche/TBA

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Projected unconsolidated joint venture

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

75/125 Binney Street/Greater Boston – Cambridge

 

386,275

 

386,275

 

244,123

 

 

142,152

 (3)

386,275

 

  63%

 

ARIAD Pharmaceuticals, Inc.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Consolidated development projects in North America

 

1,441,323

 

1,441,323

 

717,401

 

315,037

 

408,885

 

1,441,323

 

  72%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Unconsolidated joint venture

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

360 Longwood Avenue/Greater Boston – Longwood

 

413,536

 

413,536

 

154,100

 

 

259,436

 

413,536

 

  37%

 

Dana-Farber Cancer Institute, Inc.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total/weighted average

 

1,854,859

 

1,854,859

 

871,501

 

315,037

 

668,321

 

1,854,859

 

  64%

 

 

 

 

 

Investment (1)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Projected

 

 

 

Cost

 

Initial Stabilized

 

Project

 

Initial

 

 

 

 

 

 

Cost To Complete

 

Sale

 

Total at

 

Per

 

Yield (1)

 

Start

 

Occupancy

 

Stabilization

Property/Market Submarket

 

CIP

 

2013

 

Thereafter

 

of Interest

 

Completion

 

RSF

 

Cash

 

GAAP

 

Date (1)

 

Date (1)

 

Date (1)

All active development projects in North America

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Consolidated development projects in North America

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

225 Binney Street/Greater Boston – Cambridge

 

$

118,595

 

$

61,678

 

$

 

$

 

$

180,273

 

$

591

 

7.5%

 

8.1%

 

4Q11

 

4Q13

 

4Q13

499 Illinois Street/San Francisco Bay Area – Mission Bay

 

$

116,110

 

$

14,298

 

$

22,801

 

$

 

$

153,209

 

$

688

 

6.4%

 

7.2%

 

2Q11

 

2Q14

 

2014

269 East Grand Avenue/San Francisco Bay Area – South San Francisco (4)

 

$

8,037

 

$

13,100

 

$

30,163

 

$

 

$

51,300

 

$

478

 

8.1%

 

9.3%

 

1Q13

 

4Q14

 

2014

430 East 29th Street/Greater NYC – Manhattan

 

$

239,086

 

$

113,879

 

$

110,280

 

$

 

$

463,245

 

$

1,103

 

6.6%

 

6.5%

 

4Q12

 

4Q13

 

2015

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Projected unconsolidated joint venture

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

75/125 Binney Street/Greater Boston – Cambridge (5)

 

$

97,445

 

$

90,871

 

$

163,123

 

$

 

$

351,439

 

$

910

 

8.0%

 

8.2%

 

1Q13

 

1Q15

 

2015

JV partner capital/JV construction loan

 

$

 

$

(47,025

)

$

(163,123

)

$

 

$

(210,148

)

 

 

 

 

 

 

 

 

 

 

 

Projected sale of interest

 

$

 

$

 

$

 

$

(65,000

)

$

(65,000

)

 

 

 

 

 

 

 

 

 

 

 

ARE investment in 75/125 Binney Street project

 

$

97,445

 

$

43,846

 

$

 

$

(65,000

)

$

76,291

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Consolidated development projects in North America

 

$

579,273

 

$

246,801

 

$

163,244

 

$

(65,000

)

$

924,318

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Unconsolidated joint venture

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

360 Longwood Avenue/Greater Boston – Longwood

 

$

148,596

 

$

67,744

 

$

133,660

 

$

 

$

350,000

 

$

846

 

8.3%

 

8.9%

 

2Q12

 

4Q14

 

2016

JV partner capital/JV construction loan

 

$

(123,638

)

$

(51,761

)

$

(133,660

)

$

 

$

(309,059

)

 

 

 

 

 

 

 

 

 

 

 

ARE investment in 360 Longwood Avenue

 

$

24,958

 

$

15,983

 

$

 

$

 

$

40,941

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total/weighted average

 

$

604,231

 

$

262,784

 

$

163,244

 

$

(65,000

)

$

965,259

 

 

 

 

 

 

 

 

 

 

 

 

 

(1)             All project information, including rentable square feet; investment; Initial Stabilized Yields; and project start, occupancy and stabilization dates, relates to the discrete portion of each property undergoing active development or redevelopment.  A redevelopment project does not necessarily represent the entire property or the entire vacant portion of a property.  Our Initial Stabilized Yield on a cash basis reflects cash rents at date of stabilization and does not reflect contractual rent escalations beyond the stabilization date.  Our cash rents related to our value-added projects are expected to increase over time and our average stabilized cash yields are expected, in general, to be greater than our Initial Stabilized Yields.  Our estimates for initial cash and GAAP yields, and total costs at completion, represent our initial estimates at the commencement of the project.  We expect to update this information upon completion of the project, or sooner if there are significant changes to the expected project yields or costs.  As of March 31, 2013, 96% of our leases contained annual rent escalations that were either fixed or based on a consumer price index or another index

(2)             Represents 131,000 rentable square feet subject to an executed letter of intent with the remainder subject to letters of intent or lease negotiations.

(3)             ARIAD Pharmaceuticals, Inc. has potential additional expansion opportunities at 75 Binney Street through June 2014.

(4)             Funding for 70% of the estimated total investment at completion for 269 East Grand Avenue is expected to be provided primarily by a secured construction loan.

(5)             Represent the mid points of our guidance assumptions related to estimated funding amounts provided by joint venture partner capital, joint venture construction loan, and Alexandria.  See page 63 for additional information on our range of guidance for funding on this project.

 

47



Table of Contents

 

The following table provides detail on all of our active redevelopment projects in North America as of March 31, 2013 (dollars in thousands, except per rentable square foot amounts):

 

 

 

Project RSF (1)

 

Leased Status RSF (1)

 

 

 

 

 

 

 

 

 

In

 

 

 

 

 

 

 

 

 

 

 

 

 

% Leased/

 

Former

 

Use After

 

 

 

Property/Market - Submarket

 

Service

 

CIP

 

Total

 

Leased

 

Negotiating

 

Marketing

 

Total

 

Negotiating

 

Use

 

Conversion

 

Client Tenants

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

All active redevelopment projects in North America

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

400 Technology Square/

Greater Boston – Cambridge

 

162,153

 

49,971

 

212,124

 

169,939

 

 

42,185

 

212,124

 

80%

 

Office

 

Laboratory

 

Ragon Institute of MGH, MIT and Harvard; Epizyme, Inc.; Warp Drive Bio, LLC; Aramco Services Company, Inc.

 

285 Bear Hill Road/Greater Boston – Route 128

 

 

26,270

 

26,270

 

26,270

 

 

 

26,270

 

100%

 

Office/

Manufacturing

 

Laboratory

 

Intelligent Medical Devices, Inc.

 

343 Oyster Point/

San Francisco Bay Area – South San Francisco

 

 

53,980

 

53,980

 

42,445

 

 

11,535

 

53,980

 

79%

 

Office

 

Laboratory

 

Calithera BioSciences, Inc.; CytomX Therapeutics, Inc.

 

4757 Nexus Center Drive/

San Diego – University Town Center

 

 

68,423

 

68,423

 

68,423

 

 

 

68,423

 

100%

 

Manufacturing/

Warehouse/

Office/R&D

 

Laboratory

 

Genomatica, Inc.

 

9800 Medical Center Drive/

Suburban Washington, D.C. – Rockville

 

8,001

 

67,055

 

75,056

 

75,056

 

 

 

75,056

 

100%

 

Office/Laboratory

 

Laboratory

 

National Institutes of Health

 

1551 Eastlake Avenue/Seattle – Lake Union

 

77,821

 

39,661

 

117,482

 

77,821

 

 

39,661

 

117,482

 

66%

 

Office

 

Laboratory

 

Puget Sound Blood Center and Program

 

1616 Eastlake Avenue/Seattle – Lake Union

 

40,756

 

26,020

 

66,776

 

40,756

 

 

26,020

 

66,776

 

61%

 

Office

 

Laboratory

 

Infectious Disease Research Institute

 

Total/weighted average

 

288,731

 

331,380

 

620,111

 

500,710

 

 

119,401

 

620,111

 

81%

 

 

 

 

 

 

 

 

 

 

Investment (1)

 

Initial Stabilized

 

Project

 

Initial

 

 

 

 

 

March 31, 2013

 

To Complete

 

Total at

 

Cost Per

 

Yield (1)

 

Start

 

Occupancy

 

Stabilization

 

Property/Market - Submarket

 

In Service

 

CIP

 

2013

 

Thereafter

 

Completion

 

RSF

 

Cash

 

GAAP

 

Date (1)

 

Date (1)

 

Date (1)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

All active redevelopment projects in North America

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

400 Technology Square/

Greater Boston – Cambridge

 

$

99,980

 

$

32,212

 

$

9,176

 

$

3,320

 

$

144,688

 

$

682

 

8.1%

 

8.9%

 

4Q11

 

4Q12

 

4Q13

 

285 Bear Hill Road/Greater Boston – Route 128

 

$

 

$

4,654

 

$

4,542

 

$

 

$

9,196

 

$

350

 

8.4%

 

8.8%

 

4Q11

 

3Q13

 

2013

 

343 Oyster Point/

San Francisco Bay Area – South San Francisco

 

$

 

$

10,912

 

$

5,560

 

$

867

 

$

17,339

 

$

321

 

9.6%

 

9.8%

 

1Q12

 

3Q13

 

2014

 

4757 Nexus Center Drive/

San Diego – University Town Center

 

$

 

$

5,879

 

$

23,747

 

$

5,203

 

$

34,829

 

$

509

 

7.6%

 

7.8%

 

4Q12

 

4Q13

 

4Q13 (2)

 

9800 Medical Center Drive/

Suburban Washington, D.C. – Rockville

 

$

7,454

 

$

61,251

 

$

11,999

 

$

 

$

80,704

 

(3)

 

5.4%

 

5.4%

 

3Q09

 

1Q13

 

2013

 

1551 Eastlake Avenue/Seattle – Lake Union

 

$

40,711

 

$

16,841

 

$

6,458

 

$

 

$

64,010

 

$

545

 

6.7%

 

6.7%

 

4Q11

 

4Q11

 

4Q13

 

1616 Eastlake Avenue/Seattle – Lake Union

 

$

22,589

 

$

9,721

 

$

853

 

$

4,653

 

$

37,816

 

$

566

 

8.4%

 

8.6%

 

4Q12

 

2Q13

 

2014

 

Total/weighted average

 

$

170,734

 

$

141,470

 

$

62,335

 

$

14,043

 

$

388,582

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1)             All project information, including rentable square feet; investment; Initial Stabilized Yields; and project start, occupancy and stabilization dates, relates to the discrete portion of each property undergoing active development or redevelopment.  A redevelopment project does not necessarily represent the entire property or the entire vacant portion of a property.  Our Initial Stabilized Yield on a cash basis reflects cash rents at date of stabilization and does not reflect contractual rent escalations beyond the stabilization date.  Our cash rents related to our value-added projects are expected to increase over time and our average stabilized cash yields are expected, in general, to be greater than our Initial Stabilized Yields.  Our estimates for initial cash and GAAP yields, and total costs at completion, represent our initial estimates at the commencement of the project.  We expect to update this information upon completion of the project, or sooner if there are significant changes to the expected project yields or costs.  As of March 31, 2013, 96% of our leases contained annual rent escalations that were either fixed or based on a consumer price index or another index.

(2)             We expect to deliver 54,102 rentable square feet, or 79% of the total project, to Genomatica, Inc. in the fourth quarter of 2013.  Genomatica, Inc. is contractually required to lease the remaining 14,411 rentable square feet 18 to 24 months following the delivery of the initial 54,102 rentable square foot space.

(3)             Our multi-tenant four building property at 9800 Medical Center Drive contains an aggregate of 281,586 rentable square feet.  Our total cash investment in the entire four building property upon completion of the redevelopment will approximate $580 per square foot.   Our total expected cash investment for the four building property of approximately $580 per square foot includes our expected total investment at completion related to the 75,056 rentable square foot redevelopment of approximately $1,075 per square foot.

 

48



Table of Contents

 

The following table summarizes the components of the square footage of our future value-added projects in North America as of March 31, 2013 (dollars in thousands, except per square foot amounts):

 

 

 

Land Undergoing Preconstruction Activities
(Additional CIP) (1)

 

Land Held for Future Development (1)

 

Total (1)

 

Property/Market - Submarket

 

Book Value

 

Square Feet (2)

 

Cost per
Square Foot

 

Book Value

 

Square Feet (2)

 

Cost per
Square Foot

 

Book Value

 

Square Feet (2)

 

Cost per
Square Foot

 

Greater Boston:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Alexandria Center at Kendall Square-Residential - Cambridge/Inner Suburbs

 

$

1,582

 

78,000

 

$

20

 

$

3,413

 

150,000

 

$

23

 

$

4,995

 

228,000

 

$

22

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Alexandria Center at Kendall Square-Lab/Office - Cambridge/Inner Suburbs

 

251,874

 

974,264

 

259

 

 

 

-

 

251,874

 

974,264

 

259

 

Subtotal - Alexandria Center at Kendall Square

 

253,456

 

1,052,264

 

241

 

3,413

 

150,000

 

23

 

256,869

 

1,202,264

 

214

 

Technology Square - Cambridge/Inner Suburbs

 

 

 

 

7,803

 

100,000

 

78

 

7,803

 

100,000

 

78

 

Greater Boston

 

$

253,456

 

1,052,264

 

$

241

 

$

11,216

 

250,000

 

$

45

 

$

264,672

 

1,302,264

 

$

203

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

San Francisco Bay Area:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Owens Street - Mission Bay

 

$

 

 

$

 

$

27,762

 

290,059

 

$

96

 

$

27,762

 

290,059

 

$

96

 

Grand Ave - South San Francisco

 

 

 

 

42,853

 

397,132

 

108

 

42,853

 

397,132

 

108

 

Rozzi/Eccles - South San Francisco

 

 

 

 

 

72,879

 

514,307

 

142

 

72,879

 

514,307

 

142

 

San Francisco Bay Area

 

$

 

 

$

 

$

143,494

 

1,201,498

 

$

119

 

$

143,494

 

1,201,498

 

$

119

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

San Diego:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Science Park Road - Torrey Pines

 

$

16,298

 

176,500

 

$

92

 

$

 

 

$

 

$

16,298

 

176,500

 

$

92

 

5200 Illumina Way - University Town Center

 

14,298

 

392,983

 

36

 

 

 

 

14,298

 

392,983

 

36

 

10300 Campus Point - University Town Center

 

3,857

 

140,000

 

28

 

 

 

 

3,857

 

140,000

 

28

 

Executive Drive - University Town Center

 

3,919

 

49,920

 

79

 

 

 

 

3,919

 

49,920

 

78

 

San Diego

 

$

38,372

 

759,403

 

$

51

 

$

 

 

$

 

$

38,372

 

759,403

 

$

51

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Suburban Washington D.C.:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Medical Center Drive - Rockville

 

$

 

 

$

 

$

7,548

 

292,000

 

$

26

 

$

7,548

 

292,000

 

$

26

 

Research Boulevard - Rockville

 

 

 

 

6,698

 

347,000

 

19

 

6,698

 

347,000

 

19

 

Firstfield Road - Gaithersburg

 

 

 

 

4,052

 

95,000

 

43

 

4,052

 

95,000

 

43

 

Freedom Center Drive and Pyramid Place - Virginia

 

 

 

 

11,791

 

424,905

 

28

 

11,791

 

424,905

 

28

 

Suburban Washington D.C.

 

$

 

 

$

 

$

30,089

 

1,158,905

 

$

26

 

$

30,089

 

1,158,905

 

$

26

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Seattle:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Dexter/Terry Ave - Lake Union

 

$

 

 

$

 

$

18,747

 

232,300

 

$

81

 

$

18,747

 

232,300

 

$

81

 

Eastlake Ave - Lake Union

 

13,472

 

106,000

 

127

 

15,241

 

160,266

 

95

 

28,713

 

266,266

 

108

 

Seattle

 

$

13,472

 

106,000

 

$

127

 

$

33,988

 

392,566

 

$

87

 

$

47,460

 

498,566

 

$

95

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other Markets

 

$

 

 

$

 

$

20,146

 

789,212

 

$

26

 

$

20,146

 

789,212

 

$

26

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Future value-added projects in North America

 

$

305,300

 

1,917,667

 

$

159

 

$

238,933

 

3,792,181

 

$

63

 

$

544,233

 

5,709,848

 

$

95

 

 

(1)             In addition to assets included in our gross investment in real estate, we hold options/rights for parcels supporting the future ground-up development of approximately 420,000 rentable square feet in Alexandria CenterTM for Life Science - New York City related to an option under our ground lease. Also, our asset base contains additional embedded development opportunities aggregating approximately 644,000 rentable square feet which represents additional development and expansion rights related to existing rental properties. The 644,000 rentable square feet related to these additional development opportunities was previously included in land held for future development.

(2)             Square feet amounts are updated as necessary to reflect refinement of design of each building.

 

49



Table of Contents

 

The following table summarizes the components of the square footage of our future redevelopment projects in North America as of March 31, 2013:

 

 

 

Future Redevelopment (1)

 

Market - Submarket

 

Square Feet

 

 

 

 

 

Greater Boston

 

109,457

 

 

 

 

 

San Francisco Bay Area – South San Francisco

 

40,314

 

 

 

 

 

San Diego

 

87,488

 

 

 

 

 

Suburban Washington, D.C.

 

490,000

 

 

 

 

 

Seattle

 

14,914

 

 

 

 

 

Other markets

 

94,211

 

 

 

 

 

Total future redevelopment in North America

 

836,384

 

 

(1)             Our asset base also includes non-laboratory space (office, warehouse, and industrial space) identified for future conversion into life science laboratory space through redevelopment.  These spaces are classified in investments in real estate, net, in the condensed consolidated balance sheets.

 

As of March 31, 2013, our rental properties, net, in Asia, consisted of five operating properties aggregating approximately 603,987 square feet, with occupancy of 67.1%.  Annualized base rent of our operating properties in Asia was approximately $4.3 million as of March 31, 2013.  Our primary sources of revenues are rental income and tenant recoveries from leases of our properties.

 

We also had construction projects in Asia aggregating approximately 718,119 and 734,444 rentable square feet as of March 31, 2013, and December 31, 2012, respectively.

 

Our investments in real estate, net, in Asia, consisted of the following as of March 31, 2013 (dollars in thousands, except per square foot amounts):

 

 

 

March 31, 2013

 

 

 

Book Value

 

Square Feet

 

Cost per
Square Foot

 

Rental properties, net, in China

 

$

21,352

 

299,484

 

$

71

 

Rental properties, net, in India

 

35,337

 

304,503

 

116

 

 

 

 

 

 

 

 

 

CIP/current value-added projects:

 

 

 

 

 

 

 

Active development in China

 

58,500

 

309,476

 

189

 

Active development in India

 

29,713

 

309,500

 

96

 

Active redevelopment projects in India

 

13,144

 

99,143

 

133

 

 

 

101,357

 

718,119

 

141

 

 

 

 

 

 

 

 

 

Land held for future development/land undergoing preconstruction activities (additional CIP) – India

 

83,735

 

6,829,000

 

12

 

Total investments in real estate, net, in Asia

 

$

241,781

 

8,151,106

 

$

30

 

 

The following table provides detail on our development and redevelopment projects in Asia as of March 31, 2013 (dollars in thousands):

 

 

 

Project RSF

 

Leased Status RSF

 

Investment

 

 

 

In

 

 

 

 

 

 

 

 

 

 

 

 

 

Leased/

 

March 31, 2013

 

To Complete

 

Total at

 

Description

 

Service

 

CIP

 

Total

 

Leased

 

Negotiating

 

Marketing

 

Total

 

Negotiating %

 

In Service

 

CIP

 

2013

 

Thereafter

 

Completion (1)

 

China development project

 

 

309,476

 

309,476

 

 

 

309,476

 

309,476

 

–%

 

$

 

$

58,500

 

$

4,016

 

$

19,784

 

$

82,300

 

India development projects

 

 

309,500

 

309,500

 

175,000

 

 

134,500

 

309,500

 

57%

 

 

29,713

 

18,702

 

3,370

 

51,785

 

India redevelopment projects

 

41,345

 

99,143

 

140,488

 

54,960

 

6,400

 

79,128

 

140,488

 

44%

 

4,484

 

13,144

 

5,081

 

 

22,709

 

Total active development and redevelopment in Asia

 

41,345

 

718,119

 

759,464

 

 

 

 

 

 

 

 

 

 

 

$

4,484

 

$

101,357

 

$

27,799

 

$

23,154

 

$

156,794

 

 

(1)

Our estimates for total costs at completion represent our initial estimates at the commencement of the project. We expect to update this information upon completion of the project, or earlier if there are significant changes to the expected project costs.

 

Balance sheet

 

Our balance sheet capital strategy in 2013 will continue to focus on funding our significant development and redevelopment projects in 2013 with leverage-neutral sources of capital and with the continuing execution of our asset recycling program while reducing our net debt to adjusted earnings before interest, taxes, depreciation, and amortization (“Adjusted EBITDA”) to approximately 6.5x by December 31, 2013.

 

50



Table of Contents

 

We expect to source capital in excess of our projected construction spending for 2013.  As more fully described under “Liquidity and Capital Resources – Sources and Uses of Capital,” we estimate our disclosed sources of capital that our asset recycling program will range from $334 million to $397 million, as we execute on the sale of income-producing and non-income-producing assets.  Our projected cash flows from operating activities after payment of dividends will generate capital ranging from $130 million to $150 million.  Common stock offering proceeds under our “at the market” common stock offering program are projected to range from $125 million to $175 million.  These proceeds aggregate a range from $589 million to $722 million and will fund our projected range of construction spending for 2013 from $570 million to $620 million.  We expect this excess capital, combined with projected growth in NOI from development and redevelopment projects described in our table at “Item 2. Properties – Development Projects in North America,” will improve our net debt to Adjusted EBITDA to approximately 6.5x targeted by December 31, 2013.

 

As of March 31, 2013, we had three assets held for sale.  We may identify additional assets for potential sale in 2013 and thereafter.  We expect to invest net proceeds from asset sales into construction projects located in key “brain trust” cluster markets.

 

Investment-grade ratings and key credit metrics

 

In July 2011, we received investment-grade ratings from two major rating agencies.  Receipt of our investment-grade ratings was a significant milestone that we believe will provide long-term value to our debt and equity stakeholders.  Key strengths of our balance sheet and business that highlight our investment-grade credit profile include balance sheet liquidity, a diverse and creditworthy client tenant base, well-located properties proximate to leading research institutions, favorable lease terms, stable occupancy and cash flows, and demonstrated life science and real estate expertise.  This significant milestone broadens our access to another key source of debt capital and allows us to continue to pursue our long-term capital, investment, and operating strategies.  The issuance of investment-grade unsecured senior notes payable has allowed us to begin the transition from bank debt financing to unsecured senior notes payable, from variable rate debt to fixed rate debt, and from short-term debt to long-term debt.  While this transition of bank debt is in process, we will utilize interest rate swap agreements to reduce our interest rate risk.  Our unhedged variable rate debt as a percentage of total debt is targeted to decrease to less than 18% by December 31, 2013.

 

 

 

Three Months Ended March 31,

 

Key Credit Metrics (1)

 

2013

 

2012

 

Net debt to Adjusted EBITDA (2)

 

7.8x

 

7.1x

 

Net debt to gross assets (excluding cash and restricted cash) (3)

 

39%

 

36%

 

Fixed charge coverage ratio (2)

 

2.7x

 

2.6x

 

Interest coverage ratio (2)

 

3.3x

 

3.3x

 

Unencumbered net operating income as a percentage of total net operating income (2)

 

68%

 

69%

 

Liquidity – unsecured senior line of credit availability and unrestricted cash (3)

 

$1.0 billion

 

$1.4 billion

 

Non-income-producing assets as a percentage of gross real estate (3)

 

22%

 

25%

 

Unhedged variable rate debt as a percentage of total debt (3)

 

32%

 

5%

 

Investment-grade client tenants as a percentage of total annualized base rent (3)

 

46%

 

46%

 

 

(1)

These metrics reflect certain non-GAAP financial measures.  See “Non-GAAP Measures” for more information, including definitions and reconciliations to the most directly comparable GAAP measures.

(2)

Periods represent annualized metrics.  We believe key credit metrics for the three months ended March 31, 2013 and 2012, annualized, reflect the completion of many development and redevelopment projects and are indicative of the Company’s current operating trends.

(3)

At the end of the period.

 

Critical Accounting Policies

 

Refer to our annual report on Form 10-K for the year ended December 31, 2012, for a discussion of our critical accounting policies, which include rental properties, net, land held for future development, construction in progress, discontinued operations, impairment of long-lived assets, capitalization of costs, accounting for investments, interest rate hedge agreements, and recognition of rental income and tenant recoveries.  There have been no significant changes to these policies during the three months ended March 31, 2013.

 

51



Table of Contents

 

Results of operations

 

Same Properties

 

As a result of changes within our total property portfolio, the financial data presented in the table in “Comparison of the Three Months Ended March 31, 2013, to the Three Months Ended March 31, 2012” shows significant changes in revenue and expenses from period to period.  In order to supplement an evaluation of our results of operations over a given period, we analyze the operating performance for all properties that were fully operating for the entire periods presented (herein referred to as “Same Properties”) separate from properties acquired subsequent to the first period presented, properties undergoing active development and active redevelopment, and corporate entities (legal entities performing general and administrative functions), which are excluded from same property results (herein referred to as “Non-Same Properties”). Additionally, rental revenues from lease termination fees, if any, are excluded from the results of operations of the Same Properties.

 

The following table reconciles same properties to total properties for the three months ended March 31, 2013:

 

 

 

Number of
Properties

 

 

 

Number of
Properties

 

 

 

Number of
Properties

 

Development – active

 

 

 

Development – deliveries since January 1, 2012

 

 

 

Development/Redevelopment – Asia

 

7

(1)

225 Binney Street

 

1

 

259 East Grand Avenue

 

1

 

 

 

1

 

269 East Grand Avenue

 

1

 

400/450 East Jamie Court

 

2

 

Properties acquired since January 1, 2012

 

 

 

409/499 Illinois Street

 

2

 

4755 Nexus Center Drive

 

1

 

6 Davis Drive

 

1

 

430 East 29th Street

 

1

 

5200 Illumina Way

 

1

 

 

 

 

 

75/125 Binney Street

 

1

 

Canada

 

(2)

 

 

 

 

 

 

6

 

 

 

5

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Redevelopment – active

 

 

 

Redevelopment – deliveries since January 1, 2012

 

 

 

Properties held for sale

 

3

 

1551 Eastlake Avenue

 

1

 

10300 Campus Point Drive

 

1

 

Total properties excluded from Same Properties

 

38

 

1616 Eastlake Avenue

 

1

 

11119 North Torrey Pines Road

 

1

 

Same Properties

 

135

 

285 Bear Hill Road

 

1

 

20 Walkup Drive

 

1

 

Total properties as of March 31, 2013

 

173

 

343 Oyster Point Boulevard

 

1

 

3530/3550 John Hopkins Court

 

2

 

 

 

 

 

400 Technology Square

 

1

 

620 Professional Drive

 

1

 

 

 

 

 

4757 Nexus Center Drive

 

1

 

6275 Nancy Ridge Drive

 

1

 

 

 

 

 

9800 Medical Center Drive

 

3

 

 

 

7

 

 

 

 

 

 

 

9

 

 

 

 

 

 

 

 

 

 

(1)

Property count includes one development delivery, one property acquired since January 1, 2012, and five active development and redevelopment properties.

(2)

Represents two buildings included in our property listing as one property. One of the two buildings represents the ground-up development completed during the year ended December 31, 2012.

 

NOI

 

The chart below shows our NOI for the years ended December 31, 2009, through March 31, 2013 (in millions):

 

 

Refer to “Non-GAAP measures” for further discussion of NOI.

 

52



Table of Contents

 

Comparison of the three months ended March 31, 2013, to the three months ended March 31, 2012

 

The following table presents a comparison of the components of NOI for our Same Properties and Non-Same Properties for the three months ended March 31, 2013, compared to the three months ended March 31, 2012, and a reconciliation of NOI to income from continuing operations, the most directly comparable financial measure (dollars in thousands):

 

 

 

Three Months Ended March 31,

 

 

 

2013

 

2012

 

$ Change

 

% Change

 

Revenues:

 

 

 

 

 

 

 

 

 

Rental – Same Properties

 

$

91,960

 

$

91,109

 

$

851

 

1

%

Rental – Non-Same Properties

 

19,816

 

10,092

 

9,724

 

96

 

Total rental

 

111,776

 

101,201

 

10,575

 

11

 

 

 

 

 

 

 

 

 

 

 

Tenant recoveries – Same Properties

 

30,297

 

28,828

 

1,469

 

5

 

Tenant recoveries – Non-Same Properties

 

5,314

 

3,054

 

2,260

 

74

 

Total tenant recoveries

 

35,611

 

31,882

 

3,729

 

12

 

 

 

 

 

 

 

 

 

 

 

Other income – Same Properties

 

120

 

59

 

61

 

103

 

Other income – Non-Same Properties

 

2,873

 

2,569

 

304

 

12

 

Total other income

 

2,993

 

2,628

 

365

 

14

 

 

 

 

 

 

 

 

 

 

 

Total revenues – Same Properties

 

122,377

 

119,996

 

2,381

 

2

 

Total revenues – Non-Same Properties

 

28,003

 

15,715

 

12,288

 

78

 

Total revenues

 

150,380

 

135,711

 

14,669

 

11

 

 

 

 

 

 

 

 

 

 

 

Expenses:

 

 

 

 

 

 

 

 

 

Rental operations – Same Properties

 

35,824

 

33,748

 

2,076

 

6

 

Rental operations – Non-Same Properties

 

9,400

 

6,705

 

2,695

 

40

 

Total rental operations

 

45,224

 

40,453

 

4,771

 

12

 

 

 

 

 

 

 

 

 

 

 

Net operating income:

 

 

 

 

 

 

 

 

 

Net operating income – Same Properties

 

86,553

 

86,248

 

305

 

 

Net operating income – Non-Same Properties

 

18,603

 

9,010

 

9,593

 

107

 

Total net operating income

 

105,156

 

95,258

 

9,898

 

10

 

 

 

 

 

 

 

 

 

 

 

Other expenses:

 

 

 

 

 

 

 

 

 

General and administrative

 

11,648

 

10,357

 

1,291

 

13

 

Interest

 

18,020

 

16,226

 

1,794

 

11

 

Depreciation and amortization

 

46,065

 

41,786

 

4,279

 

10

 

Loss on early extinguishment of debt

 

 

623

 

(623

)

(100

)

Total other expenses

 

75,733

 

68,992

 

6,741

 

10

 

Income from continuing operations

 

$

29,423

 

$

26,266

 

$

3,157

 

12

%

 

Rental revenues

 

Total rental revenues for the three months ended March 31, 2013, increased by $10.6 million, or 11%, to $111.8 million, compared to $101.2 million for the three months ended March 31, 2012.  The increase was due to rental revenues from our Non-Same Properties, including 12 development and redevelopment projects that were completed and delivered after January 1, 2012, and one operating property that was acquired after January 1, 2012.

 

53



Table of Contents

 

Tenant recoveries

 

Tenant recoveries for the three months ended March 31, 2013, compared to the three months ended March 31, 2012, increased by $3.7 million, or 12%, to $35.6 million, compared to an increase of $4.7 million, or 12%, of rental operating expenses.  Same Properties tenant recoveries increased by $1.5 million, while Same Properties rental operating expenses increased by $2.1 million, primarily due to increased operating costs related to colder weather and higher property taxes due to increases in tax rates for our properties located in Massachusetts in the three months ended March 31, 2013, compared to the three months ended March 31, 2012.  Occupancy of Same Properties was 94.1% and 93.8% as of March 31, 2013 and 2012, respectively.  Non-Same Properties tenant recoveries increased by $2.3 million as a result of a Non-Same Properties rental operating expense increase of $2.7 million. As of March 31, 2013, approximately 94% of our leases (on a rentable square footage basis) were triple net leases, requiring client tenants to pay substantially all real estate taxes, insurance, utilities, common area expenses, and other operating expenses (including increases thereto) in addition to base rent.

 

Other income

 

Other income for the three months ended March 31, 2013 and 2012, of $3.0 million and $2.6 million, respectively, was as follows (in thousands):

 

 

 

Three Months Ended March 31,

 

Component

 

2013

 

2012

 

Change

 

Management fee income

 

$

1,606

 

$

49

 

$

1,557

 

Interest income

 

1,327

 

607

 

720

 

Investment income

 

60

 

1,972

 

(1,912

)

Total other income

 

$

2,993

 

$

2,628

 

$

365

 

 

Rental operating expenses

 

Total rental operating expenses for the three months ended March 31, 2013, increased by $4.7 million, or 12%, to $45.2 million, compared to $40.5 million for the three months ended March 31, 2012.  Approximately $2.7 million of the increase was due to an increase in rental operating expenses from our Non-Same Properties, primarily related to 12 development and redevelopment projects that were completed and delivered after January 1, 2012, and one operating property that was acquired after January 1, 2012.

 

General and administrative expenses

 

General and administrative expenses for the three months ended March 31, 2013, increased by $1.2 million, or 13%, to $11.6 million, compared to $10.4 million for the three months ended March 31, 2012.  The increase in general and administrative expenses was related to the timing of certain professional fees and an increase in the number of employees related to the growth in both the depth and breadth of our operations in multiple markets.  During the three months ended March 31, 2013, our average number of employees increased by 17 employees, or 8%, to 221, compared to an average of 204 for the three months ended March 31, 2012.  As a percentage of total revenues, general and administrative expenses were 7.7% and 7.6%, respectively, for the three months ended March 31, 2013 and 2012.

 

54



Table of Contents

 

Interest expense

 

Interest expense for the three months ended March 31, 2013, increased by $1.8 million, or 11%, to $18.0 million, compared to $16.2 million for the three months ended March 31, 2012, detailed as follows (in thousands):

 

 

 

Three Months Ended March 31,

 

Component

 

2013

 

2012

 

Change

 

Secured notes payable

 

$

9,802

 

$

10,108

 

$

(306

)

Unsecured senior convertible notes

 

7

 

222

 

(215

)

Unsecured senior notes payable

 

6,335

 

2,182

 

4,153

 

Unsecured senior line of credit

 

2,894

 

5,786

 

(2,892

)

Unsecured senior bank term loans

 

6,226

 

4,728

 

1,498

 

Interest rate swaps

 

4,308

 

5,775

 

(1,467

)

Amortization of loan fees and other interest

 

2,469

 

2,691

 

(222

)

Subtotal

 

32,041

 

31,492

 

549

 

 

 

 

 

 

 

 

 

Capitalized interest

 

(14,021

)

(15,266

)

1,245

 

Total interest expense

 

$

18,020

 

$

16,226

 

$

1,794

 

 

Interest expense increased primarily due to the issuance of our unsecured senior notes payable in February 2012 and an increase in the balance outstanding on our unsecured senior bank term loans since January 1, 2012.  This increase was partially offset by repayments of two secured notes payable approximating $15.4 million and repurchases of our 3.70% unsecured senior convertible notes  (“3.70% Unsecured Senior Convertible Notes”) aggregating $84.7 million since January 1, 2012.  Interest expense related to our unsecured senior line of credit also decreased, primarily due to a decrease in the effective interest rate of our unsecured senior line of credit from 2.7% as of March 31, 2012, to 1.4% as of March 31, 2013, as a result of the reduced interest rate provided by our April 2012 amendment.  We have entered into certain interest rate swap agreements to hedge a portion of our exposure primarily related to variable interest rates associated with our unsecured senior line of credit and unsecured senior bank term loans (see “Liquidity and Capital Resources – Contractual Obligations – Interest Rate Swap Agreements”).

 

Depreciation and amortization

 

Depreciation and amortization for the three months ended March 31, 2013, increased by $4.3 million, or 10%, to $46.1 million, compared to $41.8 million for the three months ended March 31, 2012.  The increase resulted primarily from increased depreciation related to building improvements, including 12 development and redevelopment projects that were completed and delivered after January 1, 2012, and one operating property that was acquired after January 1, 2012.

 

Income from discontinued operations, net

 

Income from discontinued operations, net, of $0.8 million for the three months ended March 31, 2013, includes the results of operations of three operating properties that were classified as “held for sale” and the results of operations of six properties sold during the three months ended March 31, 2013.

 

Income from discontinued operations, net, for the three months ended March 31, 2012, includes the results of operations of three operating properties that were classified as “held for sale” as of March 31, 2013, the results of operations of six properties sold during the three months ended March 31, 2013, and the results of operations of six properties sold during the year ended December 31, 2012.

 

55



Table of Contents

 

Projected results

 

Based on our current view of existing market conditions and certain current assumptions, we have updated guidance for earnings per share attributable to Alexandria Real Estate Equities, Inc.’s common stockholders – diluted and FFO per share attributable to Alexandria Real Estate Equities, Inc.’s common stockholders – diluted for the year ended December 31, 2013, as set forth in the table below.  The table below provides a reconciliation of FFO per share attributable to Alexandria Real Estate Equities, Inc.’s common stockholders – diluted, a non-GAAP measure, to earnings per share, the most directly comparable GAAP measure and other key assumptions included in our guidance for the year ended December 31, 2013.

 

Guidance for the Year Ended December 31, 2013

 

Reported on April 29, 2013

 

Reported on February 7, 2013

 

Earnings per share attributable to Alexandria Real Estate Equities, Inc.’s common stockholders – diluted

 

$1.43 to $1.59

 

$1.41 to $1.61

 

Depreciation and amortization

 

$2.95 to $3.11

 

$2.93 to $3.13

 

Loss on sale of real estate

 

$0.01

 

 

Other

 

$(0.01)

 

 

FFO per share attributable to Alexandria Real Estate Equities, Inc.’s common stockholders – diluted

 

$4.46 to $4.62

 

$4.44 to $4.64

 

 

 

 

 

 

 

Key projection assumptions:

 

 

 

 

 

Same property net operating income growth – cash basis

 

4% to 7%

 

4% to 7%

 

Same property net operating income growth – GAAP basis

 

Up to 3%

 

0% to 3%

 

Rental rate steps on lease renewals and re-leasing of space – cash basis

 

Up to 2%

 

Flat to slightly positive

 

Rental rate steps on lease renewals and re-leasing of space – GAAP basis

 

Up 5% to 10%

 

Up 5% to 10%

 

Occupancy percentage for all operating properties at December 31, 2013

 

93.9% to 94.3%

 

93.9% to 94.3%

 

Straight-line rents

 

$24 to $26 million

 

$24 to $26 million

 

Amortization of above and below market leases

 

$3 to $4 million

 

$3 to $4 million

 

General and administrative expenses

 

$48 to $51 million

 

$48 to $51 million

 

Capitalization of interest

 

$47 to $53 million

 

$47 to $53 million

 

Interest expense, net

 

$74 to $84 million

 

$74 to $84 million

 

Net debt to adjusted EBITDA for the annualized three months ended December 31, 2013

 

6.5x

 

6.5x

 

Fixed charge coverage ratio for the annualized three months ended December 31, 2013

 

2.9x to 3.0x

 

2.9x to 3.0x

 

 

On a short-term basis, our unhedged variable rate debt as a percentage of total debt may range up to 30%. Our strategy is to have unhedged variable rate debt available for repayment as we issue unsecured senior notes payable, extend our maturity profile, transition variable rate debt to fixed rate debt, and enhance our long-term capital structure.  Our unhedged variable rate debt as a percentage of total debt is targeted to decrease to less than 18% by December 31, 2013.

 

Monetization of non-income-producing assets

 

Non-income-producing assets as a percentage of our gross investments in real estate is targeted to decrease to a range of 15% to 17% by December 31, 2013.  As of March 31, 2013, we had approximately $579 million and $141 million of construction in progress related to our five North American development and seven North American redevelopment projects, respectively.  The completion of these projects, along with recently delivered projects, certain future projects, and contributions from same properties, is expected to contribute significant increases in rental income, NOI, and cash flows.  Operating performance assumptions related to the completion of our North American development and redevelopment projects, including the timing of initial occupancy, stabilization dates, and Initial Stabilized Yields, are included on pages 47 and 48.  Certain key assumptions regarding our projections, including the impact of various development and redevelopment projects, are included in the tables above and on page 63.

 

The completion of our development and redevelopment projects will result in increased interest expense and other direct project costs, because these project costs will no longer qualify for capitalization and these costs will be expensed as incurred.  Our projection assumptions for depreciation and amortization, general and administrative expenses, capitalization of interest, interest expense, net, and NOI growth are included in the tables on page 62 and are subject to a number of variables and uncertainties, including those discussed under the “Forward-looking Statements” section of Part I, the “Risk Factors” section of Item 1A, and the “Management’s Discussion and Analysis of Financial Condition and Results of Operations” section under Item 7, of our annual report on Form 10-K for the year ended December 31, 2012.  To the extent our full year earnings guidance is updated during the year, we will provide additional disclosure supporting reasons for any significant changes to such guidance.  Further, we believe NOI is a key performance indicator and is useful to investors as a performance measure because, when compared across periods, NOI reflects the impact on operations from trends in occupancy rates, rental rates, and operating costs, providing perspective not immediately apparent from income from continuing operations.

 

56



Table of Contents

 

Our guidance for 2013 includes the following targeted sales of non-income-producing assets (in millions):

 

 

 

2013 Non-Income-Producing Asset Sales

 

 

 

Identified

 

TBD

 

Total

 

2013 non-income-producing asset sales initially targeted for 4Q12 closing

 

 

 

 

 

 

 

Book value of land subject to sale negotiations

 

$

34

 

$

 

$

34

 

Subtotal

 

34

 

 

34

 

 

 

 

 

 

 

 

 

2013 non-income-producing asset sales initially projected on December 5, 2012

 

 

 

 

 

 

 

Book value of land subject to sale negotiations

 

11

 

 

11

 

Projected proceeds from the partial sale of the 75/125 Binney Street project (1)

 

60 - 70

 

 

60 - 70

 

Future non-income-producing asset sales expected to be identified in the next several months

 

 

104 - 144

 

104 - 144

 

Subtotal

 

71 - 81

 

104 - 144

 

175 - 225

 

 

 

 

 

 

 

 

 

Total 2013 non-income-producing asset sales target

 

$

105 - 115

 

$

104 - 144

 

$

209 - 259

 

 

(1)   See further details regarding our guidance related to our projected unconsolidated joint venture on page 64.

 

Liquidity and capital resources

 

Overview

 

We expect to meet certain long-term liquidity requirements, such as requirements for property acquisitions, development, redevelopment, other construction projects, capital improvements, tenant improvements, leasing costs, non-revenue-generating expenditures, and scheduled debt maturities, through net cash provided by operating activities, periodic asset sales, and long-term secured and unsecured indebtedness, including borrowings under our unsecured senior line of credit, unsecured senior bank term loans, and the issuance of additional debt and/or equity securities.

 

We expect to continue meeting our short-term liquidity and capital requirements, as further detailed in this section, generally through our working capital and net cash provided by operating activities.  We believe that the net cash provided by operating activities will continue to be sufficient to enable us to make the distributions necessary to continue qualifying as a REIT.

 

Over the next several years, our balance sheet, capital structure, and liquidity objectives are as follows:

 

·                  Reduce leverage as a percentage of debt to total gross assets and improve our ratio of debt to earnings before interest, taxes, depreciation, and amortization;

·                   Execute selective sales of income-producing and non-income-producing assets as a source of capital while minimizing the issuance of common equity;

·                  Maintain diverse sources of capital, including sources from net cash flows from operating activities, unsecured debt, secured debt, selective asset sales, joint ventures, preferred stock, and common stock;

·                  Manage the amount of debt maturing in a single year;

·                  Mitigate unhedged variable rate debt exposure by transitioning our balance sheet debt from short-term and medium-term variable rate bank debt to long-term unsecured fixed rate debt and utilize interest rate swap agreements in the interim period during this transition of debt;

·                  Maintain adequate liquidity from net cash provided by operating activities, cash and cash equivalents, and available borrowing capacity under our unsecured senior line of credit;

·                  Maintain available borrowing capacity under our unsecured senior line of credit in excess of 50% of the total commitments of $1.5 billion, except temporarily as necessary;

·                  Fund preferred stock and common stock dividends from net cash provided by operating activities;

·                  Retain positive cash flows from operating activities after payment of dividends for reinvestment in acquisitions and/or development and redevelopment projects; and

·                  Reduce our non-income-producing assets as a percentage of our gross investment in real estate.

 

57



Table of Contents

 

Cash flows

 

We report and analyze our cash flows based on operating activities, investing activities, and financing activities.  The following table summarizes changes in the Company’s cash flows for the three months ended March 31, 2013 and 2012 (in thousands):

 

 

 

Three Months Ended March 31,

 

 

 

2013

 

2012

 

Change

 

Net cash provided by operating activities

 

$

47,241

 

$

49,685

 

$

(2,444

)

Net cash used in investing activities

 

$

(69,524

)

$

(124,248

)

$

54,724

 

Net cash (used in) provided by financing activities

 

$

(31,509

)

$

71,351

 

$

(102,860

)

 

Operating activities

 

Cash flows provided by operating activities consisted of the following amounts (in thousands):

 

 

 

Three Months Ended March 31,

 

 

 

2013

 

2012

 

Change

 

Net cash provided by operating activities

 

$

47,241

 

$

49,685

 

$

(2,444

)

Changes in assets and liabilities

 

29,093

 

19,801

 

9,292

 

Net cash provided by operating activities before changes in assets and liabilities

 

$

76,334

 

$

69,486

 

$

6,848

 

 

Cash flows provided by operating activities are primarily dependent on the occupancy level of our asset base, rental rates of our leases, the collectability of rent and recovery of operating expenses from our tenants, the delivery of development projects and the timing and delivery of redevelopment projects, and the amount of general and administrative costs.  Net cash provided by operating activities for the three months ended March 31, 2013, decreased by $2.4 million, or 5%, to $47.2 million, compared to $49.7 million for the three months ended March 31, 2012.   Excluding the changes in assets and liabilities, net cash provided by operating activities increased by approximately $6.8 million, 10%, to $76.3 million, compared to $69.5 million for the three months ended March 31, 2012.  This increase was primarily attributable to an increase in our Same Property cash net operating income of approximately $7.0 million, or 9%, to $86.0 million, compared to $79.0 million for the three months ended March 31, 2012.   As of March 31, 2013, approximately 94% of our leases (on a rentable square footage basis) were triple net leases, requiring client tenants to pay substantially all real estate taxes, insurance, utilities, common area expenses, and other operating expenses (including increases thereto) in addition to base rent.

 

Investing activities

 

Net cash used in investing activities for the three months ended March 31, 2013, was $69.5 million, compared to $124.2 million for the three months ended March 31, 2012.  This change consisted of the following amounts (in thousands):

 

 

 

Three Months Ended March 31,

 

 

 

2013

 

2012

 

Change

 

Proceeds from sales of properties

 

$

80,203

 

$

 

$

80,203

 

Additions to properties

 

(139,245

)

(120,585

)

(18,660

)

Purchase of properties

 

 

(19,946

)

19,946

 

Other

 

(10,482

)

16,283

 

(26,765

)

Net cash used in investing activities

 

$

(69,524

)

$

(124,248

)

$

54,724

 

 

The change in net cash used in investing activities for the three months ended March 31, 2013, is primarily due to proceeds from sales of properties, a lower investment amount in property acquisitions in the three months ended March 31, 2013, as compared to the three months ended March 31, 2012, offset by increased capital expenditures related to our development and redevelopment projects during the three months ended March 31, 2013.

 

Real estate asset sales

 

See discussion in “Sources and Uses of Capital – Sources of Capital – Real Estate Asset Sales.”

 

58



Table of Contents

 

Value-added opportunities and external growth

 

As of March 31, 2013, we had six ground-up development projects in process, including an unconsolidated joint venture development project, aggregating approximately 1,854,859 rentable square feet.  We also had seven projects undergoing conversion into laboratory space through redevelopment, aggregating approximately 620,111 rentable square feet.  These projects, along with recently delivered projects, certain future projects, and contribution from same properties, are expected to contribute significant increases in rental income, NOI, and cash flows.

 

Our initial stabilized yield on a cash basis reflects cash rents at date of stabilization and does not reflect contractual rent escalations beyond the stabilization date.  We expect, on average, our cash rents related to our value-added projects to increase over time pursuant to contractual rent escalations.  As of March 31, 2013, 96% of our leases contained annual rent escalations that were either fixed or based on a consumer price index or another index.

 

During the three months ended March 31, 2013, we executed leases aggregating 355,000 and 102,000 rentable square feet related to our development and redevelopment projects, respectively.

 

The following table summarizes the commencement of key development projects for the three months ended March 31, 2013 (dollars in thousands, except per square foot amounts):

 

 

 

 

 

 

 

 

 

Investment

 

 

 

Initial

 

 

 

 

 

Commencement

 

 

 

Pre-Leased

 

at

 

Cost Per

 

Stabilized Yield

 

Key

 

Address/Market

 

Date

 

RSF

 

%

 

Completion

(1)

RSF

 

Cash

 

GAAP

 

Client Tenant

 

Development

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

75/125 Binney Street/Greater Boston

 

January 2013

 

386,275

 

63%

 

$

351,439

 

$

910

 

8.0%

 

8.2%

 

ARIAD Pharmaceuticals, Inc.

 

269 East Grand Avenue/San Francisco Bay Area

 

January 2013

 

107,250

 

100%

 

$

51,300

 

$

478

 

8.1%

 

9.3%

 

Onyx Pharmaceuticals, Inc.

 

 

(1)

See “Monetization of Non-Income Producing Assets” for additional details on current assumptions included in our guidance for funding the cost to complete the development of 75/125 Binney Street.

 

Capital expenditures and tenant improvements

 

See discussion in “Sources and Uses of Capital – Uses of Capital – Summary of Capital Expenditures.”

 

Financing activities

 

Net cash flows (used in) provided by financing activities for the three months ended March 31, 2013, decreased by $102.9 million, to $(31.5) million, compared to $71.4 million for the three months ended March 31, 2012.  This decrease consisted of the following amounts (in thousands):

 

 

 

Three Months Ended March 31,

 

 

 

2013

 

2012

 

Change

 

Borrowings from secured notes payable

 

$

17,215

 

$

 

$

17,215

 

Repayments of borrowings from secured notes payable

 

(2,749

)

(2,688

)

(61

)

Proceeds from issuance of unsecured senior notes payable

 

 

544,649

 

(544,649

)

Principal borrowings from unsecured senior line of credit

 

179,000

 

248,000

 

(69,000

)

Repayment of unsecured senior line of credit

 

(191,000

)

(451,000

)

260,000

 

Repayment of unsecured senior bank term loan

 

 

(250,000

)

250,000

 

Repurchase of unsecured senior convertible notes

 

 

(83,801

)

83,801

 

Total changes related to debt

 

2,466

 

5,160

 

(2,694

)

 

 

 

 

 

 

 

 

Proceeds from issuance of Series E Preferred Stock

 

 

124,868

 

(124,868

)

Total changes related to preferred stock

 

 

124,868

 

(124,868

)

 

 

 

 

 

 

 

 

Dividend payments

 

(42,158

)

(37,475

)

(4,683

)

Other

 

8,183

 

(21,202

)

29,385

 

 

 

 

 

 

 

 

 

Net cash (used in) provided by financing activities

 

$

(31,509

)

$

71,351

 

$

(102,860

)

 

59



Table of Contents

 

4.60% unsecured senior notes payable offering

 

In February 2012, we completed the issuance of our 4.60% unsecured senior notes (“4.60% Unsecured Senior Notes”) due in April 2022.  Net proceeds of approximately $544.6 million were used to repay certain outstanding variable rate bank debt, including the entire $250.0 million of our 2012 unsecured senior bank term loan (“2012 Unsecured Senior Bank Term Loan”), and approximately $294.6 million of outstanding borrowings under our unsecured senior line of credit.  In connection with the retirement of our 2012 Unsecured Senior Bank Term Loan, we recognized a loss on early extinguishment of debt of approximately $0.6 million related to the write-off of unamortized loan fees for the three months ended March 31, 2012.

 

The requirements of, and our actual performance with respect to, the key financial covenants under our unsecured senior notes payable as of March 31, 2013, are as follows:

 

Covenant Ratios (1)

 

Requirement

 

Actual (2)

Total Debt to Total Assets

 

Less than or equal to 60%

 

40%

Consolidated EBITDA to Interest Expense

 

Greater than or equal to 1.5x

 

5.6x

Unencumbered Total Asset Value to Unsecured Debt

 

Greater than or equal to 150%

 

246%

Secured Debt to Total Assets

 

Less than or equal to 40%

 

9%

 

(1)

For a definition of the ratios used in the table above, refer to the indenture dated February 29, 2012 (the “Indenture”), which governs the unsecured senior notes payable, which was filed as an exhibit to our Current Report on Form 8-K filed with the SEC on February 29, 2012.

(2)

Actual covenants are calculated pursuant to the specific terms of the Indenture.

 

In addition, the terms of the Indenture, among other things, limit the ability of the Company, Alexandria Real Estate Equities, L.P., and the Company’s subsidiaries to (1) consummate a merger, or consolidate or sell all or substantially all of the Company’s assets, and (2) incur certain secured or unsecured indebtedness.

 

In February 2012, we repaid the entire $250.0 million outstanding balance on our 2012 Unsecured Senior Bank Term Loan.  In connection with the retirement of our 2012 Unsecured Senior Bank Term Loan, we recognized a loss on early extinguishment of debt of approximately $0.6 million related to the write-off of unamortized loan fees for the three months ended March 31, 2012.

 

In April 2012, we also amended our $1.5 billion unsecured senior line of credit with Merrill Lynch, Pierce, Fenner & Smith Incorporated, J.P. Morgan Securities Inc., and Citigroup Global Markets Inc. as joint lead arrangers, and certain lenders, to extend the maturity date of our unsecured senior line of credit, provide an accordion option for up to an additional $500.0 million, and reduce the interest rate for outstanding borrowings.  The maturity date of the unsecured senior line of credit was extended to April 2017, assuming we exercise our sole right to extend the stated maturity date twice by an additional six months after each exercise.  Borrowings under the unsecured senior line of credit will bear interest at LIBOR or the base rate specified in the amended unsecured senior line of credit agreement, plus in either case a specified margin (the “Applicable Margin”).  The Applicable Margin for LIBOR borrowings under the unsecured senior line of credit was set at 1.20%, down from 2.40% in effect immediately prior to the modification.  In addition to the Applicable Margin, our unsecured senior line of credit is subject to an annual facility fee of 0.25%.  In connection with the modification of our unsecured senior line of credit in April 2012, we recognized a loss on early extinguishment of debt of approximately $1.6 million related to the write-off of a portion of unamortized loan fees for the three months ended June 30, 2012.

 

The requirements of, and our actual performance with respect to, the key financial covenants under our unsecured senior line of credit as of March 31, 2013, are as follows:

 

Covenant Ratios (1)

 

Requirement

 

Actual (2)

Leverage Ratio

 

Less than or equal to 60.0%

 

38%

Fixed Charge Coverage Ratio

 

Greater than or equal to 1.50x

 

2.5x

Secured Debt Ratio

 

Less than or equal to 40.0%

 

9%

Unsecured Leverage Ratio

 

Less than or equal to 60.0%

 

44%

Unsecured Interest Coverage Ratio

 

Greater than or equal to 1.75x

 

6.8x

 

(1)

For a definition of the ratios used in the table above, refer to the amended unsecured senior line of credit and unsecured senior bank term loan agreements, dated as of April 30, 2012, which were filed as an exhibit to our Quarterly Report on Form 10-Q filed with the SEC on August 8, 2012.

(2)

Actual covenants are calculated pursuant to the specific terms to our unsecured senior line of credit and unsecured senior bank term loan agreements.

 

60



Table of Contents

 

“At the market” common stock offering program

 

In June 2012, we established an “at the market” common stock offering program under which we may sell, from time to time, up to an aggregate of $250.0 million of our common stock through our sales agents, BNY Mellon Capital Markets, LLC and Credit Suisse Securities (USA) LLC, during a three-year period.  Net proceeds from the sales were used to pay down the outstanding balance on our unsecured senior line of credit or other borrowings, and for general corporate purposes.  As of March 31, 2013, approximately $150.0 million of our common stock remained available for issuance under the “at the market” common stock offering program.

 

Dividends

 

During the three months ended March 31, 2013 and 2012, we paid the following dividends (in thousands):

 

 

 

Three Months Ended March 31,

 

 

 

2013

 

2012

 

Change

 

Common stock dividends

 

$

35,687

 

$

30,386

 

$

5,301

 

Series C Preferred Stock dividends

 

 

2,714

 

(2,714

)

Series D Preferred Stock dividends

 

4,375

 

4,375

 

 

Series E Preferred Stock dividends

 

2,096

 

 

2,096

 

 

 

$

42,158

 

$

37,475

 

$

4,683

 

 

The increase in dividends paid on our common stock is primarily due to an increase in the related dividends to $0.60 per common share for the three months ended March 31, 2013, from $0.49 per common share for the three months ended March 31, 2012.  The increase was also due to an increase in common stock outstanding.  Total common stock outstanding as of March 31, 2013, was 63,317,296 shares, compared to 61,634,645 shares as of March 31, 2012.

 

61



Table of Contents

 

Sources and uses of capital

 

We expect that our principal liquidity needs for the year ended December 31, 2013, will be satisfied by the following multiple sources of capital as shown in the table below. There can be no assurance that our sources and uses of capital will not be materially higher or lower than these expectations. Our liquidity available under our unsecured senior line of credit and from cash and cash equivalents was approximately $1.0 billion as of March 31, 2013.

 

 

 

Reported on
April 29, 2013

 

Reported on
February 7, 2013

 

Sources and Uses of Capital for the Year Ended December 31, 2013 (in millions)

 

Completed

 

Projected

 

Total

 

Total

 

Sources of capital:

 

 

 

 

 

 

 

 

 

Net cash provided by operating activities less dividends (1)

 

$

34

 

$

96 - 116

 

$

130 - 150

 

$

130 - 150

 

2013 asset sales initially targeted for 4Q12 closing

 

43

 

34

(2)

77

 

77

 

2013 asset sales initially projected on December 5, 2012

 

 

 

 

 

 

 

 

 

Non-income-producing

 

 

175 - 225

(2)

175 - 225

 

175 - 225

 

Income-producing

 

82

 

0 - 13

 

82 - 95

 

75 - 125

 

Secured construction loan borrowings

 

17

 

3 - 13

 

20 - 30

 

20 - 30

 

Unsecured senior notes payable

 

 

350 - 450

 

350 - 450

 

350 - 450

 

Issuances under “at the market” common stock offering program

 

 

125 - 175

 

125 - 175

 

125 - 175

 

Total sources of capital

 

$

176

 

$

783 - 1,026

 

$

959 - 1,202

 

$

952 - 1,232

 

 

 

 

 

 

 

 

 

 

 

Uses of capital:

 

 

 

 

 

 

 

 

 

Development, redevelopment, and construction (3)

 

$

104

 

$

466 - 516

 

$

570 - 620

 

$

545 - 595

 

Seller financing of asset sales (4)

 

39

 

 

39

 

39

 

Acquisitions (5)

 

 

 

 

 

Secured notes payable repayments

 

3

 

34

 

37

 

37

 

Unsecured senior bank term loan repayment

 

 

125 - 175

 

125 - 175

 

125 - 175

 

Paydown of unsecured senior line of credit

 

30

 

158 - 301

 

188 - 331

 

206 - 386

 

Total uses of capital

 

$

176

 

$

783 - 1,026

 

$

959 - 1,202

 

$

952 - 1,232

 

 

(1)

See “Projected Results - Key Projection Assumptions”.

(2)

See table at “Monetization of Non-Income Producing Assets.

(3)

Total construction spending for 2013 increased approximately $25 million at the mid-point of our guidance since last quarter primarily as a result of our estimated share of capital required for the commencement of two new ground-up development projects during the first quarter of 2013. Our estimated construction spend for 2013 increased by approximately $13 million as a result of the commencement of our 100% pre-leased development at 269 East Grand Avenue. The total estimated cost at completion for 75/125 Binney Street has not changed since our estimate as of December 31, 2012; however, the timing of construction and completion of our projected joint venture results in an increase in our estimated share of capital contributions to fund the completion of the project by approximately $10 million.

(4)

Represents a $29.8 million note receivable with an interest rate of 3.25% and a maturity date of January 21, 2015, and a $9.0 million note receivable with an interest rate of 4.00% and a maturity date of March 1, 2019.

(5)

Our guidance has assumed no acquisitions, but we continuously and intensively review a pipeline of opportunistic acquisitions in our key core cluster markets that we would expect to fund on a leverage-neutral basis.

 

The key assumptions behind the sources and uses of capital in the table above are a favorable capital market environment and performance of our core operations in areas such as delivery of current and future development and redevelopment projects, leasing activity, and renewals.  Our expected sources and uses of capital are subject to a number of variables and uncertainties, including those discussed under the “Forward-looking statements” section of Part I, the “Risk Factors” section of Item 1A, and the “Management’s Discussion and Analysis of Financial Condition and Results of Operations” section under Item 7, of our annual report on Form 10-K for the year ended December 31, 2012.  We expect to update our forecast of sources and uses of capital on a quarterly basis.

 

62



Table of Contents

 

Projected unconsolidated joint venture

 

Our guidance for the year ended December 31, 2013, assumes a transfer of 50% of our ownership interest in the 75/125 Binney Street project to a new joint venture partner which will be accounted for as a sale of an interest in our investment in the ground-up development, with the resulting entity presented as an unconsolidated joint venture (the “Binney JV”) in our financial statements.  This projected sale of an interest in our investment in the ground-up development is included in our total non-income-producing asset sales target for 2013. We expect the sale proceeds to range from $60 million to $70 million and to exceed our share of the remaining investment of $44 million through the completion of the project.   We also anticipate the unconsolidated Binney JV to obtain a secured construction loan to fund 60% to 70% of the total project costs.

 

The following assumptions are included in our guidance for funding the cost to complete the 75/125 Binney Street project (in millions).

 

 

 

Cost to Complete (1)

 

 

 

Nine Months Ended
December 31, 2013

 

Thereafter

 

Total

 

75/125 Binney Street project – remaining cost to complete

 

$

91

 

$

163

 

$

254

 

 

 

 

 

 

 

 

 

Projected unconsolidated joint venture funding:

 

 

 

 

 

 

 

Binney JV partner capital/Binney JV construction loan

 

(47

)

(163

)

(210

)

ARE investment in Binney JV project

 

$

44

 

$

 

$

44

(2)

 

(1)

Represent the mid points of our guidance assumptions related to estimated funding amounts provided by joint venture partner capital, joint venture construction loan, and Alexandria.

(2)

Represents our share of incremental investment into the Binney JV and is included in our guidance for 2013 development, redevelopment, and construction spending in a range from $570 million to $620 million. Binney JV partner capital and secured construction loan funding for 75/125 Binney Street related to our projected unconsolidated joint venture have been excluded from our construction spend forecast for 2013.

 

Sources of capital

 

Unsecured senior line of credit

 

We use our unsecured senior line of credit to fund working capital, construction activities, and, from time to time, acquisition of properties.  As of March 31, 2013, we had $0.9 billion available under our $1.5 billion unsecured senior line of credit.

 

Cash and cash equivalents

 

As of March 31, 2013, we had approximately $87.0 million of cash and cash equivalents.  We expect existing cash and cash equivalents, cash flows from operating activities, proceeds from asset sales, secured construction loan and unsecured senior notes payable borrowings, and issuances of common stock under our “at the market” common stock offering program to continue to be sufficient to fund our operating activities and cash commitments for investing and financing activities, such as regular quarterly dividends, scheduled debt repayments, and material capital expenditures, for at least the next 12 months, and thereafter for the foreseeable future.

 

Restricted cash

 

Restricted cash consisted of the following as of March 31, 2013, and December 31, 2012 (in thousands):

 

 

 

March 31,
2013

 

December 31,
2012

 

Funds held in trust under the terms of certain secured notes payable

 

$

20,870

 

$

29,526

 

Funds held in escrow related to construction projects

 

5,653

 

5,652

 

Other restricted funds

 

3,485

 

4,769

 

Total

 

$

30,008

 

$

39,947

 

 

The funds held in escrow related to construction projects will be used to pay for certain construction costs.

 

63



Table of Contents

 

Real estate asset sales

 

We continue the disciplined execution of our asset recycling program to monetize non-strategic income-producing and non-income-producing assets as a source of capital while minimizing the issuance of common equity.  We target the following asset types for sale and redeploy the capital to fund active development and redevelopment projects with significant pre-leasing:

 

·                  Older buildings: elimination of potential capital expenditures and leasing risk;

·                  Non-strategic assets: disposition of properties not proximate to academic medical research centers in core life science cluster locations;

·                  Assets with alternative uses for buyer: transformation into non-laboratory space, such as medical office buildings, hospitals, and residential spaces;

·                  Suburban locations: reinvestment in higher-value, Class A assets in urban “brain trust” life science cluster locations; or

·                  Excess land: reduction of non-income-producing land holdings in certain clusters, while retaining specific land parcels for future growth.

 

Consistent with our asset recycling program described above, we completed all significant sales of non-strategic income-producing assets targeted for 2013 totaling $124.2 million.  These assets generated a weighted average unlevered internal rate of return (“IRR”) of 11% during our ownership period.  Our assets sales for the three months ended March 31, 2013 were comprised of the following (dollars in thousands, except per square foot amounts):

 

 

 

 

 

 

 

 

 

 

 

Annualized

 

 

 

Sales

 

Gain/

 

 

 

 

 

 

 

 

 

Date

 

 

 

GAAP

 

Sales

 

Price

 

(Loss)

 

Unlevered

 

Description

 

Date of Purchase

 

Location

 

of Sale

 

RSF

 

NOI (1)

 

Price

 

per RSF

 

on Sale (2)

 

IRR (3)

 

Sales completed in 1Q13

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1124 Columbia Street

 

May 1996

 

Seattle - First Hill

 

January 2013

 

203,817

 

$

6,802

 

$

42,600

 

$

209

 

$

 

11.9

%

 

25/35/45 West Watkins Mill Road

1201 Clopper Road

 

October 1996

May 1998

 

Suburban Washington, D.C. - Gaithersburg

 

February 2013

 

282,523

 

$

7,795

 

41,400

 

$

147

 

$

53

 

11.2

 

 

One Innovation Drive

377 Plantation Street

381 Plantation Street

 

January 1999

September 1998

March 1999

 

Greater Boston - Route 495/Worcester

 

February 2013

 

300,313

 

$

6,605

 

40,250

 

$

134

 

$

(392

)

9.6

 

 

Total/weighted average

 

 

 

 

 

 

 

 

 

 

 

$

124,250

 

 

 

 

 

11.0

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Sales completed in 2Q13

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

702 Electronic Drive

 

June 1998

 

Pennsylvania

 

April 2013

 

40,171

 

$

438

 

$

4,362

 

$

109

 

$

268

 

10.0

%

 

Total/weighted average

 

 

 

 

 

 

 

 

 

 

 

$

4,362

 

 

 

 

 

10.0

%

 

 

(1)

Annualized using actual year-to-date results as of the quarter ended prior to date of sale or March 31, 2013.

(2)

Excludes impairment charges aggregating $11.4 million recognized during the year ended December 31, 2012.

(3)

See definition of unlevered IRR in “Non-GAAP Measures.”

 

“At the market” common stock offering program

 

See discussion in “Cash Flows – Financing Activities – At the Market Common Stock Offering Program.”

 

Uses of capital

 

75/125 Binney Street project

 

The following assumptions are included in our guidance for funding the cost to complete the 75/125 Binney Street project (in thousands):

 

Construction spending - summary

 

Three Months Ended
March 31, 2013

 

Projected Nine Months
Ended December 31, 2013

 

Projected Year Ended
December 31, 2013

 

Gross construction spending (1) 

 

$

115,090

 

$

564,512 - 614,512

 

$

679,602 - 729,602

 

 

 

 

 

 

 

 

 

Unconsolidated joint venture funding:

 

 

 

 

 

 

 

75/125 Binney JV partner capital/JV construction loan (2)

 

 

(47,025

)

(47,025

)

360 Longwood Avenue JV partner capital/JV construction loan

 

(10,816

)

(51,761

)

(62,577

)

 

 

(10,816

)

(98,786

)

(109,602

)

ARE share of capital related to funding construction spending

 

$

104,274

 

$

465,726 - 515,726

 

$

570,000 - 620,000

 

 

(1)

Represents 100% of construction spending for consolidated and unconsolidated projects

(2)

Projected joint venture. See page 63 for further information.

 

64



Table of Contents

 

Summary of capital expenditures

 

The following tables summarize the components of our total actual capital expenditures for the three months ended March 31, 2013, which include interest, property taxes, insurance, payroll costs, and other indirect project costs, and total projected capital expenditures for the year ended December 31, 2013, and the period thereafter (in thousands):

 

Construction spending – actual

 

Three Months Ended
March 31, 2013

(in thousands)

 

Development projects in North America

 

$

43,831

 

Redevelopment projects in North America

 

24,562

 

Preconstruction

 

22,138

 

Generic infrastructure/building improvement projects in North America (1)

 

10,811

 

Development and redevelopment projects in Asia

 

2,932

 

Total construction spending

 

$

104,274

 

 

The following table summarizes the components of our total projected capital expenditures for the nine months ended December 31, 2013, and the period thereafter.  Expenditures include indirect project costs, including interest, property taxes, insurance, and payroll costs (in thousands):

 

Construction spending – projection

 

Nine Months Ended December 31, 2013
(in thousands)

 

Thereafter
(in thousands)

 

Active development projects in North America (2)

 

$

262,784

 

$

163,244

 

Active redevelopment projects in North America

 

62,335

 

14,043

 

Preconstruction

 

33,760

 

TBD(3)

 

Generic infrastructure/building improvement projects in North America (4)

 

36,728

 

TBD(3)

 

Future projected construction projects (5)

 

42,320 - 92,320

 

TBD(3)

 

Development and redevelopment projects in Asia

 

27,799

 

23,154

 

Total construction spending (2)

 

$

465,726 - 515,726

 

$

200,441

 

 

(1)

Includes revenue-enhancing projects and amounts shown in the table below related to non-revenue-enhancing capital expenditures.

(2)

Total construction spending for 2013 increased approximately $25 million at the mid-point of our guidance since last quarter primarily as a result of our estimated share of capital required for the commencement of two new ground-up development projects during the first quarter of 2013. Our estimated construction spend for 2013 increased by approximately $13 million as a result of the commencement of our 100% pre-leased development at 269 East Grand Avenue. The total estimated cost at completion for 75/125 Binney Street has not changed since our estimate as of December 31, 2012; however, the timing of construction and completion of our projected joint venture results in an increase in our estimated share of capital contributions to fund the completion of the project by approximately $10 million. See additional details on the 269 East Grand Avenue project on page 47 and the 75/125 Binney Street project on page 63.

(3)

Estimated spending beyond 2013 will be determined at a future date and is contingent upon many factors.

(4)

Includes, among others, generic infrastructure building improvement projects in North America, including 215 First Street, 7030 Kit Creek, and 1300 Quince Orchard Boulevard.

(5)

Includes future projected construction projects in North America, including 3013/3033 Science Park Road.

 

65



Table of Contents

 

The table below shows the average per square foot of property-related non-revenue-enhancing capital expenditures, tenant improvements, and leasing costs (excluding capital expenditures and tenant improvements that are recoverable from client tenants, revenue-enhancing, or related to properties that have undergone redevelopment).

 

 

 

Three Months Ended
March 31,

 

Non-incremental revenue-enhancing capital expenditures (1):

 

2013

 

2012

 

Major capital expenditures

 

$

14,279

 

$

 

Other building improvements

 

$

581,422

 

$

210,083

 

Square feet in asset base

 

14,214,400

 

13,495,952

 

Per square foot:

 

 

 

 

 

Major capital expenditures

 

$

 

$

 

Other building improvements

 

$

0.04

 

$

0.02

 

Tenant improvements and leasing costs:

 

 

 

 

 

Re-tenanted space (2)

 

 

 

 

 

Tenant improvements and leasing costs

 

$

766,132

 

$

672,733

 

Re-tenanted square feet

 

48,484

 

63,241

 

Per square foot

 

$

15.80

 

$

10.64

 

Renewal space

 

 

 

 

 

Tenant improvements and leasing costs

 

$

115,931

 

$

1,345,072

 

Renewal square feet

 

107,397

 

211,288

 

Per square foot

 

$

1.08

 

$

6.37

 

 

(1)

Major capital expenditures typically consist of significant improvements such as roof and HVAC system replacements. Due to unfavorable weather conditions, major capital expenditures are low during the three months ended March 31, of each year. Other building improvements exclude major capital expenditures.

(2)

Excludes space that has undergone redevelopment before re-tenanting.

 

We expect our future non-revenue-enhancing capital expenditures, tenant improvements, and leasing costs (excluding capital expenditures and tenant improvements that are recoverable from client tenants, revenue-enhancing, or related to properties that have undergone redevelopment) on a per square foot basis to approximate the amounts shown in the preceding table.

 

Capitalized interest for the three months ended March 31, 2013 and 2012, of approximately $14.0 million and $15.3 million, respectively, is classified in investments in real estate, net, as well as included in the table on the preceding page summarizing total capital expenditures.  In addition, we capitalized payroll and other indirect project costs related to development, redevelopment, and construction projects, including projects in Asia, aggregating approximately $3.9 million and $3.1 million for the three months ended March 31, 2013 and 2012, respectively.  Such costs are also included in the “Summary of Capital Expenditures” section on the preceding page.

 

We capitalize interest cost as a cost of the project only during the period for which activities necessary to prepare an asset for its intended use are ongoing, provided that expenditures for the asset have been made and interest cost has been incurred.  Indirect project costs, including construction administration, legal fees, and office costs that clearly relate to projects under development or construction, are capitalized as incurred during the period an asset is undergoing activities to prepare it for its intended use.  Additionally, should activities necessary to prepare an asset for its intended use cease, interest, taxes, insurance, and certain other direct project costs related to this asset would be expensed as incurred.  When construction activities cease and the asset is ready for its intended use, the asset is transferred out of construction in progress and classified as rental properties, net.  Additionally, if vertical aboveground construction is not initiated at completion of preconstruction activities, the land parcel will be classified as land held for future development.  Expenditures for repairs and maintenance are expensed as incurred.  Fluctuations in our development, redevelopment, and construction activities could result in significant changes to total expenses and net income.  For example, had we experienced a 10% reduction in development, redevelopment, and construction activities without a corresponding decrease in indirect project costs, including interest and payroll, total expenses would have increased by approximately $1.8 million for the three months ended March 31, 2013.

 

We also capitalize and defer initial direct costs to originate leases with independent third parties related to evaluating a prospective lessee’s financial condition, negotiating lease terms, preparing the lease agreement, and closing the lease transaction.  Costs that we have capitalized and deferred relate to successful leasing transactions, result directly from and are essential to the lease transaction, and would not have been incurred had that leasing transaction not occurred.  The initial direct costs capitalized and deferred also include the portion of our employees’ total compensation and payroll-related fringe benefits directly related to time spent performing activities previously described and related to the respective lease that would not have been performed but for that lease. 

 

66



Table of Contents

 

Total initial direct leasing costs capitalized during the three months ended March 31, 2013 and 2012, were approximately $8.3 million and $11.5 million, respectively, of which approximately $2.6 million and $2.5 million, respectively, represented capitalized and deferred payroll costs directly related and essential to our leasing activities during such periods.

 

Acquisitions

 

We did not complete any real estate acquisitions during the three months ended March 31, 2013.

 

Dividends

 

We are required to distribute at least 90% of our REIT taxable income on an annual basis in order to continue to qualify as a REIT for federal income tax purposes.  Accordingly, we intend to make, but are not contractually bound to make, regular quarterly distributions to preferred and common stockholders from cash flow from operating activities.  All such distributions are at the discretion of our Board of Directors.  We may be required to use borrowings under our unsecured senior line of credit, if necessary, to meet REIT distribution requirements and maintain our REIT status.  We consider market factors and our performance in addition to REIT requirements in determining distribution levels.  Our forecasts of taxable income and distributions do not require significant increases in our annual common stock dividends on a per share basis in order to distribute at least 90% of our REIT taxable income for the period from January 1, 2013, through December 31, 2013.

 

67



Table of Contents

 

Contractual obligations and commitments

 

Contractual obligations as of March 31, 2013, consisted of the following (in thousands):

 

 

 

 

 

Payments by Period

 

 

 

Total

 

2013

 

2014-2015

 

2016-2017

 

Thereafter

 

Secured notes payable (1) (2)

 

$

731,033

 

$

33,955

 

$

352,664

 

$

235,172

 

$

109,242

 

Unsecured senior notes payable (1)

 

550,250

 

 

250

 

 

550,000

 

Unsecured senior line of credit (3)

 

554,000

 

 

 

554,000

 

 

2016 Unsecured Senior Bank Term Loan (4)

 

750,000

 

 

 

750,000

 

 

2017 Unsecured Senior Bank Term Loan (5)

 

600,000

 

 

 

600,000

 

 

Estimated interest payments on fixed rate and hedged variable rate debt (6)

 

221,654

 

79,977

 

85,278

 

31,416

 

24,983

 

Estimated interest payments on variable rate debt (7)

 

64,125

 

6,036

 

39,689

 

18,400

 

 

Ground lease obligations

 

662,357

 

9,010

 

19,407

 

20,685

 

613,255

 

Other obligations

 

6,130

 

599

 

1,727

 

1,893

 

1,911

 

Total

 

$

4,139,549

 

$

129,577

 

$

499,015

 

$

2,211,566

 

$

1,299,391

 

 

(1)

Amounts represent principal amounts due and exclude unamortized premiums/discounts reflected on the condensed consolidated balance sheets.

(2)

Amounts include noncontrolling interests’ share of scheduled principal maturities of approximately $21.2 million, of which approximately $20.9 million matures in 2014. See discussion under Note 5, Secured and Unsecured Senior Debt, for additional information.

(3)

The maturity date of our unsecured senior line of credit is April 30, 2017, assuming we exercise our sole right to extend the maturity date of April 30, 2016, twice, by an additional six months.

(4)

Our 2016 unsecured senior bank term loan (“2016 Unsecured Senior Bank Term Loan”) matures June 30, 2016, assuming we exercise our sole right to extend the maturity date of June 30, 2015, by one year.

(5)

Our 2017 unsecured senior bank term loan (“2017 Unsecured Senior Bank Term Loan”) matures January 31, 2017, assuming we exercise our sole right to extend the maturity date of January 31, 2016, by one year.

(6)

Estimated interest payments on our fixed rate debt and hedged variable rate debt were based upon contractual interest rates, including the impact of interest rate swap agreements, interest payment dates, and scheduled maturity dates.

(7)

The interest payments on variable rate debt were based on the interest rates in effect as of December 31, 2012.

 

Estimated interest payments

 

Estimated interest payments on our fixed rate debt and hedged variable rate debt were calculated based upon contractual interest rates, including the impact of interest rate swap agreements, interest payment dates, and scheduled maturity dates.  As of March 31, 2013, approximately 68% of our debt was fixed rate debt or variable rate debt subject to interest rate swap agreements.  See additional information regarding our interest rate swap agreements under “Liquidity and Capital Resources – Contractual Obligations and Commitments – Interest Rate Swap Agreements.”  The remaining 32% of our debt is unhedged variable rate debt based primarily on LIBOR.  Interest payments on our unhedged variable rate debt have been calculated based on interest rates in effect as of March 31, 2013.  See additional information regarding our debt under Note 5, Secured and Unsecured Senior Debt, to our condensed consolidated financial statements appearing elsewhere in our annual report on Form 10-K for the year ended December 31, 2012.

 

Ground lease obligations

 

Ground lease obligations as of March 31, 2013, included leases for 25 of our properties and four land development parcels.  Excluding one ground lease related to one operating property that expires in 2036 with a net book value of approximately $7.9 million at March 31, 2013, our ground lease obligations have remaining lease terms ranging from 41 to 196 years, including extension options.

 

Commitments

 

In addition to the above, as of March 31, 2013, remaining aggregate costs under contract for the construction of properties undergoing development, redevelopment, and generic life science infrastructure improvements under the terms of leases approximated $267.1 million.  We expect payments for these obligations to occur over one to three years, subject to capital planning adjustments from time to time.  We are also committed to funding approximately $56.7 million for certain investments over the next six years.

 

A 100% owned subsidiary of the Company previously executed a ground lease, as ground lessee, for certain property in New York City.  The West Tower of the Alexandria Center™ for Life Science – New York City will be constructed on such ground-leased property.  In November 2012, we commenced vertical construction of the West Tower.  The ground lease provides that substantial completion of the West Tower occur by October 31, 2015, and requires satisfying conditions that include substantially completed

 

68



Table of Contents

 

construction in accordance with the plans.  The ground lease also provides that by October 31, 2016, the ground lessee shall obtain a temporary or permanent certificate of occupancy for the core and shell of both the East Tower of the Alexandria Center™ for Life Science – New York City (which has occurred) and the West Tower.  In each case, the target dates above are subject to force majeure, to contractual cure rights, to other legal remedies available to ground lessees generally, and to change for any reason by agreement between both parties under the ground lease.  If the above dates are not met, the ground lease provides contractual cure rights and the ground lease does not provide for the payment of additional rent, a late fee, or other monetary penalty.

 

Off-balance sheet arrangements

 

Our off-balance sheet arrangements consist of our investment in a real estate entity that is a variable interest entity for which we are not the primary beneficiary.  We account for the real estate entity under the equity method.  The debt held by the unconsolidated real estate entity is secured by the land parcel owned by the entity, and is non-recourse to us.  See Notes 2 and 3 to our condensed consolidated financial statements appearing elsewhere in our annual report on Form 10-K for the year ended December 31, 2012.

 

Interest rate swap agreements

 

We utilize interest rate swap agreements to hedge a portion of our exposure to variable interest rates primarily associated with our unsecured senior line of credit and unsecured senior bank term loans.  These agreements involve an exchange of fixed and variable rate interest payments without the exchange of the underlying principal amount (the “notional amount”).  Interest received under all of our interest rate swap agreements is based on the one-month LIBOR rate.  The net difference between the interest paid and the interest received is reflected as an adjustment to interest expense.

 

The following table summarizes our interest rate swap agreements as of March 31, 2013 (in thousands):

 

 

 

 

 

 

 

Interest Pay

 

Fair Value as of

 

Notional Amount in Effect as of

 

Transaction Date

 

Effective Date

 

Termination Date

 

Rate (1)

 

March 31, 2013 (2)

 

March 31, 2013

 

December 31, 2013

 

December 2006

 

December 29, 2006

 

March 31, 2014

 

4.990%

 

$

(2,398

)

$

50,000

 

$

50,000

 

October 2007

 

October 31, 2007

 

September 30, 2013

 

4.642%

 

(1,120

)

50,000

 

 

December 2006

 

November 30, 2009

 

March 31, 2014

 

5.015%

 

(3,616

)

75,000

 

75,000

 

December 2006

 

November 30, 2009

 

March 31, 2014

 

5.023%

 

(3,622

)

75,000

 

75,000

 

December 2011

 

December 31, 2012

 

December 31, 2013

 

0.640%

 

(791

)

250,000

 

 

December 2011

 

December 31, 2012

 

December 31, 2013

 

0.640%

 

(791

)

250,000

 

 

December 2011

 

December 31, 2012

 

December 31, 2013

 

0.644%

 

(399

)

125,000

 

 

December 2011

 

December 31, 2012

 

December 31, 2013

 

0.644%

 

(399

)

125,000

 

 

December 2011

 

December 31, 2013

 

December 31, 2014

 

0.977%

 

(1,676

)

 

250,000

 

December 2011

 

December 31, 2013

 

December 31, 2014

 

0.976%

 

(1,674

)

 

250,000

 

Total

 

 

 

 

 

 

 

$

(16,486

)

$

1,000,000

 

$

700,000

 

 

(1)

In addition to the interest pay rate, borrowings outstanding under our unsecured senior line of credit and unsecured senior bank term loans include an applicable margin currently ranging from 1.20% to 1.75%.

(2)

Includes accrued interest and credit valuation adjustment.

 

We have entered into master derivative agreements with each counterparty.  These master derivative agreements (all of which are adapted from the standard International Swaps and Derivatives Association, Inc. form) define certain terms between the Company and each counterparty to address and minimize certain risks associated with our interest rate swap agreements.  In order to limit our risk of non-performance by an individual counterparty under our interest rate swap agreements, our interest rate swap agreements are spread among various counterparties.  As of March 31, 2013 and 2012, the largest aggregate notional amount of the interest rate swap agreements in effect at any single point in time with an individual counterparty was $375.0 million.  If one or more of our counterparties fail to perform under our interest rate swap agreements, we may incur higher costs associated with our variable rate LIBOR-based debt than the interest costs we originally anticipated.

 

As of March 31, 2013, the fair values of our interest rate swap agreements were classified in accounts payable, accrued expenses, and tenant security deposits based upon their respective fair values, aggregating a liability balance of approximately $16.5 million, with the offsetting adjustment reflected as unrealized losses in accumulated other comprehensive loss in total equity.  Balances in accumulated other comprehensive loss are recognized in the period during which the hedged transactions affect earnings.  We have not posted any collateral related to our interest rate swap agreements.  For the three months ended March 31, 2013 and 2012, approximately $4.3 and $5.8 million, respectively, was reclassified from accumulated other comprehensive income to interest expense as an increase to interest expense.  During the next 12 months, we expect to reclassify approximately $14.0 million from accumulated other comprehensive loss to interest expense as an increase to interest expense.

 

69



Table of Contents

 

Other resources and liquidity requirements

 

Under our current shelf registration statement filed with the SEC, we may offer common stock, preferred stock, debt, and other securities.  These securities may be issued from time to time at our discretion based on our needs and market conditions, including as necessary to balance our use of incremental debt capital.

 

We hold interests, together with certain third parties, in companies that we consolidate in our financial statements.  These third parties may contribute equity into these entities primarily related to their share of funds for construction and financing-related activities.

 

Exposure to environmental liabilities

 

In connection with the acquisition of all of our properties, we have obtained Phase I environmental assessments to ascertain the existence of any environmental liabilities or other issues.  The Phase I environmental assessments of our properties have not revealed any environmental liabilities that we believe would have a material adverse effect on our financial condition or results of operations taken as a whole, nor are we aware of any material environmental liabilities that have occurred since the Phase I environmental assessments were completed.  In addition, we carry a policy of pollution legal liability insurance covering exposure to certain environmental losses at substantially all of our properties.

 

Inflation

 

As of March 31, 2013, approximately 94% of our leases (on a rentable square footage basis) were triple net leases, requiring client tenants to pay substantially all real estate taxes, insurance, utilities, common area expenses, and other operating expenses (including increases thereto) in addition to base rent.  Approximately 96% of our leases (on a rentable square footage basis) contained effective annual rent escalations that were either fixed (generally ranging from 3.0% to 3.5%) or indexed based on a consumer price index or another index.  Accordingly, we do not believe that our cash flow or earnings from real estate operations are subject to any significant risk from inflation.  An increase in inflation, however, could result in an increase in the cost of our variable rate borrowings, including borrowings related to our unsecured senior line of credit and unsecured senior bank term loans.

 

70



Table of Contents

 

Non-GAAP measures

 

FFO and FFO, as adjusted

 

GAAP basis accounting for real estate assets utilizes historical cost accounting and assumes that real estate values diminish over time.  In an effort to overcome the difference between real estate values and historical cost accounting for real estate assets, the Board of Governors of NAREIT established the measurement tool of FFO.  Since its introduction, FFO has become a widely used non-GAAP financial measure among equity REITs.  We believe that FFO is helpful to investors as an additional measure of the performance of an equity REIT.  Moreover, we believe that FFO, as adjusted, is also helpful because it allows investors to compare our performance to the performance of other real estate companies between periods, and on a consistent basis, without having to account for differences caused by investment and disposition decisions, financing decisions, terms of securities, capital structures, and capital market transactions.  We compute FFO in accordance with standards established by the Board of Governors of NAREIT in its NAREIT White Paper.  The NAREIT White Paper defines FFO as net income (computed in accordance with GAAP), excluding gains (losses) from sales of depreciable real estate and land parcels and impairments of depreciable real estate (excluding land parcels), plus real estate related depreciation and amortization, and after adjustments for unconsolidated partnerships and joint ventures.  Impairments of real estate relate to decreases in the estimated fair value of real estate due to changes in general market conditions and do not necessarily reflect the operating performance of the properties during the corresponding period.  Impairments of real estate represent the non-cash write-down of assets when fair value over the recoverability period is less than the carrying value.  We compute FFO, as adjusted, as FFO calculated in accordance with the NAREIT White Paper, plus losses on early extinguishment of debt, preferred stock redemption charges, and impairments of land parcels, less realized gain on equity investment primarily related to one non-tenant life science entity, and the amount of such items that is allocable to our unvested restricted stock awards.  Our calculations of both FFO and FFO, as adjusted, may differ from those methodologies utilized by other equity REITs for similar performance measurements, and, accordingly, may not be comparable to those of other equity REITs.  Neither FFO nor FFO, as adjusted, should be considered as an alternative to net income (determined in accordance with GAAP) as an indication of financial performance, or to cash flows from operating activities (determined in accordance with GAAP) as a measure of liquidity, nor are they indicative of the availability of funds for our cash needs, including funds available to make distributions.

 

Adjusted funds from operations (“AFFO”)

 

AFFO is a non-GAAP financial measure that we use as a supplemental measure of our performance.  We compute AFFO by adding to or deducting from FFO, as adjusted: (1) non-revenue-enhancing capital expenditures, tenant improvements, and leasing commissions (excludes development and redevelopment expenditures); (2) effects of straight-line rent and straight-line rent on ground leases; (3) capitalized income from development projects; (4) amortization of acquired above and below market leases, loan fees, and debt premiums/discounts; (5) non-cash compensation expense; and (6) allocation of AFFO attributable to unvested restricted stock awards.

 

We believe that AFFO is a useful supplemental performance measure because it further adjusts to: (1) deduct certain expenditures that, although capitalized and classified in depreciation expense, do not enhance the revenue or cash flows of our properties; (2) eliminate the effect of straight-lining our rental income and capitalizing income from development projects in order to reflect the actual amount of contractual rents due in the period presented; and (3) eliminate the effect of non-cash items that are not indicative of our core operations and do not actually reduce the amount of cash generated by our operations.  We believe that eliminating the effect of non-cash charges related to share-based compensation facilitates a comparison of our operations across periods and among other equity REITs without the variances caused by different valuation methodologies, the volatility of the expense (which depends on market forces outside our control), and the assumptions and the variety of award types that a company can use.  We believe that AFFO provides useful information by excluding certain items that are not representative of our core operating results because such items are dependent upon historical costs or subject to judgmental valuation inputs and the timing of our decisions.

 

AFFO is not intended to represent cash flow for the period, and is intended only to provide an additional measure of performance.  We believe that net income attributable to Alexandria Real Estate Equities, Inc.’s common stockholders is the most directly comparable GAAP financial measure to AFFO.  We believe that AFFO is a widely recognized measure of the operations of equity REITs, and presenting AFFO will enable investors to assess our performance in comparison to other equity REITs.  However, other equity REITs may use different methodologies for calculating AFFO and, accordingly, our AFFO may not be comparable to AFFO calculated by other equity REITs.  AFFO should not be considered as an alternative to net income (determined in accordance with GAAP) as an indication of financial performance, or to cash flows from operating activities (determined in accordance with GAAP) as a measure of our liquidity, nor is it indicative of funds available to fund our cash needs, including our ability to make distributions.

 

71



Table of Contents

 

The following table presents a reconciliation of net income attributable to Alexandria Real Estate Equities, Inc.’s common stockholders – basic, the most directly comparable financial measure calculated and presented in accordance with GAAP, to FFO attributable to Alexandria Real Estate Equities, Inc.’s common stockholders – basic, FFO attributable to Alexandria Real Estate Equities, Inc.’s common stockholders – diluted, as adjusted, and AFFO attributable to Alexandria Real Estate Equities, Inc.’s common stockholders – diluted, for the periods below (in thousands):

 

 

 

Three Months Ended March 31,

 

 

 

2013

 

2012

 

Net income attributable to Alexandria Real Estate Equities, Inc.’s common stockholders – basic

 

$

22,442

 

$

18,368

 

Depreciation and amortization

 

46,995

 

43,405

 

Loss on sale of real estate

 

340

 

 

Impairment of real estate

 

 

 

Gain on sale of land parcel

 

 

(1,864

)

Amount attributable to noncontrolling interests/unvested restricted stock awards:

 

 

 

 

 

Net income

 

1,324

 

946

 

FFO

 

(1,064

)

(1,156

)

FFO attributable to Alexandria Real Estate Equities, Inc.’s common stockholders – basic

 

70,037

 

59,699

 

Assumed conversion of 8.00% Unsecured Senior Convertible Notes

 

5

 

5

 

FFO attributable to Alexandria Real Estate Equities, Inc.’s common stockholders – diluted

 

70,042

 

59,704

 

Realized gain on equity investment primarily related to one non-tenant life science entity

 

 

 

Impairment of land parcel

 

 

 

Loss on early extinguishment of debt

 

 

623

 

Preferred stock redemption charge

 

 

5,978

 

Allocation to unvested restricted stock awards

 

 

(53

)

FFO attributable to Alexandria Real Estate Equities, Inc.’s common stockholders – diluted, as adjusted

 

70,042

 

66,252

 

 

 

 

 

 

 

Non-revenue-enhancing capital expenditures:

 

 

 

 

 

Building improvements

 

(596

)

(210

)

Tenant improvements and leasing commissions

 

(882

)

(2,019

)

Straight-line rent

 

(6,198

)

(8,796

)

Straight-line rent on ground leases

 

538

 

1,406

 

Capitalized income from development projects

 

22

 

478

 

Amortization of acquired above and below market leases

 

(830

)

(800

)

Amortization of loan fees

 

2,386

 

2,643

 

Amortization of debt premiums/discounts

 

115

 

179

 

Stock compensation

 

3,349

 

3,293

 

Allocation to unvested restricted stock awards

 

19

 

31

 

AFFO attributable to Alexandria Real Estate Equities, Inc.’s common stockholders – diluted

 

$

67,965

 

$

62,457

 

 

72



Table of Contents

 

The following table presents a reconciliation of net income per share attributable to Alexandria Real Estate Equities, Inc.’s common stockholders – basic, the most directly comparable financial measure calculated and presented in accordance with GAAP, to FFO per share attributable to Alexandria Real Estate Equities, Inc.’s common stockholders – basic, FFO per share attributable to Alexandria Real Estate Equities, Inc.’s common stockholders – diluted, as adjusted, and AFFO per share attributable to Alexandria Real Estate Equities, Inc.’s common stockholders – diluted, for the periods below:

 

 

 

Three Months Ended March 31,

 

 

 

2013

 

2012

 

Net income attributable to Alexandria Real Estate Equities, Inc.’s common stockholders – basic

 

$

0.36

 

$

0.30

 

Depreciation and amortization

 

0.74

 

0.70

 

Loss on sale of real estate

 

 

 

Impairment of real estate

 

0.01

 

 

Gain on sale of land parcel

 

 

(0.03

)

Amount attributable to noncontrolling interests/unvested restricted stock awards:

 

 

 

 

 

Net income

 

0.02

 

0.02

 

FFO

 

(0.02

)

(0.02

)

FFO attributable to Alexandria Real Estate Equities, Inc.’s common stockholders – basic

 

1.11

 

0.97

 

Assumed conversion of 8.00% Unsecured Senior Convertible Notes

 

 

 

FFO attributable to Alexandria Real Estate Equities, Inc.’s common stockholders – diluted

 

1.11

 

0.97

 

Realized gain on equity investment primarily related to one non-tenant life science entity

 

 

 

Impairment of land parcel

 

 

 

Loss on early extinguishment of debt

 

 

0.01

 

Preferred stock redemption charge

 

 

0.10

 

FFO attributable to Alexandria Real Estate Equities, Inc.’s common stockholders – diluted, as adjusted

 

1.11

 

1.08

 

 

 

 

 

 

 

Non-revenue-enhancing capital expenditures:

 

 

 

 

 

Building improvements

 

(0.01

)

 

Tenant improvements and leasing commissions

 

(0.01

)

(0.03

)

Straight-line rent

 

(0.10

)

(0.14

)

Straight-line rent on ground leases

 

0.01

 

0.02

 

Capitalized income from development projects

 

 

0.01

 

Amortization of acquired above and below market leases

 

(0.01

)

(0.01

)

Amortization of loan fees

 

0.04

 

0.04

 

Amortization of debt premiums/discounts

 

 

 

Stock compensation

 

0.05

 

0.05

 

AFFO attributable to Alexandria Real Estate Equities, Inc.’s common stockholders – diluted

 

$

1.08

 

$

1.02

 

 

73



Table of Contents

 

Adjusted EBITDA and Adjusted EBITDA margins

 

EBITDA represents earnings before interest, taxes, depreciation, and amortization (“EBITDA”), a non-GAAP financial measure, and is used by us and others as a supplemental measure of performance.  We use Adjusted EBITDA and Adjusted EBITDA margins to assess the performance of our core operations, for financial and operational decision making, and as a supplemental or additional means of evaluating period-to-period comparisons on a consistent basis.  Adjusted EBITDA also serves as a proxy for a component of a financial covenant under certain of our debt obligations.  Adjusted EBITDA is calculated as EBITDA excluding net stock compensation expense, gains or losses on early extinguishment of debt, gains or losses on sales of real estate, gains or losses on sales of land parcels, impairments of real estate, and impairments of land parcels.  We believe Adjusted EBITDA and Adjusted EBITDA margins provide investors relevant and useful information because they permit investors to view income from our operations on an unleveraged basis before the effects of taxes, non-cash depreciation and amortization, net stock compensation expense, gains or losses on early extinguishment of debt, gains or losses on sales of real estate, gains or losses on sales of land parcels, impairments of real estate, and impairments of land parcels.  By excluding interest expense and gains or losses on early extinguishment of debt, EBITDA, Adjusted EBITDA, and Adjusted EBITDA margins allow investors to measure our performance independent of our capital structure and indebtedness and, therefore, allow for a more meaningful comparison of our performance to that of other companies, both in the real estate industry and in other industries.  We believe that excluding non-cash charges related to share-based compensation facilitates a comparison of our operations across periods and among other equity REITs without the variances caused by different valuation methodologies, the volatility of the expense (which depends on market forces outside our control), and the assumptions and the variety of award types that a company can use.  We believe that adjusting for the effects of gains or losses on sales of real estate, gains or losses on sales of land parcels, impairments of real estate, and impairments of land parcels provides useful information by excluding certain items that are not representative of our core operating results.  These items are dependent upon historical costs, and are subject to judgmental inputs and the timing of our decisions.  EBITDA, Adjusted EBITDA, and Adjusted EBITDA margins have limitations as measures of our performance.  EBITDA, Adjusted EBITDA, and Adjusted EBITDA margins do not reflect our historical cash expenditures or future cash requirements for capital expenditures or contractual commitments.  While EBITDA, Adjusted EBITDA, and Adjusted EBITDA margins are relevant and widely used measures of performance, they do not represent net income or cash flows from operations as defined by GAAP, and they should not be considered as alternatives to those indicators in evaluating performance or liquidity.  Further, our computation of EBITDA, Adjusted EBITDA, and Adjusted EBITDA margins may not be comparable to similar measures reported by other companies.

 

The following table reconciles net income, the most directly comparable financial measure calculated and presented in accordance with GAAP, to EBITDA, Adjusted EBITDA, and Adjusted EBITDA margins, for the three months ended March 31, 2013 and 2012 (dollars in thousands):

 

 

 

Three Months Ended March 31,

 

 

 

2013

 

2012

 

Net income

 

$

30,237

 

$

32,775

 

Interest expense – continuing operations

 

18,020

 

16,226

 

Interest expense – discontinued operations

 

 

1

 

Depreciation and amortization – continuing operations

 

46,065

 

41,786

 

Depreciation and amortization – discontinued operations

 

930

 

1,619

 

EBITDA

 

95,252

 

92,407

 

 

 

 

 

 

 

Stock compensation expense

 

3,349

 

3,293

 

Loss on early extinguishment of debt

 

 

623

 

Loss on sale of real estate

 

340

 

 

Gain on sale of land parcel

 

 

(1,864

)

Impairment of real estate

 

 

 

Impairment of land parcel

 

 

 

Adjusted EBITDA

 

$

98,941

 

$

94,459

 

 

 

 

 

 

 

Total revenues

 

$

150,380

 

$

135,711

 

Adjusted EBITDA margins

 

66%

 

70%

 

 

74



Table of Contents

 

Fixed charge coverage ratio

 

The fixed charge coverage ratio is useful to investors as a supplemental measure of the Company’s ability to satisfy fixed financing obligations and dividends on preferred stock.  Cash interest is equal to interest expense calculated in accordance with GAAP, plus capitalized interest, less amortization of loan fees, and amortization of debt premiums/discounts.  The fixed charge coverage ratio calculation below is not directly comparable to the computation of “Consolidated Ratio of Earnings to Fixed Charges and Consolidated Ratio of Earnings to Combined Fixed Charges and Preferred Stock Dividends” included in Exhibit 12.1 to our annual report on Form 10-K, as of December 31, 2012.

 

The following table presents a reconciliation of interest expense, the most directly comparable GAAP financial measure to cash interest and fixed charges, for the three months ended March 31, 2013 and 2012 (dollars in thousands):

 

 

 

Three Months Ended March 31,

 

 

 

2013

 

2012

 

Adjusted EBITDA

 

$

98,941

 

$

94,459

 

 

 

 

 

 

 

Interest expense – continuing operations

 

$

18,020

 

$

16,226

 

Interest expense – discontinued operations

 

 

1

 

Add: capitalized interest

 

14,021

 

15,266

 

Less: amortization of loan fees

 

(2,386

)

(2,643

)

Less: amortization of debt premium/discounts

 

(115

)

(179

)

Cash interest

 

29,540

 

28,671

 

Dividends on preferred stock

 

6,471

 

7,483

 

Fixed charges

 

$

36,011

 

$

36,154

 

 

 

 

 

 

 

Fixed charge coverage ratio

 

2.7x

 

2.6x

 

 

Interest coverage ratio

 

The interest coverage ratio is the ratio of Adjusted EBITDA to cash interest.  This ratio is useful to investors as an indicator of our ability to service our cash interest obligations.

 

The following table summarizes the calculation of the interest coverage ratio for the three months ended March 31, 2013 and 2012  (dollars in thousands):

 

 

 

Three Months Ended March 31,

 

 

 

2013

 

2012

 

Adjusted EBITDA

 

$

98,941

 

$

94,459

 

 

 

 

 

 

 

Interest expense – continuing operations

 

$

18,020

 

$

16,226

 

Interest expense – discontinued operations

 

 

1

 

Add: capitalized interest

 

14,021

 

15,266

 

Less: amortization of loan fees

 

(2,386

)

(2,643

)

Less: amortization of debt premium/discounts

 

(115

)

(179

)

Cash interest

 

$

29,540

 

28,671

 

 

 

 

 

 

 

Interest coverage ratio

 

3.3x

 

3.3x

 

 

75


 


Table of Contents

 

Net debt to Adjusted EBITDA

 

Net debt to Adjusted EBITDA is a non-GAAP financial measure that we believe is useful to investors as a supplemental measure in evaluating our leverage.  Net debt is equal to the sum of total debt less cash, cash equivalents, and restricted cash.  See “Adjusted EBITDA” for further information on the calculation of Adjusted EBITDA.

 

The following table summarizes the calculation of net debt to Adjusted EBITDA as of March 31, 2013, and December 31, 2012 (dollars in thousands):

 

 

 

As of

 

 

 

March 31,
2013

 

December 31,
2012

 

Secured notes payable

 

$

730,714

 

$

716,144

 

Unsecured senior notes payable

 

549,816

 

549,805

 

Unsecured senior line of credit

 

554,000

 

566,000

 

Unsecured senior bank term loans

 

1,350,000

 

1,350,000

 

Less: cash and cash equivalents

 

(87,001

)

(140,971

)

Less: restricted cash

 

(30,008

)

(39,947

)

Net debt

 

$

3,067,521

 

$

3,001,031

 

 

 

 

 

 

 

Adjusted EBITDA (quarter annualized) (1)

 

$

395,764

 

$

408,876

 

 

 

 

 

 

 

Net debt to Adjusted EBITDA (quarter annualized) (1)

 

7.8x

 

7.3x

 

 

 

 

 

 

 

Adjusted EBITDA (trailing 12 months)

 

$

397,606

 

$

393,124

 

 

 

 

 

 

 

Net debt to Adjusted EBITDA (trailing 12 months)

 

7.7x

 

7.6x

 

 

(1)         We believe the Adjusted EBITDA and net debt to Adjusted EBITDA for the three months ended March 31, 2013, and December 31, 2012, annualized, reflect the completion of many development and redevelopment projects and are indicative of the Company’s current operating trends.

 

Net debt to gross assets (excluding cash and restricted cash)

 

Net debt to gross assets (excluding cash and restricted cash) is a non-GAAP financial measure that we believe is useful to investors as a supplemental measure in evaluating our leverage.  Net debt is calculated as described in “Net Debt to Adjusted EBITDA.”  Gross assets (excluding cash and restricted cash) are equal to total assets plus accumulated depreciation less cash, cash equivalents, and restricted cash.

 

The following table summarizes the calculation of net debt to gross assets (excluding cash and restricted cash) as of March 31, 2013, and December 31, 2012 (dollars in thousands):

 

 

 

As of

 

 

 

March 31,
2013

 

December 31,
2012

 

Net debt

 

$

3,067,521

 

$

3,001,031

 

 

 

 

 

 

 

Total assets

 

$

7,090,919

 

$

7,150,116

 

Add: accumulated depreciation

 

849,891

 

875,035

 

Less: cash and cash equivalents

 

(87,001

)

(140,971

)

Less: restricted cash

 

(30,008

)

(39,947

)

Gross assets (excluding cash and restricted cash)

 

$

7,823,801

 

$

7,844,233

 

 

 

 

 

 

 

Net debt to gross assets (excluding cash and restricted cash)

 

39%

 

38%

 

 

76



Table of Contents

 

NOI

 

NOI is a non-GAAP financial measure equal to income from continuing operations, the most directly comparable GAAP financial measure, plus loss (gain) on early extinguishment of debt, impairment of land parcel, depreciation and amortization, interest expense, and general and administrative expense.  We believe NOI provides useful information to investors regarding our financial condition and results of operations because it reflects primarily those income and expense items that are incurred at the property level.  Therefore, we believe NOI is a useful measure for evaluating the operating performance of our real estate assets.  NOI on a cash basis is NOI on a GAAP basis, adjusted to exclude the effect of straight-line rent adjustments required by GAAP.  We believe that NOI on a cash basis is helpful to investors as an additional measure of operating performance because it eliminates straight-line rent adjustments to rental revenue.

 

Further, we believe NOI is useful to investors as a performance measure, because when compared across periods, NOI reflects the impact on operations from trends in occupancy rates, rental rates, and operating costs, providing perspective not immediately apparent from income from continuing operations.  NOI excludes certain components from income from continuing operations in order to provide results that are more closely related to the results of operations of our properties.  For example, interest expense is not necessarily linked to the operating performance of a real estate asset and is often incurred at the corporate level rather than at the property level.  In addition, depreciation and amortization, because of historical cost accounting and useful life estimates, may distort operating performance at the property level.  Real estate impairments have been excluded in deriving NOI because we do not consider impairment losses to be property-level operating expenses.  Real estate impairment losses relate to changes in the values of our assets and do not reflect the current operating performance with respect to related revenues or expenses.  Our real estate impairments represent the write-down in the value of the assets to the estimated fair value less cost to sell.  These impairments result from investing decisions and the deterioration in market conditions that adversely impact underlying real estate values.  Our calculation of NOI also excludes charges incurred from changes in certain financing decisions, such as losses on early extinguishment of debt, as these charges often relate to the timing of corporate strategy.  Property operating expenses that are included in determining NOI consist of costs that are related to our operating properties, such as utilities; repairs and maintenance; rental expense related to ground leases; contracted services, such as janitorial, engineering, and landscaping; property taxes and insurance; and property-level salaries.  General and administrative expenses consist primarily of accounting and corporate compensation, corporate insurance, professional fees, office rent, and office supplies that are incurred as part of corporate office management.  NOI presented by us may not be comparable to NOI reported by other equity REITs that define NOI differently.  We believe that in order to facilitate a clear understanding of our operating results, NOI should be examined in conjunction with income from continuing operations as presented in our condensed consolidated statements of income.  NOI should not be considered as an alternative to income from continuing operations as an indication of our performance, or as an alternative to cash flows as a measure of liquidity or a measure of our ability to make distributions.

 

The following table is a reconciliation of NOI from continuing operations to income from continuing operations and NOI from discontinued operations to income from discontinued operations, the most directly comparable financial measure calculated and presented in accordance with GAAP (in thousands):

 

 

 

Three Months Ended

 

Continuing operations

 

March 31, 2013

 

March 31, 2012

 

Total revenues

 

$

150,380

 

$

135,711

 

Rental operations

 

45,224

 

40,453

 

Net operating income

 

105,156

 

95,258

 

Operating margins

 

70%

 

70%

 

General and administrative

 

11,648

 

10,357

 

Interest

 

18,020

 

16,226

 

Depreciation and amortization

 

46,065

 

41,786

 

Loss on early extinguishment of debt

 

 

623

 

Income from continuing operations

 

$

29,423

 

$

26,266

 

 

 

 

 

 

 

Discontinued operations

 

 

 

 

 

Total revenues

 

$

3,496

 

$

9,308

 

Rental operations

 

1,412

 

3,043

 

Net operating income (1)

 

2,084

 

6,265

 

Operating margins

 

60%

 

67%

 

Interest

 

 

1

 

Depreciation and amortization

 

930

 

1,619

 

Loss on sale of real estate

 

340

 

 

Income from discontinued operations, net

 

$

814

 

$

4,645

 

 

(1)             Net operating income from discontinued operations for the three months ended March 31, 2013, is comprised of $0.2 million for the three assets classified as “held for sale” as of March 31, 2013, and $1.9 million for the 6 assets sold during the three months ended March 31, 2013.  Net operating income from discontinued operations for the three months ended March 31, 2012, is comprised of $0.3 million for the three assets classified as “held for sale” as of March 31, 2013, and $6.0 million for the 12 assets sold since January 1, 2012.

 

77



Table of Contents

 

Same property NOI

 

See discussion of Same Properties and reconciliation of NOI to income from continuing operations in “Results of Operations.”

 

Unencumbered NOI as a percentage of total NOI

 

Unencumbered NOI as a percentage of total NOI is a non-GAAP financial measure that we believe is useful to investors as a performance measure of our results of operations of our unencumbered real estate assets, as it reflects primarily those income and expense items that are incurred at the unencumbered property level.  We use unencumbered NOI as a percentage of total NOI in order to assess our compliance with our financial covenants under our debt obligations because the measure serves as a proxy for a financial measure under such debt obligations.  Unencumbered NOI is derived from assets classified in continuing operations that are not subject to any mortgage, deed of trust, lien, or other security interest as of the period for which income is presented.  Unencumbered NOI for periods prior to the three months ended March 31, 2013, has been reclassified to conform to current period presentation related to discontinued operations.  See the reconciliation of NOI to income from continuing operations in “Results of Operations.”

 

The following table summarizes unencumbered NOI as a percentage of total NOI for the three months ended March 31, 2013 and 2012 (dollars in thousands):

 

 

 

Three Months Ended March 31,

 

 

 

2013

 

2012

 

Unencumbered net operating income

 

$

71,402

 

$

66,199

 

Encumbered net operating income

 

33,754

 

29,059

 

Total net operating income

 

$

105,156

 

$

95,258

 

 

 

 

 

 

 

Unencumbered net operating income as a percentage of total net operating income

 

68%

 

69%

 

 

Unlevered IRR

 

We believe Unlevered IRR is a useful supplemental performance measure used by investors to evaluate the performance of a specific real estate investment.  Unlevered IRR is the annualized implied discount rate calculated from the cash flows of a real estate asset over the holding period for such asset.  Unlevered IRR represents the return that equates the present value of all capital invested in a real estate asset to the present value of all cash flows generated by that real estate asset, or the discount rate that provides a net present value of all cash flows related to a real estate asset to zero. Unlevered IRR is calculated based upon the actual timing of cash flows, including among others i) the initial cash purchase price; ii) cash NOI (GAAP NOI excluding the impact of straight-line rents); iii) capital expenditures; iv) leasing costs, and v) the net sales proceeds of each respective real estate asset.  Losses incurred upon sale or non-cash impairment charges recognized during our ownership period are reflected in the unlevered IRR through the net sales proceeds of each real estate asset.  The calculation of unlevered IRR does not include general and administrative costs of the Company or interest expense related to the Company’s financing costs, because they are not directly related or attributable to the operations of the real estate asset.

 

78



Table of Contents

 

Item 3.  QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

Interest rate risk

 

The primary market risk to which we believe we are exposed is interest rate risk, which may result from many factors, including government monetary and tax policies, domestic and international economic and political considerations, and other factors that are beyond our control.

 

In order to modify and manage the interest rate characteristics of our outstanding debt and to limit the effects of interest rate risks on our operations, we may utilize a variety of financial instruments, including interest rate swap agreements, caps, floors, and other interest rate exchange contracts.  The use of these types of instruments to hedge a portion of our exposure to changes in interest rates carries additional risks, such as counterparty credit risk and the legal enforceability of hedging contracts.

 

Our future earnings and fair values relating to financial instruments are primarily dependent upon prevalent market rates of interest, such as LIBOR.  However, our interest rate swap agreements are intended to reduce the effects of interest rate changes.  The following table illustrates the effect of a 1% increase/decrease in interest rates, assuming a LIBOR floor of 0%, on our variable rate debt, including our unsecured senior line of credit and unsecured senior bank term loans, after considering the effect of our interest rate swap agreements, secured debt, unsecured senior notes payable, and unsecured senior convertible notes (in thousands):

 

 

 

As of
March 31, 2013

 

As of
December 31, 2012

 

Impact to future earnings due to variable rate debt:

 

 

 

 

 

Rate increase of 1%

 

$

(2,527

)

$

(5,870

)

Rate decrease of 1%

 

$

6,352

 

$

1,101

 

 

 

 

 

 

 

Effect on fair value of secured debt:

 

 

 

 

 

Rate increase of 1%

 

$

(33,844

)

$

(37,146

)

Rate decrease of 1%

 

$

25,547

 

$

27,260

 

 

These amounts are determined by considering the impact of the hypothetical interest rates on our borrowing cost and our interest rate swap agreements in effect on March 31, 2013.  These analyses do not consider the effects of the reduced level of overall economic activity that could exist in such an environment.  Further, in the event of a change of such magnitude, we would consider taking actions to further mitigate our exposure to the change.  However, because of the uncertainty of the specific actions that would be taken and their possible effects, the sensitivity analyses assume no changes in our capital structure.

 

Equity price risk

 

We have exposure to equity price market risk because of our equity investments in certain publicly traded companies and privately held entities.  We classify investments in publicly traded companies as “available for sale” and, consequently, recognize them in the accompanying condensed consolidated balance sheets at fair value, with unrealized gains or losses reported as a component of accumulated other comprehensive income or loss.  Investments in privately held entities are generally accounted for under the cost method because we do not influence any of the operating or financial policies of the entities in which we invest.  For all investments, we recognize other-than-temporary declines in value against earnings in the same period during which the decline in value was deemed to have occurred.  There is no assurance that future declines in value will not have a material adverse impact on our future results of operations.  The following table illustrates the effect that a 10% change in the fair value of our equity investments would have on earnings (in thousands):

 

 

 

As of
March 31, 2013

 

As of
December 31, 2012

 

Equity price risk:

 

 

 

 

 

Increase in fair value of 10%

 

$

12,354

 

$

11,505

 

Decrease in fair value of 10%

 

$

(12,354

)

$

(11,505

)

 

79



Table of Contents

 

Foreign currency exchange rate risk

 

We have exposure to foreign currency exchange rate risk related to our subsidiaries operating in Canada and Asia.  The functional currencies of our foreign subsidiaries are the respective local currencies.  Gains or losses resulting from the translation of our foreign subsidiaries’ balance sheets and statements of income are classified in accumulated other comprehensive income as a separate component of total equity.  Gains or losses will be reflected in our statements of income when there is a sale or partial sale of our investment in these operations or upon a complete or substantially complete liquidation of the investment.  The following table illustrates the effect that a 10% increase or decrease in foreign currency rates relative to the U.S. dollar would have on our earnings, based on our current operating assets outside the U.S. (in thousands):

 

 

 

As of
March 31, 2013

 

As of
December 31, 2012

 

Foreign currency exchange rate risk:

 

 

 

 

 

Increase in foreign currency exchange rate of 10%

 

$

(20

)

$

(29

)

Decrease in foreign currency exchange rate of 10%

 

$

20

 

$

29

 

 

This sensitivity analysis assumes a parallel shift of all foreign currency exchange rates with respect to the U.S. dollar; however, foreign currency exchange rates do not typically move in such a manner and actual results may differ materially.

 

Item 4.  CONTROLS AND PROCEDURES

 

Evaluation of disclosure controls and procedures

 

As of March 31, 2013, we had performed an evaluation, under the supervision of our Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), of the effectiveness of the design and operation of our disclosure controls and procedures.  These controls and procedures have been designed to ensure that information required for disclosure is recorded, processed, summarized, and reported within the requisite time periods.  Based on our evaluation, the CEO and CFO concluded that our disclosure controls and procedures were effective as of March 31, 2013.

 

Changes in internal control over financial reporting

 

There has not been any change in our internal control over financial reporting during the three months ended March 31, 2013, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 

PART II OTHER INFORMATION

 

Item 1A.               RISK FACTORS

 

In addition to the information set forth in this quarterly report on Form 10-Q, one should also carefully review and consider the information contained in our other reports and periodic filings that we make with the SEC, including, without limitation, the information contained under the caption “Item 1A.  Risk Factors” in our annual report on Form 10-K for the year ended December 31, 2012.  Those risk factors could materially affect our business, financial condition, and results of operations.  The risks that we describe in our public filings are not the only risks that we face.  Additional risks and uncertainties not currently known to us, or that we presently deem to be immaterial, also may materially adversely affect our business, financial condition, and results of operations.

 

80



Table of Contents

 

Item 6.  EXHIBITS

 

3.1*

 

Articles of Amendment and Restatement of the Company, filed as an exhibit to the Company’s quarterly report on Form 10-Q filed with the SEC on August 14, 1997.

3.2*

 

Certificate of Correction of the Company, filed as an exhibit to the Company’s quarterly report on Form 10-Q filed with the SEC on August 14, 1997.

3.3*

 

Bylaws of the Company (as amended December 15, 2011), filed as an exhibit to the Company’s current report on Form 8-K filed with the SEC on December 19, 2011.

3.4*

 

Articles Supplementary, dated June 9, 1999, relating to the 9.50% Series A Cumulative Redeemable Preferred Stock, filed as an exhibit to the Company’s quarterly report on Form 10-Q filed with the SEC on August 13, 1999.

3.5*

 

Articles Supplementary, dated February 10, 2000, relating to the election to be subject to Subtitle 8 of Title 3 of the Maryland General Corporation Law, filed as an exhibit to the Company’s current report on Form 8-K filed with the SEC on February 10, 2000.

3.6*

 

Articles Supplementary, dated February 10, 2000, relating to the Series A Junior Participating Preferred Stock, filed as an exhibit to the Company’s current report on Form 8-K filed with the SEC on February 10, 2000.

3.7*

 

Articles Supplementary, dated January 18, 2002, relating to the 9.10% Series B Cumulative Redeemable Preferred Stock, filed as an exhibit to the Company’s Form 8-A for registration of certain classes of securities filed with the SEC on January 18, 2002.

3.8*

 

Articles Supplementary, dated June 22, 2004, relating to the 8.375% Series C Cumulative Redeemable Preferred Stock, filed as an exhibit to the Company’s Form 8-A for registration of certain classes of securities filed with the SEC on June 28, 2004.

3.9*

 

Articles Supplementary, dated March 25, 2008, relating to the 7.00% Series D Cumulative Convertible Preferred Stock, filed as an exhibit to the Company’s current report on Form 8-K filed with the SEC on March 25, 2008.

3.10*

 

Articles Supplementary, dated March 12, 2012, relating to the 6.45% Series E Cumulative Redeemable Preferred Stock, filed as an exhibit to the Company’s current report on Form 8-K filed with the SEC on March 14, 2012.

4.1*

 

Specimen certificate representing shares of common stock, filed as an exhibit to the Company’s quarterly report on Form 10-Q filed with the SEC on May 5, 2011.

4.2*

 

Specimen certificate representing shares of 7.00% Series D Cumulative Convertible Preferred Stock, filed as an exhibit to the Company’s current report on Form 8-K filed with the SEC on March 25, 2008.

4.3*

 

Indenture, dated as of April 27, 2009, among the Company, as Issuer, Alexandria Real Estate Equities, L.P., as Guarantor, and Wilmington Trust Company, as Trustee, filed as an exhibit to the Company’s quarterly report on Form 10-Q filed with the SEC on August 10, 2009.

4.4*

 

Indenture, dated as of February 29, 2012, among the Company, as Issuer, Alexandria Real Estate Equities, L.P., as Guarantor, and the Bank of New York Mellon Trust Company, N.A., as Trustee, filed as an exhibit to the Company’s current report on Form 8-K filed with the SEC on February 29, 2012.

4.5*

 

Supplemental Indenture No. 1, dated as of February 29, 2012, among the Company, as Issuer, Alexandria Real Estate Equities, L.P., as Guarantor, and the Bank of New York Mellon Trust Company, N.A., as Trustee, filed as an exhibit to the Company’s current report on Form 8-K filed with the SEC on February 29, 2012.

4.6*

 

Form of 4.60% Senior Note due 2022 (included in Exhibit 4.5 above).

4.7*

 

Specimen certificate representing shares of 6.45% Series E Cumulative Redeemable Preferred Stock, filed as an exhibit to the Company’s Form 8-A for registration of certain classes of securities filed with the SEC on March 12, 2012.

11.1

 

Statement of Computation of Per Share Earnings (included in Note 8 to the Condensed Consolidated Financial Statements).

12.1

 

Computation of Consolidated Ratios of Earnings to Fixed Charges and Combined Fixed Charges and Preferred Stock Dividends.

31.1

 

Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2

 

Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.0

 

Certification of Chief Executive Officer and Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101

 

The following materials from the Company’s quarterly report on Form 10-Q for the three months ended March 31, 2013, formatted in XBRL (eXtensible Business Reporting Language): (i) Condensed Consolidated Balance Sheets as of March 31, 2013, and December 31, 2012 (unaudited), (ii) Condensed Consolidated Statements of Income for the three months ended March 31, 2013 and 2012 (unaudited), (iii) Condensed Consolidated Statements of Comprehensive Income for the three months ended March 31, 2013 and 2012 (unaudited), (iv) Condensed Consolidated Statement of Changes in Stockholders’ Equity and Noncontrolling Interests for the three months ended March 31, 2013 (unaudited), (v) Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2013 and 2012 (unaudited), and (vi) Notes to Condensed Consolidated Financial Statements (unaudited).

 


(*)         Incorporated by reference.

 

81



Table of Contents

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, on May 3, 2013.

 

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

 

 

 

 

 

/s/ Joel S. Marcus

 

Joel S. Marcus

Chairman/Chief Executive Officer

(Principal Executive Officer)

 

 

 

 

 

/s/ Dean A. Shigenaga

 

Dean A. Shigenaga

Chief Financial Officer

(Principal Financial Officer)

 

82